JohnCFierce	726145358091436032	2016-04-29T20:25:19	Passing the young blond on horseback on Nevsky made me think that leaving Russia tomorrow will be like leaving a Bunuel film at intermission
JohnCFierce	726144787250839552	2016-04-29T20:23:03	It's reflective of the emotions involved. A rumble of emotions. 
JohnCFierce	726070740190154752	2016-04-29T15:28:48	First the WaPo opinion page endorses eteplirsen; now it's the WSJ op/ed page.Interesting major league pressure/$SRPT 
JohnCFierce	726033123599876096	2016-04-29T12:59:20	Have to love the Hermitage. Oh, here's a big room full of Rubens. Here's the Van Dyke wing, and so on and on and on.....
JohnCFierce	726031611360370688	2016-04-29T12:53:19	Translation: Please substantially increase offer. Think of Stemcentrx. We have a product. And cc AZN on reply. 
JohnCFierce	725802366469992448	2016-04-28T21:42:23	JohnCFierce perhaps we should set up a spoof biotech site modelled after the Onion. I propose "the Bunion".
JohnCFierce	725716019675811842	2016-04-28T15:59:16	RT emilywfierce: Abbott changes its tune, snatches up St. Jude in $25M deal: … ABT STJ
JohnCFierce	725697644375511040	2016-04-28T14:46:15	This piece on “The Problem with patient Power” is very relevant:  ForbesHealth 
JohnCFierce	725697671953014784	2016-04-28T14:46:22	mmm-hmmm 
JohnCFierce	725696998502965248	2016-04-28T14:43:41	To the community, this is about winning or losing. Logic got punted some time ago. 
JohnCFierce	725696163186401282	2016-04-28T14:40:22	John_LaMattina If OK'd, it's because the FDA buckles to advocates,how do you think the same groups would handle insurers who refuse to pay?
JohnCFierce	725694937111625728	2016-04-28T14:35:30	Heard on the Street won't let you down today. Here's helenwsj on Sanofi/Medivation 
JohnCFierce	725692205785071616	2016-04-28T14:24:39	To be clear: Im arguing FDA shud not approve etep - not that they will not. While I think its 80:20 against, thats still 20% for SRPT
JohnCFierce	725692057503846400	2016-04-28T14:24:03	Interesting thing about Addyi, the FDA team backed the drug. With eteplirsen, the insiders hated eteplirsen data 
JohnCFierce	725689602095341569	2016-04-28T14:14:18	It's the dialogue about DMD, of course, that I treasure most. 
JohnCFierce	725688670246817794	2016-04-28T14:10:36	It's not a bad thing, Adam. Some of my favorite stories are filled with chatter :) 
JohnCFierce	725688236887183361	2016-04-28T14:08:52	SRPT up 16% on chatter that the FDA will approve eteplirsen regardless of, well, everything. Maybe so. It's DMD, anything is possible
JohnCFierce	725662715918860288	2016-04-28T12:27:28	It will be fun to see David Hung go out and start a new company after Medivation gets acquired. He was fun to track in the early R&amp;D days.
JohnCFierce	725661182842028032	2016-04-28T12:21:22	It's biotech a go-go day. Blockbuster buyout, big pay package, weird little marginal drugs. So 2015!
JohnCFierce	725659140949987328	2016-04-28T12:13:15	AbbVie bags a unicorn with $9.8B buyout deal for Stemcentrx ABBV 
JohnCFierce	725650979987853312	2016-04-28T11:40:50	So ABBV is paying a bubble price for Stemcentrx? What does it know?
JohnCFierce	725648312829906944	2016-04-28T11:30:14	I swear, I've been laughing for the last 3 minutes. Biotech reporting as if done for The Onion. AVXL
JohnCFierce	725647930800111616	2016-04-28T11:28:43	Somehow, I unfortunately missed this exquisitely ridiculous story on Anavex. AVXL 
JohnCFierce	725644818806890497	2016-04-28T11:16:21	What’s a billionaire biotech CEO worth? Soon-Shiong’s price is $148M NK 
JohnCFierce	725634662408839169	2016-04-28T10:35:59	JohnCFierce Usual paclitaxel dosing vehicle is pretty horrendous, so there's room for something better. Don't know if this is it, though.
JohnCFierce	725631543927013376	2016-04-28T10:23:36	George Clooney teams up with Flagship Ventures NoubarAf   The Boston Globe 
JohnCFierce	725632022518091776	2016-04-28T10:25:30	Every time I hear this Oasmia story, the weirder the whole thing sounds. Revised paclitaxel? OASM 
JohnCFierce	725619396958380033	2016-04-28T09:35:20	Love this Russian schedule. Sleep in, and still posting pre-dawn stories for the U.S.
JohnCFierce	725617299454070784	2016-04-28T09:27:00	Top story Wednesday: Biogen recruits Pfizer neuroscience star Michael Ehlers as new R&amp;D chief BIIB 
JohnCFierce	725615107179425792	2016-04-28T09:18:17	CRISPR/Cas9 pioneer Intellia outlines its plans for $140M IPO NTLA 
JohnCFierce	725597749534711808	2016-04-28T08:09:19	JohnCFierce That feels exactly how this one will go.
JohnCFierce	725593132822351872	2016-04-28T07:50:58	I want to point out this is best explanation for vrx 
JohnCFierce	725592208552910848	2016-04-28T07:47:18	Game on -- $9.4B bid for MDVN from SNY. And this one ends with a buyout, but not necessarily by SNY.  
JohnCFierce	725538548603039744	2016-04-28T04:14:04	Great dinner with Alex Zhavoronkov - biogerontology - suzannewriter and friends last night. Looking for aging R&amp;D to explode, in good way
JohnCFierce	725436998194987009	2016-04-27T21:30:32	Na Zdorovie!
JohnCFierce	725332008465895424	2016-04-27T14:33:21	ACAD PDUFA is this Sunday, May 1st
JohnCFierce	725322760487063552	2016-04-27T13:56:36	Celgene helps push the startup raise at I/O player FLX to $79M CELG 
JohnCFierce	725319849220694016	2016-04-27T13:45:02	Biogen recruits Pfizer neuroscience star Michael Ehlers as new R&amp;D chief BIIB 
JohnCFierce	725313990906228737	2016-04-27T13:21:45	Pfizer's Michael Ehlers - neuro/pain - joins Biogen as new R&amp;D chief -- BIIB 
JohnCFierce	725312173136842752	2016-04-27T13:14:32	NVS Jimenez: Late to checkpoint inh, but if you think about Novartis in 3-5 yr time period, we’ll be strong in next gen IO. WMIF16
JohnCFierce	725312363382071296	2016-04-27T13:15:17	"We're thinking about this as a very long horizon... a 10 to 15, maybe even 20 yr play" - says NVS CEO on I/O
JohnCFierce	725258957930008580	2016-04-27T09:43:04	JohnCFierce delivered a stellar talk on trends in biotech at ivaoconf the future is bright insilicoveritas! 
JohnCFierce	725196043135098880	2016-04-27T05:33:04	Actually, that's quite good, considering. If you look at standout deals, flexus and so on, big $$ still in play. 
JohnCFierce	725194590244982784	2016-04-27T05:27:18	Of course, as long as Congress focuses on individuals, it won't have to deal with the systemic issues. Bad players so much more convenient
JohnCFierce	725194313001504768	2016-04-27T05:26:12	I'll bet he does... 
JohnCFierce	725177805097566209	2016-04-27T04:20:36	Sun is up in Mother Russia. 4 hours of sleep. Let's do this.
JohnCFierce	725177513253675008	2016-04-27T04:19:26	During my panel biotrinity, I noted that it didn't seem that I/O valuations had come down. Heads nodded in unison.
JohnCFierce	725040329246793728	2016-04-26T19:14:19	Indeed, instantly clear the moment the questions hit. Which is why I was so befuddled by the soaring stock $$ SRPT 
JohnCFierce	725039599727304708	2016-04-26T19:11:25	well, Riga airport. That's one off the old bucket list.
JohnCFierce	724979474555609088	2016-04-26T15:12:30	cool 
JohnCFierce	724974365826252800	2016-04-26T14:52:12	glad to see you got by satan, with room to spare. #666 
JohnCFierce	724966703315177472	2016-04-26T14:21:45	My SRPT live blog set a viewership record at TheStreet, topping even Apple/Tesla live blogs, so thx all for helping make that happen.
JohnCFierce	724961851138781184	2016-04-26T14:02:29	Source code -- essential reading for all start-ups to be.  
JohnCFierce	724949577305083905	2016-04-26T13:13:42	JohnCFierce LEMS patients will only be able to get the cheaper un-marketed version of firdapse now....just like the last 30 yrs
JohnCFierce	724943525717135360	2016-04-26T12:49:39	My crystal ball tells me that Catalyst will have to run another study of firdapse -- it's getting clearer... 
JohnCFierce	724942699254693889	2016-04-26T12:46:22	In setback, a majority of FDA experts reject Sarepta’s emotional campaign to gain Duchenne drug OK SRPT -47% 
JohnCFierce	724938667232497665	2016-04-26T12:30:21	GSK doubles down on Zymeworks’ platform technologies with $908M deal 
JohnCFierce	724888917498060802	2016-04-26T09:12:40	But lesinurad PhIII data was oddly revealed in bits and pieces, holding back the messy bits. AZN
JohnCFierce	724887571143204865	2016-04-26T09:07:19	At one point lesinurad was listed as a top PhIII drug at AZN. Now sold off for milestones to Ironwood.  
JohnCFierce	724872113832730624	2016-04-26T08:05:54	Now on to my immuno-oncology panel biotrinity '16 -- (rather miss the old race track)
JohnCFierce	724869978013446144	2016-04-26T07:57:24	JohnCFierce Sorry I had to give it a miss, but a little girl demanded my attention.
JohnCFierce	724853103187644416	2016-04-26T06:50:21	ICYMI: In setback, a majority of FDA experts reject Sarepta’s emotional campaign to gain Duchenne drug OK SRPT 
JohnCFierce	724852390705397760	2016-04-26T06:47:31	Great seeing kristen_hallam yesterday. Hopefully next time ByJonGardner will be able to join us. And thanks for a great lunch NoomanHaque
JohnCFierce	724846110284636160	2016-04-26T06:22:34	GlaxoSmithKline doubles down on Zymeworks’ platform technologies with $908M development deal GSK 
JohnCFierce	724837855680405504	2016-04-26T05:49:46	Evotec &amp; exScientia announce partnership to discover bispecific small molecule immuno-oncology therapeutics; 
JohnCFierce	724832982482194432	2016-04-26T05:30:24	Someone please follow Jessica now so she can remove the mark of Satan and go to sleep! :) 
JohnCFierce	724826805262274561	2016-04-26T05:05:51	Sandy Weill donating $185 million to UCSF for neuroscience research. 
JohnCFierce	724745114766159872	2016-04-25T23:41:15	Look for the SRPT roller coaster to plunge downward  -- 
JohnCFierce	724742707516706816	2016-04-25T23:31:41	It's a saying. I'm not referring to any one person. I'm not Trump 
JohnCFierce	724742343002324992	2016-04-25T23:30:14	They will probably make them wait for pivotal data, but the fat lady at the FDA hasn't sung yet.  
JohnCFierce	724741183562498049	2016-04-25T23:25:37	7 no on substantial evidence of efficacy
JohnCFierce	724735249700257792	2016-04-25T23:02:03	Have only really heard one panelist vote so far that would favor SRPT w/a clear justification
JohnCFierce	724735107018448897	2016-04-25T23:01:29	The patient advocate on this panel is incoherent.
JohnCFierce	724730644207656960	2016-04-25T22:43:45	ZacharyBrennan Again, 4 of the yes votes were consumer/patient reps
JohnCFierce	724730795978567680	2016-04-25T22:44:21	7 definite nos, no objective, bias free ability to compare drug, control. 5 yes, 1 abstention
JohnCFierce	724726647149203456	2016-04-25T22:27:52	In setback, a majority of FDA experts reject Sarepta’s emotional campaign to gain Duchenne drug OK SRPT 
JohnCFierce	724724123491000320	2016-04-25T22:17:50	JohnCFierce tough but integrity of science needs 'no's. sympathy w patients but more chance of b/through now than w approving poor drugs
JohnCFierce	724722971865178112	2016-04-25T22:13:15	Not over yet, though 
JohnCFierce	724721410426449924	2016-04-25T22:07:03	3 of 5 Yes votes were patient advocates/patient representatives
JohnCFierce	724721313126993924	2016-04-25T22:06:40	Eteplirsen goes down. Sorry SRPT believers
JohnCFierce	724721146487250944	2016-04-25T22:06:00	there it is 8 no on likely clinical benefit, 5 yes
JohnCFierce	724701196078948352	2016-04-25T20:46:44	Duchenne parent says our kids are not your (FDA's) science experiment. But they are. That's what a clinical trial is. Emotion vs data. SRPT
JohnCFierce	724690877952614400	2016-04-25T20:05:44	PETX - global collaboration with Elanco ($LLY). $45 million upfront.
JohnCFierce	724630130535047169	2016-04-25T16:04:20	Pathophilia He's struggling. Not nearly as coherent as SRPT 
JohnCFierce	724629825328189440	2016-04-25T16:03:07	"reason to be concerned this was not an appropriate control to pick"
JohnCFierce	724629492577251328	2016-04-25T16:01:48	FDA is saying the trial was a mess. SRPT
JohnCFierce	724622707967569920	2016-04-25T15:34:51	FDA starts unrolling problems with SRPT data; dystrophin production
JohnCFierce	724614136760553472	2016-04-25T15:00:47	Janet Woodcock takes the podium (!)
JohnCFierce	724608239330045952	2016-04-25T14:37:21	JohnCFierce I'm not using paid feed, using FDA stream, no complaints.
JohnCFierce	724608004436430848	2016-04-25T14:36:25	This paid streaming is a hell of a lot better than the FDA stream. Something for the agency to aspire to.
JohnCFierce	724604635055558656	2016-04-25T14:23:02	extended whooping and hollering. SRPT
JohnCFierce	724601015350251521	2016-04-25T14:08:39	forget the data, let's get the moms up front. SRPT
JohnCFierce	724600110789869569	2016-04-25T14:05:03	There's that 'unequivocal' word again from SRPT's Edward Kaye  eteplirsen
JohnCFierce	724600163705196545	2016-04-25T14:05:16	First ad com I've seen where there's applause from the audience SRPT
JohnCFierce	724600041139220487	2016-04-25T14:04:46	Jerry Mendell whips up some cheers. SRPT "I can't see any grounds for denying this drug for DMD boys."
JohnCFierce	724589636274802688	2016-04-25T13:23:26	Expect complete disconnect between SRPT and FDA today. Like they're looking at 2 different sets of data. --dmd
JohnCFierce	724525316178325504	2016-04-25T09:07:51	RNAiAnalyst It's the massive disconnect they've been feeding all along. Create your own narrative, cry unfair when opposed.
JohnCFierce	724525024187699204	2016-04-25T09:06:41	RNAiAnalyst I have to say, though, that I'm surprised so much of the MSM has gone along with the emotional tide.
JohnCFierce	724524613095571456	2016-04-25T09:05:03	RNAiAnalyst Of course, at this stage you could prove the drug causes cancer, and it wouldn't sway the advocates at all.
JohnCFierce	724524361265352704	2016-04-25T09:04:03	RNAiAnalyst The FDA is clearly upset with the way SRPT embellished things, essentially saying they rigged data. Any other drug/disease...
JohnCFierce	724521621487276032	2016-04-25T08:53:10	rajalonghorn After Addyi was OK'd on a weak case, the FDA guys responsible published a defense. Hard to see that happening with SRPT.
JohnCFierce	724520895902023681	2016-04-25T08:50:17	You bet.  
JohnCFierce	724520152876912640	2016-04-25T08:47:20	rajalonghorn Maybe there should be a new option. The "punt approval." We don't know if it works, may be safe, so what the heck...$SRPT
JohnCFierce	724516456508055552	2016-04-25T08:32:38	Today we'll find out if lobbying pressure alone can sway an FDA expert panel. I'd say there's a pretty decent chance of that. SRPT
JohnCFierce	724249160451522560	2016-04-24T14:50:30	Clinic today and we have kanafeh in our honor. Cheese + noodles + sweet syrup + almonds + "spices" + ❤️ 
JohnCFierce	724234282621771776	2016-04-24T13:51:23	10 Podcasts for the Biotech, Health &amp; Science Crowd via forbes 
JohnCFierce	724228847227535361	2016-04-24T13:29:47	I must have missed out on that whole Prince thing when I was living in Ireland. The response to his death is Elvis big.
JohnCFierce	724223343155617792	2016-04-24T13:07:55	Blown away by the art gallery at Wellngton's Apsley House. Velazquez, Rubens -- much of it war loot turned trophies.
JohnCFierce	723622024623566848	2016-04-22T21:18:29	Another story about Google's Verily with almost no information about Google's Verily. 
JohnCFierce	723611944167575556	2016-04-22T20:38:26	JohnCFierce Looking forward to your immunooncology panel next week at biotrinity2016 AND delighted to see growth in Fierce EU reporting
JohnCFierce	723598484331483136	2016-04-22T19:44:57	Today is a day of magical thinking in biotech. 
JohnCFierce	723595758545604613	2016-04-22T19:34:07	Sarepta soars after FDA questions revive advocates’ hope for Duchenne drug SRPT bizarre 
JohnCFierce	723579583031816196	2016-04-22T18:29:50	Simeonidis: Bull case is any ? from the FDA puts pressure on panel to vote yes. But the language still reinforces likelihood of no. SRPT
JohnCFierce	723567827635044353	2016-04-22T17:43:08	Leerink's Jos. Schwartz says ? 7 implies possible pos. vote (I don't see it). He remains skeptical, for lotso reasons.So do I. SRPT
JohnCFierce	723557749880180736	2016-04-22T17:03:05	It's more clear than ever that lobbying is the only hope that SRPT has left.
JohnCFierce	723555849101291520	2016-04-22T16:55:32	We've rejected your defense, think you gilded the lilly with your data and want to persuade advisers to vote no. +? 
JohnCFierce	723552461856890880	2016-04-22T16:42:04	So you're saying there's a chance? %SRPT 
JohnCFierce	723551838298079232	2016-04-22T16:39:35	So the FDA couches q.s for SRPT designed for a no vote, and its shares skyrocket. Anyone care to offer some explanation? I don't get it.
JohnCFierce	723550398196260865	2016-04-22T16:33:52	FDA has posted the draft questions for Monday's adcomm for Sarepta's eteplirsen SRPT 
JohnCFierce	723548801122881544	2016-04-22T16:27:31	and falling back to earth....$SRPT
JohnCFierce	723548653152030720	2016-04-22T16:26:56	Why is SRPT stock up 32%?
JohnCFierce	723548203451334656	2016-04-22T16:25:09	So on monday the FDA will spend all its time saying the answer to its big question is no. h/t adamfeuerstein
JohnCFierce	723547685882585088	2016-04-22T16:23:05	Has the Applicant provided substantial evidence from adequate and well controlled studies...? Goodbye, SRPT
JohnCFierce	723531724890755072	2016-04-22T15:19:40	Personally, I think (late) JMW Turner was a genius. But Alan Turing would have been better for the £20 note.  
JohnCFierce	723486619458756608	2016-04-22T12:20:26	Recent graduates of the Death Star School of Public Relations. Keeping up a proud tradition. 
JohnCFierce	723485582119297025	2016-04-22T12:16:19	Somebody should just buy VRX, cherry pick some decent products and sell off the rest for parts. It's business model has been destroyed.
JohnCFierce	723463035487162368	2016-04-22T10:46:43	AstraZeneca teams with Venter to mine millions of genomes for R&amp;D insights AZN 
JohnCFierce	723452648742072320	2016-04-22T10:05:27	ICYMI: Allergan’s new $85M buyout adds a cosmetic drug to a growing portfolio AGN 
JohnCFierce	723444471698845698	2016-04-22T09:32:57	AbbVie pens third oncology tie-up this week:  ABBV
JohnCFierce	723399070149038080	2016-04-22T06:32:33	The advocacy case for eteplirsen. Which is interesting. If FDA followed this path, they'd self destruct 
JohnCFierce	723258059338948609	2016-04-21T21:12:13	Allergan’s new $85M buyout adds a cosmetic drug to a growing portfolio AGN 
JohnCFierce	723240988341235713	2016-04-21T20:04:23	CTMX has a lot of great partners. Can add ABBV to this list today.  
JohnCFierce	723238111673638912	2016-04-21T19:52:57	The first comprehensive study on women in venture capital and their impact on female founders  via techcrunch
JohnCFierce	723235533309239296	2016-04-21T19:42:42	New recruits get to work with the leading company in the world in checkpoint inhibition. Not too shabby! BMY 
JohnCFierce	723229977416728576	2016-04-21T19:20:38	drrichjlaw ryanzbrady IttaMac Just referred to Evotec the other day. Second Genome. Many connections 
JohnCFierce	723214738625277953	2016-04-21T18:20:05	plus zafgen, bavarian nordic 
JohnCFierce	723180798011170816	2016-04-21T16:05:12	On the face of it, seeking an accelerated approval on a study with 12 subjects was ALWAYS ridiculous. Don't forget that. SRPT.
JohnCFierce	723179623664611328	2016-04-21T16:00:32	Also, more patients are harmed by regulatory mirages than regulatory walls. SRPT 
JohnCFierce	723179505997746176	2016-04-21T16:00:04	So Amazon won't let me buy any shows in London, but I can jump on a streaming site through private internet access in Romania and have at it
JohnCFierce	723173145784492036	2016-04-21T15:34:48	Bfly is a smart idea....business
JohnCFierce	723168032382586881	2016-04-21T15:14:29	FDA Reviewers Still Skeptical on SRPT DMD Drug, Slow Sales for PCSK9s Amid Pricing Debate - 
JohnCFierce	723155289898377216	2016-04-21T14:23:51	icymi: With Sarepta’s fate uncertain, BioMarin CEO Bienaimé weighs the future of Duchenne drug SRPT BMRN 
JohnCFierce	723138663778013184	2016-04-21T13:17:47	The FDA didn't come out and accuse Sarepta of trying to stack the deck, but they came real close. SRPT
JohnCFierce	723137472692137984	2016-04-21T13:13:03	FDA bats back Sarepta’s counterattack as a final showdown looms over Duchenne drug SRPT -41% 
JohnCFierce	723123924398170112	2016-04-21T12:19:13	blow by blow, Sarepta really fought back against the January review, the FDA looks more even handed, but isn't rolling over
JohnCFierce	723119951146561536	2016-04-21T12:03:25	shooting down evidence of dystrophin distribution -- not good for SRPT
JohnCFierce	723114526632214528	2016-04-21T11:41:52	ICYMI: Novartis’ ‘breakthrough’ muscle drug bimagrumab flunks a late-stage trial NVS 
JohnCFierce	723094621769715712	2016-04-21T10:22:46	tricky business. 
JohnCFierce	723093405262184448	2016-04-21T10:17:56	GSK can't get past its big PhIII failures: Drisapersen, darapladib, MAGE-A3. So new CEO will be a dealmaker. 
JohnCFierce	723070319561457664	2016-04-21T08:46:12	JohnCFierce welcome to London John, in time for the Spring sunshine
JohnCFierce	723057799744229376	2016-04-21T07:56:27	I was just reviewing the FDA review on eteplirsen from last January. Just damning. I don't see how they turn that around. SRPT
JohnCFierce	722908539312689157	2016-04-20T22:03:21	Here's the Semler Untitled Letter issued today  trail2dataintegrity JohnCFierce
JohnCFierce	723048898583998464	2016-04-21T07:21:05	it's a disaster zone. 
JohnCFierce	723047859470393344	2016-04-21T07:16:57	Novartis’ ‘breakthrough’ muscle drug bimagrumab flunks a late-stage trial NVS 
JohnCFierce	723031367139885056	2016-04-21T06:11:25	London Heathrow. All aboard the express.
JohnCFierce	722891479144730625	2016-04-20T20:55:33	With Sarepta’s fate uncertain, BioMarin CEO Bienaimé weighs the future of their Duchenne drug SRPT BMRN 
JohnCFierce	722805428804042752	2016-04-20T15:13:37	adamfeuerstein I do fear that continued price rises by bioPharma will bring public wrath down on the system that is bringing so much good
JohnCFierce	722791908116938752	2016-04-20T14:19:54	So ... are we expecting a new set of briefing docs for SRPT? askingforafriend
JohnCFierce	722791987158597632	2016-04-20T14:20:13	Monday’s SRPT FDA panel scheduled for 8 am to 6:30 pm EDT. 10.5 hours!   And I will live blog the entire panel. &lt;gulp&gt; Please join me.
JohnCFierce	722787856117313536	2016-04-20T14:03:48	Fear and greed make uneasy companions 
JohnCFierce	722787527690739716	2016-04-20T14:02:30	As a participant in this game of web traffic, I have to admire how easy it is to google up a nytimes story.
JohnCFierce	722784483808661504	2016-04-20T13:50:24	johncfierce Tiny indication so the economic value of the CALD program is only worth $2-$3 total of $BLUE’s stock price to begin with.
JohnCFierce	722783329452486656	2016-04-20T13:45:49	BLUE goes red -- market shrugs. Are we getting jaded or do these 'snapshots' mean less and less?
JohnCFierce	722782878917136385	2016-04-20T13:44:01	Weaknesses and possibilities -- big gamble. 
JohnCFierce	722764566795522050	2016-04-20T12:31:15	CETP inhibitions rides again, weirdly, with a new genetic rationale. Crazy or not? 
JohnCFierce	722753843096875008	2016-04-20T11:48:38	New cms is giving me link headaches -- Roche, Pfizer lead $42M round for Second Genome’s PoC play in the micro biome 
JohnCFierce	722749413060448256	2016-04-20T11:31:02	Roche, Pfizer lead $42M round for Second Genome’s PoC play in the microbiome ’s-poc-play-microbiome
JohnCFierce	722746846553235456	2016-04-20T11:20:50	FierceBiotech JohnCFierce great article- Dr. Rosenberg is a living legend and can figure this out no doubt!
JohnCFierce	722737081672409088	2016-04-20T10:42:02	Unless, of course, some labs get contaminated.... 
JohnCFierce	722736097999118337	2016-04-20T10:38:08	Let me try that again: NIH clamps down on two labs, interrupting trial work by Kite’s star scientist KITE 
JohnCFierce	722732983216680960	2016-04-20T10:25:45	and the endpoints look...odd 
JohnCFierce	722708607989608448	2016-04-20T08:48:54	Nestlé Health Science leads $16.5M Enterome round, biotech set for IBD human trials this year: 
JohnCFierce	722464784814317568	2016-04-19T16:40:02	JohnCFierce Tomorrow's blog post is set, then - thanks!
JohnCFierce	722426238351093760	2016-04-19T14:06:51	Yes! CETP is all but completely discredited at this point -- yet here we go on a $250M study. Damned interesting. 
JohnCFierce	722420459141136386	2016-04-19T13:43:54	Also curious to hear Dereklowe 's reaction to CETP news -- 
JohnCFierce	722417932568031236	2016-04-19T13:33:51	What a toddler and her tumor can teach us about cancer research.  
JohnCFierce	722414435009110016	2016-04-19T13:19:57	Biotech upstart gambles $150M believing it can succeed after Big Pharmas failed on CETP (CETP!) Paging cardiobrief 
JohnCFierce	722384166575325184	2016-04-19T11:19:41	Will a riot-sized audience of patient advocates persuade an FDA panel to back eteplirsen? Well, we shall see. 
JohnCFierce	722195130497830912	2016-04-18T22:48:31	CGrantWSJ I was thinking reflex action, like running fast after you've been shot in the belly.
JohnCFierce	722191680858886144	2016-04-18T22:34:49	2 biotech IPOs filed today. PhaseRx 30M PZRX (PreClinical) and Gemphire Therapeutics 60M GEMP (Cardiovascular) HT IPOtweet
JohnCFierce	722186078623391745	2016-04-18T22:12:33	Cardiovascular biotech Gemphire Therapeutics files for a $60 million IPO GEMP IPO IPO 
JohnCFierce	722168014452469760	2016-04-18T21:00:46	ICYMI: North Carolina’s controversial transgender House Bill 2 irks CROs:  Q
JohnCFierce	722158465435705344	2016-04-18T20:22:49	My 87-year-old mother: Who's your friend Ted? 
JohnCFierce	722155402926940160	2016-04-18T20:10:39	Congrats to colleagues/Pulitzer finalists jonathanrockoff JeanneWhalen Loftus joewalkerWSJ + stefaniei (ed.) 4 great drug price series
JohnCFierce	722121590989832192	2016-04-18T17:56:18	Earlier on I posted several heme trials @ Stanford suspended, including 1 w/ Revlimid. CPXX. Bot several k shares 
JohnCFierce	722120898581401600	2016-04-18T17:53:33	adamfeuerstein Is that Stanford?
JohnCFierce	722114076428615682	2016-04-18T17:26:26	FitBit will have great medical products -- once they get their stuff to work accurately. Right now it's 80% crap. 
JohnCFierce	722078563751632899	2016-04-18T15:05:19	OrGenix Don't know for sure, but I'd say it probably wasn't distinct/good enough for a hyper competitive field. muerto
JohnCFierce	722053866317950976	2016-04-18T13:27:11	ICYMI: A PhIII flop, spurned by FDA, but NICE OKs PTC’s Duchenne drug:  PTCT via JohnCFierce
JohnCFierce	722057402653241345	2016-04-18T13:41:14	Eli Lilly spurns a PhIII-ready diabetes drug, and Transition tanks (again) LLY TTHI 
JohnCFierce	722051453162885122	2016-04-18T13:17:36	NimbusTx honored to be nominated for the Buzz of BIO award this year!  Would love if my fellow tweeps would vote: 
JohnCFierce	722043746561482753	2016-04-18T12:46:58	Loxo plays PhI cards in a lightning round of the new cancer R&amp;D game LOXO 
JohnCFierce	722018829593776128	2016-04-18T11:07:58	matthewherper Yes, they have a snapshot of activity in a handful of cases. Pretty good for an ongoing Phase I. Long way from pivotal.
JohnCFierce	721836994452713472	2016-04-17T23:05:25	LOXO looks like an overreach to me. 6 responses are fine, but much remains to be proven -- 
JohnCFierce	721782956436623362	2016-04-17T19:30:41	Add AZN to list of Medivation suitors --£7bn MDVN SNY 
JohnCFierce	721158755484831744	2016-04-16T02:10:20	So who paid Hillary Clinton the most for a speech? More than any big bank? BIO $335,000. BIO, you were rooked. 
JohnCFierce	721112124903264257	2016-04-15T23:05:02	Chiasma gets a CRL. Can't say I know much about this drug or this co. CHMA 
JohnCFierce	721050785614794753	2016-04-15T19:01:18	JohnCFierce as a daily reader, I really like it
JohnCFierce	721020969813417984	2016-04-15T17:02:49	A flop in PhIII, spurned by the FDA, but NICE recommends PTC’s Duchenne drug PTCT ’s-duchenne-drug
JohnCFierce	721009913162502144	2016-04-15T16:18:53	JohnCFierce To be fair though, calling the Daily Fascist "press" is stretching the point a little
JohnCFierce	721009686766579714	2016-04-15T16:17:59	Whatever else, PTCT case proves that regulators look at Duchenne's differently. Some reason to encourage the Sarepta enthusiasts. SRPT
JohnCFierce	721009045478449152	2016-04-15T16:15:26	With some dozens of new patients and a bad drug, PTCT up 50%.
JohnCFierce	721008011347697664	2016-04-15T16:11:20	Getting lots of feedback on the new daily report format. Happy to field more john@fiercemarkets.com. I don't control any of this.
JohnCFierce	721007211124621314	2016-04-15T16:08:09	MartinEglitis different, universal VC data for the country, vs a siloed look at biotech. Not the same thing.
JohnCFierce	721006176096358400	2016-04-15T16:04:02	According to european regulators they were going to reconsider the whole accelerated OK issue...at some point. 
JohnCFierce	720996227257667584	2016-04-15T15:24:30	And the UK press is full of smiles and giggles - not even a mention of the RTF.  
JohnCFierce	720995177863716864	2016-04-15T15:20:20	NICE recommends PTCT's Ataluren for Duchenne's. With no evidence at all that it helps patients. 
JohnCFierce	720984016766296064	2016-04-15T14:35:59	There's a red carpet for cancer? Really? 
JohnCFierce	720954479659651072	2016-04-15T12:38:37	Topsy turvy week for biotech IPOs: Bavarian Nordic, GenSight crash out but GenNeuro manages a low but successful $37M IPO. Meanwhile, VC $$$
JohnCFierce	720953381833969665	2016-04-15T12:34:15	JohnCFierce 3nt once AZN leapfrogged into ph 2 the race was largely over although too many people put their hands on their ears la-la-la
JohnCFierce	720951554321358851	2016-04-15T12:26:59	GILD 3DAA data for prior failed from yesterday.12 wk w/o RBV 99% across GT1-6 ABBV MRK ENTA 
JohnCFierce	720951789252657152	2016-04-15T12:27:55	ICYMI: Bristol-Myers expands I/O hub, may hire up to 150 more for discovery team BMY 
JohnCFierce	720949123676037120	2016-04-15T12:17:20	Any musings from the biotech VC crowd on Q1 numbers, trends?  
JohnCFierce	720947581409435648	2016-04-15T12:11:12	AZN easily won that race, then CLVS imploded at the finish line. Have to credit AZN's speed. Interesting piece.  
JohnCFierce	720942745787973632	2016-04-15T11:51:59	Q1 '16: Venture cash is still pouring into U.S. biotechs 
JohnCFierce	720936489337667584	2016-04-15T11:27:08	Forbion closes €183M fund, targets CNS. 'It is within the reach of a VC-backed budget to get meaningful endpoints' 
JohnCFierce	720708700399280129	2016-04-14T20:21:58	Illumina Invests $100M In New Venture Fund 
JohnCFierce	720708826236874752	2016-04-14T20:22:28	Bad timing. 
JohnCFierce	720685156575653889	2016-04-14T18:48:25	PharmaceuticBen JohnCFierce Time horizons differ. Long term innovation v. different from short term, as you know
JohnCFierce	720680745916887040	2016-04-14T18:30:54	JohnCFierce would be great to assess the effectiveness of this compared to Parker's $250M grant. Im guessing BMY would win out
JohnCFierce	720679775145172993	2016-04-14T18:27:02	Bristol-Myers expands I/O hub, may hire up to 150 more for discovery team BMY 
JohnCFierce	720626210376704000	2016-04-14T14:54:11	More than half of 2015 drug launches were for orphan disorders; new (free) Citeline report pharma 
JohnCFierce	720614527130320896	2016-04-14T14:07:46	Buffeted by headwinds, Bavarian Nordic cancels IPO: 
JohnCFierce	720613181081706496	2016-04-14T14:02:25	If no safety issue, then payers must be telling MRK that they won't pay premium for 1X/week vs generic daily dose. 
JohnCFierce	720611723745587201	2016-04-14T13:56:37	Pfizer, NEA help supply Cydan’s second startup with a $31M launch round (more biotechs to come) PFE 
JohnCFierce	720609612957892608	2016-04-14T13:48:14	Muerto: Merck’s big PhIII drive for diabetes drug omarigliptin grinds to a stop MRK 
JohnCFierce	720579674708033536	2016-04-14T11:49:16	I'll pass along the kind offer after I go see if there's any Glenfiddich left. 
JohnCFierce	720578496272154625	2016-04-14T11:44:35	Looks like the new CMS is broken down by the side of the road. Mechanics dispatched to the scene. Posting will be delayed. That is all.
JohnCFierce	720437445393719297	2016-04-14T02:24:06	Yup. Parker held forth at  length on PBS today; apparently immune cells can be induced to attack cancer. Who knew? 
JohnCFierce	720429467487879168	2016-04-14T01:52:24	If you add up all the biotech news that people read or heard today, the average person just got even more stupid. sparker hepC etc
JohnCFierce	720428562122162176	2016-04-14T01:48:48	That guardian story was just a dumb rewrite of this PR. Is Presidio still in business? New hep C combo? Really? 
JohnCFierce	720420071089176577	2016-04-14T01:15:04	GILD sells Sovaldi in Egypt at a 99% discount. But that doesn't stop dumbbiotechreporting using U.S. pricing -- 
JohnCFierce	720413444239966208	2016-04-14T00:48:44	Stick to acting out characters that kill folks and what nots. also STFU 
JohnCFierce	720374633757691905	2016-04-13T22:14:31	Quick segue from Nina Simone to Saliva -- 
JohnCFierce	720373499735330817	2016-04-13T22:10:00	fderubertis Worshipping at the altar of billionaires is how we got Trump.
JohnCFierce	720372976181489664	2016-04-13T22:07:56	Omg, wasted 10' of my time reading this! Hopefully not much focus on this in the future!!!! matthewherper 
JohnCFierce	720371999151824897	2016-04-13T22:04:03	Not too many fields where someone says "I'm gonna spend $250M!" and general response is "Fat lotta good that'll do." 
JohnCFierce	720369492996456448	2016-04-13T21:54:05	Nina Simone -- Feeling Good  
JohnCFierce	720369075013206016	2016-04-13T21:52:25	This is one of those days you have to wind up listening to nina simone. chilling
JohnCFierce	720328327261605892	2016-04-13T19:10:30	JohnCFierce Really like the new design of the website. Great work. Very clean.
JohnCFierce	720323947368198144	2016-04-13T18:53:06	Nice cardiobrief; great demonstration why sharing of trial data so essential. Need possibility of different views. 
JohnCFierce	720321840413954048	2016-04-13T18:44:44	Theranos letter: 
JohnCFierce	720314621878530048	2016-04-13T18:16:03	"They're in a lot of trouble." 
JohnCFierce	720304488658014211	2016-04-13T17:35:47	Industry is pumping billions into IO. And companies will make billions. 
JohnCFierce	720303435183067137	2016-04-13T17:31:36	True. Tho lowering $ barriers (grant cycle rigamarole) &amp; making collabo &amp; start-up spawning easier never bad. 
JohnCFierce	720302015667138560	2016-04-13T17:25:57	You have to praise Sean Parker's generosity, but no one is curing cancer with $250M.
JohnCFierce	720300744256004098	2016-04-13T17:20:54	Shameless promotion alert: if you want to learn what companies are working on immunotherapy, here’s a good start —&gt; 
JohnCFierce	720295957078896640	2016-04-13T17:01:53	othersbringdata JohnCFierce nytimes I loved that dry closing line too!!  Glad someone commented on it!
JohnCFierce	720279716427509764	2016-04-13T15:57:21	This new PwC report also has a super handy chart comparing all the drug value approaches:  
JohnCFierce	720279421316247552	2016-04-13T15:56:10	One Nucleus BIO Breakfast Seminar 
JohnCFierce	720279449535705088	2016-04-13T15:56:17	+1, very efficient use of time. Also, limit outside speakers/patients to 5 
JohnCFierce	720261560300617728	2016-04-13T14:45:12	Altered states: Imperial investigators explore the promise of LSD for depression (David Nutt) 
JohnCFierce	720256897824243712	2016-04-13T14:26:40	I hate people who do nothing but gripe all day long on Twitter. (ohcrapnowI'moneofthem)
JohnCFierce	720246721771479041	2016-04-13T13:46:14	Absolutely nothing.  
JohnCFierce	720246203896766464	2016-04-13T13:44:11	Langer-backed startup Kala Pharma bags $68M round for PhIII drive Preclin to PhIII in 3 years 
JohnCFierce	720215317390168064	2016-04-13T11:41:27	As far as I know, Sean Parker didn't contribute to Napster and Facebook by betting on the well-established, well-funded horses...
JohnCFierce	720218076449529856	2016-04-13T11:52:25	othersbringdata adamfeuerstein A good point. We're in the second wave stage of IO with tons of $$ pumping in.
JohnCFierce	720215011717582848	2016-04-13T11:40:14	Not celebrity, but focused investment guided by innovative scientist leaders could well deliver 
JohnCFierce	720214897817206784	2016-04-13T11:39:47	It's like Big Pharma's nonprofit research. Sounds good, lots of attention, no results. But hey, more $$ for projects 
JohnCFierce	720213902932504576	2016-04-13T11:35:50	Serious question: Does celebrity science mean much in drug development?
JohnCFierce	720211933467684865	2016-04-13T11:28:00	Facebook, Napster pioneer Sean Parker sets up $250M immuno-oncology fund by PharmaceuticBen 
JohnCFierce	719992210385715200	2016-04-12T20:54:54	Scoop from deals team... MDVN SNY 
JohnCFierce	719993370370838528	2016-04-12T20:59:30	cardiobrief I doubt that GILD gives a damn -- or they're really good about hiding it.
JohnCFierce	719991560134336512	2016-04-12T20:52:19	Steve Pearson at ICER, though, is on board.
JohnCFierce	719990886424256513	2016-04-12T20:49:38	I'm getting my drug pricing panel together for BIO. Would have loved to have GILD, but they always seem to be busy elsewhere. Alackandalas
JohnCFierce	719983481435119616	2016-04-12T20:20:13	MDVN - *MEDIVATION SAID TO HAVE REBUFFED TAKEOVER APPROACH FROM SANOFI SNY
JohnCFierce	719979252255313920	2016-04-12T20:03:24	JohnCFierce Liking the revised email format, John. Cheers!
JohnCFierce	719978903612321792	2016-04-12T20:02:01	CLVS ends the day down 5% -- no great surprise that it got shut out at the FDA
JohnCFierce	719976300375617536	2016-04-12T19:51:41	Yep, it's gone from the report.  
JohnCFierce	719961708228423680	2016-04-12T18:53:42	It really requires quite a lot of detail.  
JohnCFierce	719961231231172612	2016-04-12T18:51:48	Got my visa for Russia. Quite a process.
JohnCFierce	719953817463181312	2016-04-12T18:22:20	CLVS opens up down 15% $12.50s...  decent amount of cash, but loads of debt and $250M convert
JohnCFierce	719946812359110657	2016-04-12T17:54:30	Standard "best path forward" comment 
JohnCFierce	719939737793007616	2016-04-12T17:26:23	physicans believe FDA breakthrough desingation singifies drugs have higher level of evidence than law requires. 
JohnCFierce	719939361245163520	2016-04-12T17:24:54	Have to hand it to ODAC. They heard both sides, saw which way the wind was blowing and voted down roci in record time. CLVS
JohnCFierce	719926972260958208	2016-04-12T16:35:40	I've been pessimistic about SRPT, but with nothing else out there and patients revved up, you can't rule it out 
JohnCFierce	719924883812151298	2016-04-12T16:27:22	adamfeuerstein But that took forever. Mahaffy has to be on the chopping block, this week
JohnCFierce	719924693390778369	2016-04-12T16:26:37	No doubts: FDA advisors pile on Clovis’s rociletinib, turn thumbs-down on fast approval CLVS 
JohnCFierce	719921466880471040	2016-04-12T16:13:47	12-1, demanding Ph3 data
JohnCFierce	719920755820097536	2016-04-12T16:10:58	Done talking, let's vote the drug down already
JohnCFierce	719918634970255360	2016-04-12T16:02:32	FDA's attitude on CLVS: No way, no how. Do your PhIII
JohnCFierce	719914420714004480	2016-04-12T15:45:47	I have no idea 
JohnCFierce	719909015128514560	2016-04-12T15:24:19	Really negative commentary at ODAC. Not pretty for CLVS
JohnCFierce	719906811562827779	2016-04-12T15:15:33	Pazdur's critical stance on CLVS won't go unnoticed.
JohnCFierce	719903146106089472	2016-04-12T15:00:59	Panel criticizes CLVS for data gaps. why so hard in the U.S.?
JohnCFierce	719901782361694208	2016-04-12T14:55:34	Pazdur says FDA does not really know what's going on in regards to  how bad the QT is
JohnCFierce	719898554710564864	2016-04-12T14:42:45	Pazdur steps in
JohnCFierce	719888280288944130	2016-04-12T14:01:55	Maybe it's both 
JohnCFierce	719887221915041793	2016-04-12T13:57:43	daviesbj You can troll me any day -- you get a pass
JohnCFierce	719885515995090944	2016-04-12T13:50:56	daviesbj Did you troll me?
JohnCFierce	719884248870690817	2016-04-12T13:45:54	You troll me repeatedly -- you get blocked.
JohnCFierce	719883472966402048	2016-04-12T13:42:49	Told CLVS that PK data does not support the 625 mg dose
JohnCFierce	719883287712370688	2016-04-12T13:42:05	CLVS is getting slammed.
JohnCFierce	719882184904044545	2016-04-12T13:37:42	But it blows roci away. AZN
JohnCFierce	719882119439347713	2016-04-12T13:37:26	There was some question about Tagrisso's role in FDA's response, as it technically can't be considered an "available" drug.
JohnCFierce	719869102756642816	2016-04-12T12:45:43	I should get a Pulitzer for tortured sports metaphors. I make em scream. 
JohnCFierce	719868785927307266	2016-04-12T12:44:27	I wonder what the mood was this a.m. for CLVS team. morituri te salutant
JohnCFierce	719868180194308096	2016-04-12T12:42:03	OK, right off the bat the tone is distinctly negative for CLVS
JohnCFierce	719865920424947713	2016-04-12T12:33:04	FDA Richard Pazdur in the house at CLVS rociletinib ODAC pharma biotech
JohnCFierce	719863875626213376	2016-04-12T12:24:57	How long does it take FDA to act when a biopharma doesn't run required postmarketing study?  ZacharyBrennan 
JohnCFierce	719858347541983232	2016-04-12T12:02:59	JohnCFierce unless the playing field measures risk rather than capital; then the early guys go 90 yards :)
JohnCFierce	719858066754301957	2016-04-12T12:01:52	LifeSciVC: Asset-centric is often a low-cost model for early-stage R&amp;D. Then make a sale and let someone else go 90 yds for the touchdown.
JohnCFierce	719854964676231168	2016-04-12T11:49:32	Speaking of hype and reality, on to CLVS this a.m.
JohnCFierce	719854801270366210	2016-04-12T11:48:53	Absolutely. But I bet u love the revolution. Go big or go home is what works in biotech. U can find PoV in transit 
JohnCFierce	719850970675552256	2016-04-12T11:33:40	OK, guys, and how long from Padlock's launch to approved drug? Best case?  PoC or PoV is different. 
JohnCFierce	719849141564796928	2016-04-12T11:26:24	sciencescanner What's funny about this convo; you make more super high-risk investments than I would dream of. And ur the conservative!
JohnCFierce	719847196347232256	2016-04-12T11:18:40	sciencescanner Tell that to Steve Jobs' ghost, David. The real winners are the pioneers who stick with the revolution.
JohnCFierce	719845451969785856	2016-04-12T11:11:44	sciencescanner I heard Peter Drucker speak on this. Three classic stages of new tech adoption: Hype ($), disillusionment (-$), victory ($).
JohnCFierce	719843627199909889	2016-04-12T11:04:29	That wouldn't be terribly surprising. Actually quite fast, if you think about it.  
JohnCFierce	719842130148073473	2016-04-12T10:58:32	ICYMI: $125M Regeneron deal in hand, CRISPR/Cas9 star Intellia files for IPO REGN 
JohnCFierce	719833265167798272	2016-04-12T10:23:18	We're waiting for just the right occasion. 
JohnCFierce	719833009290153984	2016-04-12T10:22:17	To be fair, I said "new" shots. We've got another 50-100 of these.  
JohnCFierce	719832247856181248	2016-04-12T10:19:16	But wait, Arsalan. We still haven't done "the needle" or "man in white coat" or, um, new shots of "pills" 
JohnCFierce	719684873146011648	2016-04-12T00:33:39	KevinJudice It got off to a very slow start. I'm skeptical, but I like the actors involved.
JohnCFierce	719682189403799552	2016-04-12T00:22:59	Game of Thrones, though. That's a different story. Tyrion must rule as the wise king.
JohnCFierce	719681872612237314	2016-04-12T00:21:44	I'm going to stop with walking dead -- The story is played out and Negan can't revive it. Time to find a quiet island and retire the story.
JohnCFierce	719667708107694080	2016-04-11T23:25:27	And SontheimerLab UMassMedNow is part of it! 
JohnCFierce	719662180937895936	2016-04-11T23:03:29	Great fit and perfect kind of deal for NY-based Regeneron today - always been a genetics and technology-driven biotech
JohnCFierce	719640336604205058	2016-04-11T21:36:41	The Intellia S-1 also includes juicy details about its pact with NVS as well as REGN 
JohnCFierce	719626355776876544	2016-04-11T20:41:07	JohnCFierce The REGN management team are no slouches themselves
JohnCFierce	719631521838211072	2016-04-11T21:01:39	1st day buyers of Editas Medicine did ok.  nasdaq biotech index was unchanged over period. EDIT 
JohnCFierce	719632427090624513	2016-04-11T21:05:15	UPDATED: With a $125M Regeneron deal in hand, CRISPR/Cas9 star Intellia files for an IPO REGN 
JohnCFierce	719629616357470208	2016-04-11T20:54:05	Regeneron commits $125M in quick cash to kickstart a CRISPR/Cas9 deal with Intellia REGN 
JohnCFierce	719619786926342145	2016-04-11T20:15:01	What I love about Intellia is that they know how to partner with the best in the biz.
JohnCFierce	719619611956789248	2016-04-11T20:14:20	$125M in cash for Intellia in this REGN deal. As I said before, Intellia is run by very sharp people 
JohnCFierce	719603810025480192	2016-04-11T19:11:32	I'm also looking forward to tomorrow's adcomm. Will tweet about it using "$CLVS AdComm". Hope to hear from everyone 
JohnCFierce	719603988736425986	2016-04-11T19:12:15	ProfDavidNutt at Imperial College London has been making progress on his LSD research. Serious business. 
JohnCFierce	719602801345740801	2016-04-11T19:07:32	wbouzg CLVS either gets shown the door or they leave it largely crippled for commercial use. But I may be wrong.
JohnCFierce	719597273970159616	2016-04-11T18:45:34	JohnCFierce FierceBiotech banner size in phone version needs to be adjusted to smaller screen :)
JohnCFierce	719596433863753733	2016-04-11T18:42:13	Looking forward to tomorrow. Could be high drama. CLVS
JohnCFierce	719585486738759680	2016-04-11T17:58:43	Pathophilia FierceBiotech JohnCFierce lol
JohnCFierce	719584525748158466	2016-04-11T17:54:54	Thanks. Any feedback at all is helpful now. We're the guinea pigs at fierce.  
JohnCFierce	719579301897748480	2016-04-11T17:34:09	MartinShkreli 
JohnCFierce	719577369934237696	2016-04-11T17:26:28	Roche/AbbVie team score a ‘breakthrough’ FDA OK of leukemia drug venetoclax 
JohnCFierce	719548498144817152	2016-04-11T15:31:45	That feeling you get when a new CMS system is breaking you in and you want to take a Louisville slugger to the chifferobe
JohnCFierce	719541902903746561	2016-04-11T15:05:32	We are so proud to be supporting EuroMed_Awards for 3rd year running. Only a week left to submit your nominations! 
JohnCFierce	719524494184943616	2016-04-11T13:56:22	Celgene pays Juno $50M as it drives deeper into a $1B CAR-T collaboration:  CELG via JohnCFierce
JohnCFierce	719523175399366657	2016-04-11T13:51:07	Celgene pays Juno $50M as it drives deeper into a $1B CAR-T collaboration CELG JUNO 
JohnCFierce	719491696334123008	2016-04-11T11:46:02	Please don’t hate us anymore; KaloBios’s new CEO takes a drug pricing oath, via JohnCFierce 
JohnCFierce	719215180253700096	2016-04-10T17:27:16	JohnCFierce It's a business that's surprisingly easy to get wrong - people think that they know more about biopharma than they actually do.
JohnCFierce	719210556310347777	2016-04-10T17:08:53	It's just that the context is all wrong - tone deaf. And these are smart, experienced writers. 
JohnCFierce	719200081849651200	2016-04-10T16:27:16	JohnCFierce statesdj Nobody invests in biotech if they don't believe  in the big upside.  Too much risk, time &amp; $$. rtnarch Bobmorevc
JohnCFierce	719174325887188992	2016-04-10T14:44:55	Over-optimism is endemic to biopharma -- so, never. 
JohnCFierce	719165975791329281	2016-04-10T14:11:44	Painful to see nytimes whiff so badly on the flibanserin story. Bad drug, a little insider deal by Ackman gone sour. Could have been great.
JohnCFierce	718879726010527745	2016-04-09T19:14:17	matthewherper To blame VRX for the commercial failure of Addyi, as NYT article mostly does, seems unfair. Most drugs that hardly work fail
JohnCFierce	718872675351977984	2016-04-09T18:46:16	.dealbook it's ridiculous to call this one of the most intriguing pharmaceuticals in a generation. Seriously.
JohnCFierce	718868892651618304	2016-04-09T18:31:14	Exactly. They cashed in.  
JohnCFierce	718867049389387777	2016-04-09T18:23:55	AltumResearch And I'm not short or long on any stock.
JohnCFierce	718866880824545280	2016-04-09T18:23:14	AltumResearch No. They hid material info, as any investor who lost $$$ could tell you. Data going forward is irrelevant to that fact
JohnCFierce	718861474500845570	2016-04-09T18:01:45	Yes. And they chose the worst possible path for themselves and their investors.  
JohnCFierce	718810964448161792	2016-04-09T14:41:03	PredatorDiaries The SEC seems to be about 2 years behind the curve on enforcement, even on a Shkreli.
JohnCFierce	718806667756978176	2016-04-09T14:23:59	Usually, that argument would win the day for any marginal cancer drug. OK it, watch it fail. This one is different 
JohnCFierce	718804496885932032	2016-04-09T14:15:21	Oh, yeah. 
JohnCFierce	718778007289217024	2016-04-09T12:30:05	Different levels of dishonesty, but AVEO, ZFGN and CLVS all succumbed to the appeal of hiding material info from investors. caveatemptor
JohnCFierce	718772402830884864	2016-04-09T12:07:49	I said that whatever level of melodrama the show reaches, it has brought the color taupe to an art level. 
JohnCFierce	718609575813865476	2016-04-09T01:20:48	JohnCFierce Please disclose your short positions
JohnCFierce	718571700154183680	2016-04-08T22:50:18	no, it's a bad drug -- CLVS 
JohnCFierce	718556782843535361	2016-04-08T21:51:01	Well, whatever Falcon Crest-level melodrama Season 4 of House of Cards fell to early on, they brought taupe to an art level.
JohnCFierce	718542170551140353	2016-04-08T20:52:57	And who is on Dr. Caligiuri's cabinet? 
JohnCFierce	718536251465416705	2016-04-08T20:29:26	Wondering, is there any office pool on a sudden retreat from CLVS? Jerk the NDA, live to fight another day?
JohnCFierce	718497626631618561	2016-04-08T17:55:57	I bet that meeting will be very closely followed.  
JohnCFierce	718459296564940800	2016-04-08T15:23:39	Turningquartet The Clovis team was great. Great CEO, great CSO. Great story. Of course, it turned out to be BS
JohnCFierce	718452513930760193	2016-04-08T14:56:42	agamemnus_dev you are indeed entitled to your opinion, but as far as I can tell the documents corroborate my story and JohnCFierce's
JohnCFierce	718439132054196225	2016-04-08T14:03:31	Regulatory Recon for 4/8: Top stories from JohnCFierce, bydavidcrow, NatalieGrover, antonioregalado 
JohnCFierce	718451284504887297	2016-04-08T14:51:49	CLOVIS’S ROCILETINIB ‘DRUG IS DEAD,’ STIFEL SAYS CLVS
JohnCFierce	718445853699153920	2016-04-08T14:30:14	CLVS Smart Move is to Drop Damaged Lung Cancer Drug Altogether  Roci approval is actually bad for CLVS.
JohnCFierce	718436641266929665	2016-04-08T13:53:37	CLVS up 1% on that FDA review.
JohnCFierce	718431117519495168	2016-04-08T13:31:40	CLVS is in deep(er) trouble. No way the adcomm says it's better than tagrisso. An OK now would leave it largely unmarketable.  AZN
JohnCFierce	718429159312240641	2016-04-08T13:23:54	after review of BDs, Dhingra looking pretty damn accurate 
JohnCFierce	718423902893031425	2016-04-08T13:03:00	FDA reviewers question efficacy, raise safety issues and cite a challenge on Clovis's rociletinib CLVS 
JohnCFierce	718414415603896320	2016-04-08T12:25:18	All sorts of trouble for CLVS
JohnCFierce	718413635933102080	2016-04-08T12:22:12	The timeline is there for a reason. 11/09/2015 -- FDA objected to CLVS data, noting it included unconfirmed tumor responses.
JohnCFierce	718408748021235713	2016-04-08T12:02:47	rock. thank you autocorrect
JohnCFierce	718408656673497090	2016-04-08T12:02:25	So the FDA wants a comparison of rock with other drugs. That won't work well. Plus a black box. CLVS
JohnCFierce	718200069011275777	2016-04-07T22:13:34	JUNO and Wuxi team up in China.  
JohnCFierce	718196868237434882	2016-04-07T22:00:51	Lilly CEO Lechleiter rides 2013-2015 stock gains to $16.6M in pay, including hefty boost to bonus  via FiercePharma
JohnCFierce	718189606194278400	2016-04-07T21:32:00	After the whole women-in-biotech issue took the top two spots in my top 5 stories, YTD, CLVS has already entered the inner circle.
JohnCFierce	718174336474066949	2016-04-07T20:31:19	Looking forward to tomorrow a.m. CLVS
JohnCFierce	718169568670257152	2016-04-07T20:12:22	JohnCFierce Street is modeling anywhere from $10K-$30K/year.  Big range.
JohnCFierce	718169475263172608	2016-04-07T20:12:00	Historical data, sounds so reasonable until a company starts to massage the numbers 
JohnCFierce	718169226394124288	2016-04-07T20:11:01	I don't -- anyone care to offer a thought on this? 
JohnCFierce	718167837643313153	2016-04-07T20:05:30	interesting ICPT panelist point: Who will sign up for a randomized OCA study when you can just get the drug?
JohnCFierce	718167337015361536	2016-04-07T20:03:30	No drama at all. The consensus was clear early on. ICPT 
JohnCFierce	718164343330848768	2016-04-07T19:51:36	FDA advisory panel supports approval for Intercept's drug OCA for liver disease ICPT 
JohnCFierce	718163605477265408	2016-04-07T19:48:41	Support accelerated approval for OCA? unanimous yes
JohnCFierce	718163140865835009	2016-04-07T19:46:50	Finally...$ICPT
JohnCFierce	718142838291177472	2016-04-07T18:26:09	Support for dose titration 5 mg - 10 mg seems solid. Another positive. ICPT
JohnCFierce	718142021370818560	2016-04-07T18:22:54	Consensus on ALP as a surrogate endpoint for OCA benefit. The rest of the discussion is largely superfluous. ICPT
JohnCFierce	718120592482938881	2016-04-07T16:57:45	adamfeuerstein Any1 interested can follow my tweets. I’ll at least get the vote &amp; try 2 summarize discussion points (by tweet or in report)
JohnCFierce	718119670109380609	2016-04-07T16:54:06	And then look to the confirmatory study for better data? 
JohnCFierce	718114110773280771	2016-04-07T16:32:00	FDA notes ICPT Ocaliva confirmatory trial (747-302) will take 8 years to complete GDAC
JohnCFierce	718111471272648704	2016-04-07T16:21:31	Completely agree. Broad personal and business tax reform should be at the top of any political agenda. noteasy 
JohnCFierce	718109260106883072	2016-04-07T16:12:44	My rule: 1/2 assaults on my IQ, truthfulness, essential evil are fine and disregarded. But you go on and on=blocked 
JohnCFierce	718099117839400960	2016-04-07T15:32:25	Soul? 
JohnCFierce	718092525958000641	2016-04-07T15:06:14	A capricious bureaucracy taking something away is irritating. Treasury targeting a megainversion is predictable. 
JohnCFierce	718088286489677827	2016-04-07T14:49:23	ubuntu58 I would feel that I was the subject of a capricious bureaucracy, which is one definition of government.
JohnCFierce	718085346509119490	2016-04-07T14:37:42	AriCIsaacs The Obama adm. made it clear that they would use rules to derail inversions. They did just what they signaled.
JohnCFierce	718085143345278977	2016-04-07T14:36:54	AriCIsaacs One of the first things I tweeted after the deal was announced was that now we get to see how clever Treasury is. notsurprising
JohnCFierce	718080778039640068	2016-04-07T14:19:33	Still can't get over how outraged and surprised Ian Read is that Treasury came up with a clever way to scuttle his deal. PFE politics101
JohnCFierce	718076048936669186	2016-04-07T14:00:45	Ian Read's op-ed: Obama is unfair to me, the rules are unfair, U.S. taxes are unfair; and it's not easy being a multinational megacorp. PFE
JohnCFierce	718065302420848641	2016-04-07T13:18:03	AGN goes solo, goes big with HeptaresTL. Nice piece by JohnCFierce  biotech
JohnCFierce	718065057582682112	2016-04-07T13:17:05	Roche steps in to help fund $34M Lumos round for rare disease R&amp;D 
JohnCFierce	718041823801958400	2016-04-07T11:44:46	bio_clouseau Pazdur's presence could mean everything -- or absolutely nothing. CLVS has + data, what they lack is trust. We will see
JohnCFierce	718033153382817792	2016-04-07T11:10:18	Washington Post is working on a  “WaPo bot” chatbot that will talk to readers, research news, and more 
JohnCFierce	718010451490168834	2016-04-07T09:40:06	Rociletinib data questions from FierceBiotech  Kapil Dhingra explains in Annals  pharma
JohnCFierce	718028800798375937	2016-04-07T10:53:01	ICYMI: Solo again, Allergan strikes a $3.3B deal on Heptares' Alzheimer's portfolio AGN 
JohnCFierce	717875572450451457	2016-04-07T00:44:08	Indeed. Go big or go home. 
JohnCFierce	717872936254849026	2016-04-07T00:33:40	JohnCFierce and we will all be virtual flies on the proverbial wall
JohnCFierce	717871828283355140	2016-04-07T00:29:15	brentlsaunders You do like tough targets. NMDA, Alzheimer's. No bunt singles.
JohnCFierce	717870586270257152	2016-04-07T00:24:19	Ha! Guess who went after M1 for Alzheimer's? LLY (and failed, Heptares thinks it figured out target selectivity) 
JohnCFierce	717866041418891265	2016-04-07T00:06:16	Going solo, Allergan strikes a $3.3 billion deal on Heptares' Alzheimer's portfolio AGN 
JohnCFierce	717862003784724481	2016-04-06T23:50:13	That didn't take long. AGN strikes $3.3B Alzheimer's deal with Heptares 
JohnCFierce	717832059310489600	2016-04-06T21:51:14	This is interesting. Just got direct confirmation from Richard Pazdur that he's going to the Clovis panel. How about that? CLVS
JohnCFierce	717822183456813056	2016-04-06T21:11:59	My Texas-born wife is cranking up Merle Haggard this evening. Give my regards to Johnny Cash. RIP
JohnCFierce	717818879607717888	2016-04-06T20:58:51	Valeant is up another 5% after hours on yet another WSJ scoop vipalmonga 
JohnCFierce	717782221164142592	2016-04-06T18:33:11	JohnCFierce Right. Admit strengths &amp; weaknesses; play to strengths. Don't build big R&amp;D infrastructure if others do it more efficiently.
JohnCFierce	717772069845528576	2016-04-06T17:52:51	JohnCFierce True true, John. Because too often R like that leads to ARRRRGGHhhhh!!!  brentlsaunders
JohnCFierce	717772203023077376	2016-04-06T17:53:23	For the record, I've always thought that AGN had a smart R&amp;D strategy. Why waste billions on early-stage research you don't understand?
JohnCFierce	717771791335342080	2016-04-06T17:51:45	I think he doesn't like the r so much, but the d works fine. And you''re right. brentlsaunders 
JohnCFierce	717740598191656960	2016-04-06T15:47:48	AKAarsalan -- You can take the boy out of Wichita, but you can't take Wichita out of the boy.
JohnCFierce	717739089190129665	2016-04-06T15:41:48	Thank the media gods, I've never had a rapt audience to be photographed in front of. Interested, sometimes. 
JohnCFierce	717738388238049285	2016-04-06T15:39:01	ubuntu58 I agree that the breakup fee was small. Ridiculously small, really. So maybe they started this with an eye on the 'exit' door.
JohnCFierce	717730551399104513	2016-04-06T15:07:52	joeguinta Every president interprets the law (GW regularly used opinions as a constitutional hall pass), few understand it as well as Obama
JohnCFierce	717727678246305793	2016-04-06T14:56:27	Whatever your opinion on Megamess, you do have to hand the Obama adm. some credit for pure smarts. They set out to scuttle the deal, and did
JohnCFierce	717726730681782272	2016-04-06T14:52:41	And he didn't know this was an election year when he tried striking his 2nd controversial megainversion? 
JohnCFierce	717722067446140929	2016-04-06T14:34:10	UPDATED: J&amp;J grabs prostate cancer rights for Tesaro's niraparib in $500M deal Adds comments from CEO Lonnie Moulder 
JohnCFierce	717713897365626880	2016-04-06T14:01:42	waiting on a conference call line and there's a hilarious song about being on hold. humor
JohnCFierce	717712593964646400	2016-04-06T13:56:31	Big trouble at BIND -- -27% 
JohnCFierce	717708136195497985	2016-04-06T13:38:48	Apricus wields axe to its pipeline, staff after key testosterone drug fails: 
JohnCFierce	717691872878133248	2016-04-06T12:34:11	Have to say, PFE looks ridiculous with this latest megamiss. A Treasury move was almost certain. And Ian Read just walks away?
JohnCFierce	717687411220877312	2016-04-06T12:16:27	J&amp;J grabs prostate cancer rights for Tesaro's niraparib in $500M deal JNJ TSRO 
JohnCFierce	717685499163447297	2016-04-06T12:08:51	Allergan pivots back to dealmaking as analysts link Pfizer to AbbVie, Biogen and Regeneron PFE PharmaceuticBen 
JohnCFierce	717678226995339264	2016-04-06T11:39:57	Lblegend33 JohnCFierce brentlsaunders Analysts are putting AbbVie, Biogen and Regeneron forward as potentials for Pfizer
JohnCFierce	717677397655556097	2016-04-06T11:36:40	Boom. Done.  
JohnCFierce	717678040352964608	2016-04-06T11:39:13	Pfizer's $160B megadeal for Allergan collapses under new tax rules by TracyStaton 
JohnCFierce	717669271623569409	2016-04-06T11:04:22	That puts brentlsaunders and PFE right back at the bargaining table.  
JohnCFierce	717474761752887296	2016-04-05T22:11:27	PFE weasels on price, JNJ does a little trash talking, the FDA is proud and slow and careful. biosimilars : 
JohnCFierce	717472742895927298	2016-04-05T22:03:26	Those PFE people are deep. CELG would just run at an approval, grab market share, and boast about it.  
JohnCFierce	717463292155965441	2016-04-05T21:25:53	Day of story, no trolls. Which was surprising. Why so late to the party? 
JohnCFierce	717454734165151744	2016-04-05T20:51:52	Like blacks, the Irish, Muslims or Korean Catholics?  
JohnCFierce	717452809915002880	2016-04-05T20:44:14	Mississippi: We reserve the right to deny service to gays. Despicable. 
JohnCFierce	717449064267321344	2016-04-05T20:29:21	Celltrion, Pfizer win FDA OK for a biosimilar of J&amp;J's blockbuster Remicade PFE JNJ 
JohnCFierce	717443560346415104	2016-04-05T20:07:28	Remicade biosim gets FDA nod --  
JohnCFierce	717443028886093825	2016-04-05T20:05:22	There it is 
JohnCFierce	717442010882379776	2016-04-05T20:01:19	oakazaki FiercePharma CarlyHFierce I'd go back, try to see how you could develop top drugs effectively with a budget of $7B a year.
JohnCFierce	717441552352690176	2016-04-05T19:59:30	JohnCFierce terrific story. Also read the write up Dhingra was pretty interesting too
JohnCFierce	717440662413643776	2016-04-05T19:55:57	But you want to know what's the top story, second day running? CLVS 
JohnCFierce	717440387372212226	2016-04-05T19:54:52	ICYMI: Intercept surges as FDA review hesitates on endorsing OCA data, but doesn't hate it ICPT 
JohnCFierce	717439280684146688	2016-04-05T19:50:28	FYI -- I'm setting up an executive panel on pharmacoeconomics /integrating drug pricing into clinical trials for the BIO meeting in June.
JohnCFierce	717435318971064320	2016-04-05T19:34:44	Will Ian Read crater just like that? This was unexpected? Treasury just too smart? 
JohnCFierce	717434523458355206	2016-04-05T19:31:34	Exposed! For making a gazillion dollars as a blogger in the pay of Big Pharma--why I'm always praising AZN. 
JohnCFierce	717418030649708545	2016-04-05T18:26:02	jeffonco Exactly. Thank you. Here's a couple of hundred bucks for not trashing my place. And you're grounded for a month.
JohnCFierce	717417064990908416	2016-04-05T18:22:11	I don't know that it's as black and white as all that. The co. is responsible for what is presented.  
JohnCFierce	717407174750765056	2016-04-05T17:42:53	JohnCFierce 3NT was surprised the NEJM allowed the data but then they also published AR-V7 n=7 from a single centre
JohnCFierce	717382268172574720	2016-04-05T16:03:55	So, overall, everyone seems fairly confident in an OCA endorsement this week, OK to follow. We will see, ICPT
JohnCFierce	717379248206561281	2016-04-05T15:51:55	Old guard meets new as Pfizer and Merck start PDL1-TKI combo trial for kidney cancer: 
JohnCFierce	717350715975471104	2016-04-05T13:58:33	Miss our story on CLVS being accused of misrepresenting its data on rociletinib? 
JohnCFierce	717346380931534848	2016-04-05T13:41:19	You can lead a horse to water, but you can never get it to sing a German opera. 
JohnCFierce	717345081469050880	2016-04-05T13:36:09	That's a very interesting point, David. And NASH is the elephant in the room. 
JohnCFierce	717343399666429952	2016-04-05T13:29:28	Seems to get down to ALP as a single biomarker, which FDA is not excited about ICPT
JohnCFierce	717343224671633408	2016-04-05T13:28:47	Intercept surges as FDA review hesitates on endorsing OCA data, but doesn't hate it ICPT 
JohnCFierce	717320814928986112	2016-04-05T11:59:44	FDA: Thank you. ICPT 
JohnCFierce	717318469503553537	2016-04-05T11:50:24	Memo to FDA: Please post your OCA docs promptly.  ICPT 
JohnCFierce	717306383650197504	2016-04-05T11:02:23	PFE Announces Positive Top-Line Results From First Phase 3 Trial Of Tofacitinib In Adults With Psoriatic Arthritis 
JohnCFierce	717313474750234628	2016-04-05T11:30:34	I wrote up all my thoughts about the treasury and PFE - AGN. Here you go:  
JohnCFierce	717305061572001792	2016-04-05T10:57:08	They understand disclosure very well. 
JohnCFierce	717125015343403012	2016-04-04T23:01:41	I'd rather see AGN and brentlsaunders keep on going without a PFE merger anyway. Got to be smarter than that. 
JohnCFierce	717100723897548800	2016-04-04T21:25:10	Scoop: *VALEANT SAID TO TERMINATE ADDYI SALES FORCE IN REORGANIZATION 
JohnCFierce	717099977193955329	2016-04-04T21:22:12	DNA dollars! JCVenter's Human Longevity raises $220 million from investors including ILMN and CELG. 
JohnCFierce	717085757308055558	2016-04-04T20:25:42	I added the response to the CLVS story in an update, along with the 11% hit to the share price. 
JohnCFierce	717084669687238657	2016-04-04T20:21:22	CLVS finally responded: "strongly disagree" with Dhingra's analysis -- OK then. On to Friday.
JohnCFierce	717083758374031360	2016-04-04T20:17:45	OREX paid $60M to Takeda as part of their separation agreement for Contrave 
JohnCFierce	717083717001416704	2016-04-04T20:17:35	CLVS ended the day down 11% -
JohnCFierce	717047408950185984	2016-04-04T17:53:19	CLVS down 5%
JohnCFierce	717024188595310594	2016-04-04T16:21:02	Need to catch up on ACC16? Here's what you need to read:  FiercePharma
JohnCFierce	717011135736770561	2016-04-04T15:29:10	Happy to. (adamfeuerstein may have beaten me on the fast draw. Not quite sure.) 
JohnCFierce	717007286275817472	2016-04-04T15:13:53	iangtobin It's just another way of saying go big or go home. Biotechs start at that point and Big Pharma is forever failing at it.
JohnCFierce	717002605214482433	2016-04-04T14:55:17	Axel is a great guy.  
JohnCFierce	716989624250400768	2016-04-04T14:03:42	This JohnCFierce story on CLVS roci data debacle  is why FDA briefing documents coming Fri. should be fun read.
JohnCFierce	716989004445523968	2016-04-04T14:01:14	Trending nicely: Did Clovis play a deceptive game with rociletinib data in leadup to its PhIII stunner? CLVS 
JohnCFierce	716988104289157120	2016-04-04T13:57:39	A-listers provide a $50M B round to AstraZeneca's antibiotics spinout Entasis AZN 
JohnCFierce	716986866042540032	2016-04-04T13:52:44	ZFGN sat on material news of pat. death for too long. Handled disclosure poorly. Criticism missing from otherwise v. good Signal podcast.
JohnCFierce	716982419165954048	2016-04-04T13:35:04	We've all been arrested once or twice for hooliganism in our youth, right?
JohnCFierce	716982095604793350	2016-04-04T13:33:47	A friend is lamenting her teen daughter's arrest after hosting a rowdy party at an airbnb place. Sounds like a classic rite of passage.
JohnCFierce	716974409072963584	2016-04-04T13:03:14	the best morning read in my inbox  
JohnCFierce	716975794950639616	2016-04-04T13:08:44	Since LifeSciVC is no longer my boss and I don't have to suck up any more, free to say he was largely responsible for broad Nimbus vision.
JohnCFierce	716974184283373568	2016-04-04T13:02:20	"Nimbus was named a Fierce 15 company in 2013." 
JohnCFierce	716973863649677312	2016-04-04T13:01:04	We all would have put money on it &lt;—7am endpts e-mail.   Close to 2,000 readers.  Subscribe: 
JohnCFierce	716970444914470912	2016-04-04T12:47:29	Biotech valuations don't look to be declining much --  Gilead bags early-stage NASH drug in $1.2B Nimbus deal GILD 
JohnCFierce	716966344634273792	2016-04-04T12:31:11	GILD buying nimbus apollo unit, 400M upfront
JohnCFierce	716961444852531200	2016-04-04T12:11:43	The failure of Lilly's evacetrapib may prove the final nail in the coffin for CETP:  by PharmaceuticBen LLY MRK
JohnCFierce	716953037693169665	2016-04-04T11:38:19	GSK tells me its new 'bubble boy' gene therapy will be 'significantly less' expensive than the $1m price tag for first gene drug Glybera
JohnCFierce	716952542324920320	2016-04-04T11:36:21	My biotechstrategy post today: a new first-in-field CRPC target that may overcome acquired resistance to Xtandi 
JohnCFierce	716941287920787456	2016-04-04T10:51:37	A case of "black and white": Did CLVS play a deceptive game with rociletinib data in leadup to its PhIII stunner? 
JohnCFierce	716910039529877504	2016-04-04T08:47:27	Did Clovis play a deceptive game with rociletinib data in leadup to its PhIII stunner? CLVS 
JohnCFierce	716796797801381889	2016-04-04T01:17:28	Was MRK simply stuck with cetp, or was it the old hubris shining through? AMGN investors may have some questions for R&amp;D.
JohnCFierce	716795578013888512	2016-04-04T01:12:37	Interesting: Seamus Fernandez at Leerink believes that AMGN will now drop its recently acquired cetp program (Dezima). MRK - RIP
JohnCFierce	716738643486834688	2016-04-03T21:26:23	sciencescanner johncfierce matthewherper Three big pharmas are running CVOTs with their PCSK9 inhibitors. We'll soon have a clear answer.
JohnCFierce	716734469135278080	2016-04-03T21:09:48	sciencescanner JohnCFierce Anything might fail, and I think there's a good argument we should have waited. Nobody's using them anyway.
JohnCFierce	716710100791066626	2016-04-03T19:32:58	Do we argue that 55-50% lowering with PCSK9s will be effective simply because its a larger effect?
JohnCFierce	716702606475804672	2016-04-03T19:03:11	hmkyale matthewherper ddiamond A quote from an EU colleague:"The US is the only country where people appear to believe death is optional"
JohnCFierce	716618339972431872	2016-04-03T13:28:21	Confoundingly funny. And then, how would you sell a drug like that?  
JohnCFierce	716615107258748929	2016-04-03T13:15:30	Bottom line: CETP inhibition doesn't work. RIP MRK program. Right, Larry? 
JohnCFierce	716437632889307136	2016-04-03T01:30:17	Damn, how I hate mimes.
JohnCFierce	716418745636372484	2016-04-03T00:15:14	Follow up question: what about "intertubes"? How about "Series of Pipes"? 
JohnCFierce	716392815186591746	2016-04-02T22:32:11	I've been doing a lot more back channel bio-communicating over linkedin the last few months. Works pretty well.
JohnCFierce	716283932505980929	2016-04-02T15:19:32	Wow; nytimes responds NFL call to retract article critical of concussion studies. A must read. HT RetractionWatch 
JohnCFierce	716064389107986432	2016-04-02T00:47:08	arenella1 Not vrx at all.
JohnCFierce	716038432997384192	2016-04-01T23:04:00	Just to twist the knife - it's about a public biotech! 
JohnCFierce	716027955839954944	2016-04-01T22:22:22	Intriguing biotech piece teed up for Monday a.m. Be sure to check in.
JohnCFierce	716008480159567872	2016-04-01T21:04:59	ktibus JohnCFierce we're all asking difficult scientific questions. and we all should want honest answers. trolls don't ask; they attack
JohnCFierce	716002696541691905	2016-04-01T20:42:00	And here we go! 
JohnCFierce	715999574033301504	2016-04-01T20:29:35	As soon as they move ASCO or BIO or a major scientific conference to Atlanta. 
JohnCFierce	715998790956744704	2016-04-01T20:26:29	Yep. careygillam was also a standout reporter for Reuters in KC for a good stretch. 
JohnCFierce	715997981560938501	2016-04-01T20:23:16	Carey and I worked at KCBJ together, then I tried to recruit her to Dallas (until Ray Shaw - RIP - got in my face) 
JohnCFierce	715997188673945600	2016-04-01T20:20:07	Yes, indeed. Hey, Carey... 
JohnCFierce	715964728686821376	2016-04-01T18:11:07	FierceBiotech PharmaceuticBen  ICYMI, I said this to JohnCFierce 6 mos. ago. being ahead of the curve is better. 
JohnCFierce	715941479043244034	2016-04-01T16:38:44	Market's saying 'meh' to FOLD news on migalastat. Up 3.4% on CHMP recommendation.
JohnCFierce	715923854573584385	2016-04-01T15:28:42	migalastat got their the chmp recommendation in europe -- 
JohnCFierce	715903795843227648	2016-04-01T14:09:00	And let's not forget NWBO
JohnCFierce	715903628696023044	2016-04-01T14:08:20	There should be a $10 fee for each troll attack on Twitter. I'd be happy to split it. ACAD SRPT et al
JohnCFierce	715899889348161536	2016-04-01T13:53:29	Step right up and place your bets on who might buy Medivation:  SNY RHHBY AZN MDVN via PharmaceuticBen
JohnCFierce	715898080210583552	2016-04-01T13:46:17	PFE's outraged response to price hoax PR speaks volumes about their sensitivity to the issue. Maybe they should post a 'no joking' sign.
JohnCFierce	715886197395034113	2016-04-01T12:59:04	Web traffic plus mobile for fiercelifesci hit 1.5M in March, a million uniques, according to Google analytics. Solid numbers. Good to see.
JohnCFierce	715870851636310016	2016-04-01T11:58:05	FDA publishes more biosimilar labeling advice after pharma voices its concerns:  by PharmaceuticBen
JohnCFierce	715869721086836736	2016-04-01T11:53:36	Proving once again that the Regeneron/Sanofi team do great work together: 
JohnCFierce	715866385554006016	2016-04-01T11:40:21	ICPT FDA panel preview in this wk’s Biotech Stock Mailbag -&gt;  + ACAD takeover thesis, KERX GALE (still blech)
JohnCFierce	715858505979179008	2016-04-01T11:09:02	JohnCFierce I tried finding it. No luck.
JohnCFierce	715858191880470529	2016-04-01T11:07:47	Like to see WaPo hoax story on drug pricing at PFE. Fake PR might as well have said they're donating all profits. 
JohnCFierce	715854443523280897	2016-04-01T10:52:53	That blockbuster anti-NGF pain drug fulranumab? J&amp;J doesn't want it anymore JNJ PFE REGN 
JohnCFierce	715841901669310465	2016-04-01T10:03:03	Regeneron/Sanofi team hustling to the FDA with stellar PhIII dupilumab data REGN 
JohnCFierce	715828283447885826	2016-04-01T09:08:56	First I've heard of it.  
JohnCFierce	715685843717984256	2016-03-31T23:42:56	Theranos PSA testing wildly inaccurate....ruh roh  
JohnCFierce	715652057202630657	2016-03-31T21:28:41	you should check out the  web site to see what's trending on biotwitter. Damned interesting. AKAarsalan
JohnCFierce	715649710426558465	2016-03-31T21:19:21	Mooshu69 Userpriority Looks like GNCA next ph2b study will have placebo arm for 12 months, which will yield better data.
JohnCFierce	715606283487952897	2016-03-31T18:26:47	What to know why AMGN Blincyto sales are poor and how it can be improved? Read MaverickNY on BiotechStrategy 
JohnCFierce	715577339590139904	2016-03-31T16:31:47	Have to say statnews web site is looking great. Draws you in. Good to see some real innovation.
JohnCFierce	715566779712544768	2016-03-31T15:49:49	Genfit moves liver disease pill into mid-stage, hints at upcoming IPO by PharmaceuticBen 
JohnCFierce	715564227474432000	2016-03-31T15:39:41	Study in Nature points to a rise in sea level of 3 feet by 2100 from melting ice sheet in Antarctica -- 
JohnCFierce	715545455178956800	2016-03-31T14:25:05	adamfeuerstein That seems to be key here (safety), which PureTech didn't hit on. Instead they hit on unproven link to health benefits(?)
JohnCFierce	715544627424714752	2016-03-31T14:21:48	Great point. DIY increasingly common, so why pay for it? A. It could be unsafe, you can pass on infections as well.  
JohnCFierce	715541962938519552	2016-03-31T14:11:12	PureTech startup sets out to develop new tech for controversial 'vaginal seeding' 
JohnCFierce	715532336562044928	2016-03-31T13:32:57	robertcoffin3 JohnCFierce Rob, there's ample precedent: steal $200 or rack up unpaid parking tickets -&gt; jail. Defraud pensions -&gt; no jail
JohnCFierce	715514903033946112	2016-03-31T12:23:41	JohnCFierce One would have thought a prison term should result from stealing $5m...
JohnCFierce	715512703016538112	2016-03-31T12:14:56	Jazz Pharma's much delayed rare liver disease drug finally wins FDA approval:  from PharmaceuticBen JAZZ
JohnCFierce	715511968128438272	2016-03-31T12:12:01	ICYMI: SEC: Biotech venture chief Burrill handing over $6M to cover what he stole, plus a penalty 
JohnCFierce	715508333738901504	2016-03-31T11:57:34	What several big vaccine companies failed to do, we have now done in spades.  Great day for patients and Genoceans. 
JohnCFierce	715508229342699520	2016-03-31T11:57:10	So where's the unmet medical need, John? Looks like a co. based on a theory and gut emotion. (And autism?) 
JohnCFierce	715242508406628352	2016-03-30T18:21:17	Loot a biotech fund, go buy jewelry at Tiffany's.  
JohnCFierce	715238218757771264	2016-03-30T18:04:14	So quite the rogues gallery this week. Burrill, Tuan Ha-Ngoc. Who's next? Never a dull moment in biotech
JohnCFierce	715237649506779136	2016-03-30T18:01:58	I remember Elk Run. Huge promises of building a big hub in MN. Must have been using some of that stolen $$ on weed 
JohnCFierce	715235758450352129	2016-03-30T17:54:27	SEC: Biotech venture chief Burrill handing over $6M to cover what he stole, plus a penalty 
JohnCFierce	715174169168777216	2016-03-30T13:49:43	We’re hiring an Associate or Principal. Come join us, we’re building the next leading Nordic life science investment company !
JohnCFierce	715128704024895488	2016-03-30T10:49:04	Not surprising. Publish or perish versus rigors of reproducibility.  
JohnCFierce	715179952090517504	2016-03-30T14:12:42	Dear PR pro: Please don't send me an email and then call me to basically read me the email.
JohnCFierce	715171268027396098	2016-03-30T13:38:12	From the midnight bureau:  Upstart Zavante raises $45M, takes aim at a pivotal antibiotic study 
JohnCFierce	715145622446338049	2016-03-30T11:56:17	Newron faces further FDA delay for Parkinson's drug as regulator demands addiction evidence:  by PharmaceuticBen
JohnCFierce	715139055441338368	2016-03-30T11:30:12	Sanofi-Genzyme helps cancer biotech ImmuneXcite close $8.6M financing round by PharmaceuticBen 
JohnCFierce	715136216220327937	2016-03-30T11:18:55	Mmm.. King did not work out so well – Embeda, Remoxy etc. ... 
JohnCFierce	715135618142101504	2016-03-30T11:16:32	ICYMI: UPDATED: FDA AdComm experts acknowledge problems, but give a thumbs-up on Acadia's Parkinson's antipsychotic 
JohnCFierce	715128872380067840	2016-03-30T10:49:44	Lots of great links yesterday in biotech summed up in today’s endpts newsletter: 
JohnCFierce	715131694718795776	2016-03-30T11:00:57	Jeff Kindler's biotech startup sets out to create a 'pain powerhouse,' bags Boehringer portfolio 
JohnCFierce	715128797230718976	2016-03-30T10:49:26	Aveo hit with $4M SEC fraud penalty, feds set out to bar former execs for deception AVEO by PharmaceuticBen 
JohnCFierce	715105033449242624	2016-03-30T09:15:00	Upstart Zavante raises $45M, takes aim at a pivotal antibiotic study 
JohnCFierce	714826826326142977	2016-03-29T14:49:30	PBYI down 89% from a year ago
JohnCFierce	714936565185642496	2016-03-29T22:05:34	Acadia is located 2 floors below us. I think I will head down there and grab some good mojo.
JohnCFierce	714904131383721985	2016-03-29T19:56:41	Unusual for SAGE to be down on a green day. After all the expert rebuttals, could the Kerrisdale hatchet job be working?
JohnCFierce	714934327037931520	2016-03-29T21:56:41	ACAD up 23%  
JohnCFierce	714924374600458241	2016-03-29T21:17:08	Wow. I'm having a pretty serious "appreciation of beauty through a nerdy lens" moment here.  
JohnCFierce	714898983374753792	2016-03-29T19:36:14	FDA AdComm experts acknowledge problems, but give a thumbs-up on Acadia's Parkinson's antipsychotic 
JohnCFierce	714895905548316672	2016-03-29T19:24:00	black box warning getting some discussion -- ACAD -- still assumes approval
JohnCFierce	714892283708104704	2016-03-29T19:09:37	clear understanding of safety issues - 11 yes, 3 no
JohnCFierce	714887677577789441	2016-03-29T18:51:18	panel seems very favorable, overall, to pimavanserin. More work, but after OK. ACAD
JohnCFierce	714886454137126912	2016-03-29T18:46:27	12 yes, 2 no
JohnCFierce	714886397094600704	2016-03-29T18:46:13	Is pimavanserin efficacy established? 12- 2 yes
JohnCFierce	714847808961056768	2016-03-29T16:12:53	AVEO paying $4M for hiding the FDA's position on tivo. 
JohnCFierce	714847233389305856	2016-03-29T16:10:36	Maybe Tuan Ha-Ngoc, David Johnston, and William Slichenmyer would now like to formally apologize for lying to investors? AVEO
JohnCFierce	714841850222395392	2016-03-29T15:49:12	Cool. Your choice on location. Drop me a line at john@fiercemarkets.com. See you then.  
JohnCFierce	714840829672742913	2016-03-29T15:45:09	FDA's Andreason clearly hates the small size of the numbers. Bound to require more work, but before or after OK? 
JohnCFierce	714840091659747328	2016-03-29T15:42:13	FDA Bob Temple: No rules on breakthrough; it comes w/ putative benefit is something that isn't otherwise available ACAD PDAC Nuplazid
JohnCFierce	714839310315302912	2016-03-29T15:39:07	Member-In absence of CIs 4 NNT/NNH we should b aware of high degree of uncertainty w/small s. FDA agrees, but doesn't think due 2 chance.
JohnCFierce	714836368170598400	2016-03-29T15:27:25	JohnCFierce Oops, those zero deaths and lower SAEs for clozapine vs placebo in PDP patients has gotta be a worry.
JohnCFierce	714835732746084352	2016-03-29T15:24:54	Treat 91 people for 7 full responses, 5 SAEs. FDA ACAD  the math on risk/benefit
JohnCFierce	714833393477885953	2016-03-29T15:15:36	Absolutely! Monday evening, April 25?  
JohnCFierce	714832401604681728	2016-03-29T15:11:40	FDA really doesn't like pimavanserin safety profile at all. ACAD
JohnCFierce	714827352782405632	2016-03-29T14:51:36	Sanofi's new research chief will initially office in Cambridge, MA, no final word on where he'll be based. (Really?) 
JohnCFierce	714819127693672449	2016-03-29T14:18:55	Hey, Biotech London -- FYI, I'll be in the city April 23-25 (early 26th).
JohnCFierce	714816414499123201	2016-03-29T14:08:08	JohnCFierce statnews data only stretches till August 2015 when the endpts bot went live. you can bet we'll do one then.
JohnCFierce	714815844119916544	2016-03-29T14:05:52	AKAarsalan statnews A top 10 list YTD would be interesting, Arsalan. endpts
JohnCFierce	714814570490146817	2016-03-29T14:00:48	No matter your opinion, yesterday’s statnews story on Verily is BioTwtitter's most popular story in 2016 so far. 
JohnCFierce	714807800497643520	2016-03-29T13:33:54	Another FDA delay at Puma triggers fresh doubts, sharp drop in share price PBYI down 20% 
JohnCFierce	714796328660893696	2016-03-29T12:48:19	Baxalta, Medicxi back upstart's work on building a better T cell for immuno-oncology 
JohnCFierce	714545658464587776	2016-03-28T20:12:15	ALXA 'If Alexza is unable to source additional capital, it may be forced to shut down operations altogether.'
JohnCFierce	714511873379467264	2016-03-28T17:58:00	Thanks, Nooman 
JohnCFierce	714498756037767169	2016-03-28T17:05:52	Merck's $200M damages in Gilead hep C case falls far short of expectations  MRK GILD pharma by TracyStaton
JohnCFierce	714491147910037507	2016-03-28T16:35:38	JohnCFierce except those Europeans that are US-based! 😊
JohnCFierce	714486226842218496	2016-03-28T16:16:05	This MRK/Harvard preclinical deal was my no.1 biotech story last week. Which is cool. 
JohnCFierce	714485911321452546	2016-03-28T16:14:50	Man, I am missing a big part of the European audience today. Off about 80%. Holidays.
JohnCFierce	714482765295648768	2016-03-28T16:02:20	Fascinating statnews read on GOOG 's Verily, says an exodus of talent driven by CEO Conrad 
JohnCFierce	714480792190246912	2016-03-28T15:54:29	Remember testosterone therapies? APRI sounds taps on trial failure -- trouble for the class 
JohnCFierce	714456926113939456	2016-03-28T14:19:39	Not currently. 
JohnCFierce	714452411558051840	2016-03-28T14:01:43	Under pressure XenoPort sells U.S. rights of failed psoriasis pill to Dr. Reddy's:  by PharmaceuticBen RDY XNPT
JohnCFierce	714451953657462784	2016-03-28T13:59:54	ACAD up 25% -- 
JohnCFierce	714440809064439809	2016-03-28T13:15:37	So ALDR up 30% now -- that spike was kinda slow in coming.
JohnCFierce	714439369931632641	2016-03-28T13:09:54	Also from the weekend bureau: ACAD faces some tough questions on Parkinson's drug -- 
JohnCFierce	714438967777603589	2016-03-28T13:08:18	From the weekend bureau: Forum faces the end o' the road -- 
JohnCFierce	714435856661155840	2016-03-28T12:55:56	.JohnCFierce The answer first question was in there as a table, and totally makes the story.
JohnCFierce	714434964373176323	2016-03-28T12:52:23	Classic overreach.  
JohnCFierce	714430319915446272	2016-03-28T12:33:56	Alder bags promising migraine data in frenzied race for pioneering CGRP drug approval ALDR +10% 
JohnCFierce	714420421118963715	2016-03-28T11:54:36	Harvard spinout Emulate scores $28M, revs up marketing for organs-on-chip tech 
JohnCFierce	714245390069927936	2016-03-28T00:19:05	Alder BioPharmaceuticals to Hold Conference Call on Monday, March 28, at 8:30 am ET  [h/t bradloncar]
JohnCFierce	714161020391002112	2016-03-27T18:43:50	It's how you cover crazy in politics today.  
JohnCFierce	714106307519848452	2016-03-27T15:06:25	Increased risk of death 4 Parkinson's patients taking antipsychotics - increased likelihood of black box for ACAD? ?
JohnCFierce	713866721816391680	2016-03-26T23:14:24	Some very good news  
JohnCFierce	713806503468212225	2016-03-26T19:15:06	ICYMI: With two PhIII schizophrenia trials in ruins and Alzheimer's on hold, Forum chops staff and considers options 
JohnCFierce	713705792822779904	2016-03-26T12:34:55	ICYMI -- UPDATED: FDA's internal review of Acadia's Parkinson's drug raises safety, benefit concerns ACAD 
JohnCFierce	713577652045672448	2016-03-26T04:05:44	BREAKING: Tribeca Film Festival adds “Sunned” to its schedule. De Niro supports “discussion” of the church’s charges against Galileo.
JohnCFierce	713514395117174784	2016-03-25T23:54:22	Oh, hey, I'm moderating a Zika webinar featuring experts from NIAID, Sanofi &amp; UT Medical Branch. Join us on 4/14! 
JohnCFierce	713452536108335104	2016-03-25T19:48:34	Still amazes me, though, how many (media) companies actively hobble/prevent innovation in favor of process.  
JohnCFierce	713433335511392256	2016-03-25T18:32:16	One of our biggest insights about the most innovative companies - it is still about people, not process... 
JohnCFierce	713422416433790976	2016-03-25T17:48:53	Probably not, but it does demonstrate just what these people were planning while making assurances to the FDA. 
JohnCFierce	713417655957458945	2016-03-25T17:29:58	johncfierce There it is on pg. 16 of Sprout BD. Educational efforts discussed too. Full BD  
JohnCFierce	713417468803424256	2016-03-25T17:29:13	RxRegA I always thought it was bogus. I'm sure they meant to allow for plenty of "education" for consumers
JohnCFierce	713417121280237568	2016-03-25T17:27:51	The FDA asked me to correct my piece to clarify that Sprout had made that commitment on their own. 
JohnCFierce	713415180261146624	2016-03-25T17:20:08	And yet Sprout told the FDA they wouldn't advertise Addyi for 18 months after OK (?)  
JohnCFierce	713391520829804549	2016-03-25T15:46:07	Overall, very balanced -- FDA's internal review of Acadia's Parkinson's drug raises safety concerns ACAD 
JohnCFierce	713355444648067072	2016-03-25T13:22:46	With two PhIII schizophrenia trials in ruins and Alzheimer's on hold, Forum chops staff and considers options 
JohnCFierce	713176655729205248	2016-03-25T01:32:19	GILD ordered to pay MRK $200M for infringing on patents. Like a $3 fine for speeding. 
JohnCFierce	713124303319896067	2016-03-24T22:04:17	Sad about Garry Shandling. Larry Sanders was WONDERFUL,and at my daughter Cynthia's wedding he made the funniest bad taste speech ever given
JohnCFierce	713135402165661697	2016-03-24T22:48:23	Thinking Q for ACAD will b how 2 interpret data 40mg. 1 failed trial, partly 4 pbo response, another w -3 pnts on PD tool. Clin sig? Safe?
JohnCFierce	713110469934989314	2016-03-24T21:09:19	Another startup jumps into antibiotics R&amp;D as Iterum grabs a $40M round 
JohnCFierce	713070025645637632	2016-03-24T18:28:36	"Live, eat and self-replicate." Prompt them to divide into hostile groups and you'd have an existential lesson.  
JohnCFierce	713067637253791745	2016-03-24T18:19:07	Craig Venter Just Hacked Bacteria To Have The Smallest Genome Possible 
JohnCFierce	713067273913819136	2016-03-24T18:17:40	+1 
JohnCFierce	713029835094941696	2016-03-24T15:48:54	Slate has started the Trump apocalypse watch; currently rates two horsemen out of a possible 4. -- 
JohnCFierce	713019215771512832	2016-03-24T15:06:42	Another startup jumps into antibiotics R&amp;D as Iterum grabs a $40M round (Durata vets) 
JohnCFierce	713006246337576960	2016-03-24T14:15:10	Bayer looks to protect blockbuster Eylea franchise with $130M Regeneron pact REGN 
JohnCFierce	712993329873559553	2016-03-24T13:23:51	Portola plunges as PhIII blood thinner misses key goal in head-to-head comparison study PTLA 
JohnCFierce	712956947000123392	2016-03-24T10:59:16	PTC Therapeutics to cull its ranks after FDA spurns Duchenne drug:  PTCT by PharmaceuticBen
JohnCFierce	712782349352767489	2016-03-23T23:25:29	drrichjlaw Thanks, Richard. Couldn't have done it without you guys.
JohnCFierce	712810864424845312	2016-03-24T01:18:48	Sequoia Capital China Expects to Raise $1.5 Billion in Two Investment Funds  China biotech
JohnCFierce	712739953189457920	2016-03-23T20:37:01	Sorry- GILD needs to do a deal &amp; everyone with a pulse knows it. 
JohnCFierce	712708448287387652	2016-03-23T18:31:50	Updated Sage/KerrisdaleCap story with a response from the company: 
JohnCFierce	712691443199041538	2016-03-23T17:24:15	,michael_gilman You should stick with this biotech thing. 
JohnCFierce	712688577981890560	2016-03-23T17:12:52	VRX hiked the price on Seconal, used in physician assisted suicide, after California passed an aid-in-dying law. 
JohnCFierce	712671489854726145	2016-03-23T16:04:58	Never trust a movie in which Ben Affleck wears a costume.  
JohnCFierce	712665886323245057	2016-03-23T15:42:42	But we'll see. KaloBios was a screwy little co. when shkreli stepped in. That hasn't changed. 
JohnCFierce	712665692940664832	2016-03-23T15:41:56	As I understand it, the new deal they were working on required that he be crammed down to minority shareholder -- 
JohnCFierce	712662728461193216	2016-03-23T15:30:09	Bye, bye MartinShkreli 
JohnCFierce	712637505221189632	2016-03-23T13:49:56	JohnCFierce FierceBiotech 
JohnCFierce	712636744538177540	2016-03-23T13:46:54	Not a single RT on the SAGE story, but it's already trending to #1: every gang fight draws a crowd 
JohnCFierce	712633743652032514	2016-03-23T13:34:59	He shoots and scores - SAGE down 15% - harsh environment out there. -- 
JohnCFierce	712632204950704128	2016-03-23T13:28:52	Sahm Adrangi's hedge fund ridicules Sage Therapeutics' rare disease drug in short attack 
JohnCFierce	712618770473295872	2016-03-23T12:35:29	What challenges does the biomedical ecosystem face in years ahead? What I and others say in NatureBiotech 
JohnCFierce	712618639246102528	2016-03-23T12:34:58	This time last yr I was totting up the no. of new Fierce 15 co.s that were going public. This yr, we start with a buyout. That is not random
JohnCFierce	712606938245238784	2016-03-23T11:48:28	Bristol-Myers bags the biotech upstart Padlock in $600M autoimmune deal BMY 
JohnCFierce	712441101341351936	2016-03-23T00:49:29	Vikas-GSK's cancer pipeline is a well kept secret in the biopharma biz. Evidently takes PhIII to be noticed 
JohnCFierce	712426266310418433	2016-03-22T23:50:32	It's, um, very distinctive, too. I can't shake images of shag carpeting and bell bottom pants for men when I see it. 
JohnCFierce	712389339968315392	2016-03-22T21:23:48	Jury finds one MRK patent valid in GILD hep C case; MRK up 1.9%, GILD down 2.1%
JohnCFierce	712382608047480834	2016-03-22T20:57:03	Something about Taltz also sounds like it should be a Yiddish name for potato. cc JohnCFierce
JohnCFierce	712381954012880896	2016-03-22T20:54:27	Really? Sounds like an order or command in German. Taltz! Whereas ixekizumab rolls off the tongue.  
JohnCFierce	712376701800599558	2016-03-22T20:33:35	Eli Lilly scores a big win with FDA OK for blockbuster psoriasis contender ixekizumab LLY Taltz 
JohnCFierce	712297342653894656	2016-03-22T15:18:14	As promised, the Syntimmune CEO interview is live after the NY biotech saw a $10M tranche from its funding nest egg: 
JohnCFierce	712293733954408448	2016-03-22T15:03:54	Anthem sues Express Scripts over drug pricing, considers calling it quits on the PBM:  ANTM ESRX pharma
JohnCFierce	712281912048525312	2016-03-22T14:16:56	Read John_LaMattina on pricing and value 
JohnCFierce	712273272327577600	2016-03-22T13:42:36	Hey, that’s me! Looking forward to this call, hope you are, too.  
JohnCFierce	712270192265568256	2016-03-22T13:30:21	J&amp;J joins up with Genentech for a pair of atezo/Darzalex combo cancer studies JNJ 
JohnCFierce	712268599759609856	2016-03-22T13:24:02	by PharmaceuticBen 
JohnCFierce	712262398107893760	2016-03-22T12:59:23	I applaud honesty. I make mistakes everyday. Charles is a great person and erudite journalist 
JohnCFierce	712253469172899840	2016-03-22T12:23:54	San Diego's Acutus grabs $75 million to get 3-D, real-time surgical cardiac imaging past regulators 
JohnCFierce	712252506957586432	2016-03-22T12:20:05	Evotec evolves as it announces first ever spinoff and new business model:  by PharmaceuticBen
JohnCFierce	712249629669244928	2016-03-22T12:08:39	Will Eli Lilly's 11th-hour regulatory gambit salvage or sink its Alzheimer's drug? (Couldn't resist) LLY 
JohnCFierce	712236976024526848	2016-03-22T11:18:22	ICYMI: Duchenne docs-AKA Sarepta investigators, advisers and advocates-back controversial case for eteplirsen SRPT 
JohnCFierce	712076715762253826	2016-03-22T00:41:33	.JohnCFierce I remember I tried to use the headphones on my Blackberry and he couldn't hear me. don't remember what he said. It was funny.
JohnCFierce	712076035991445504	2016-03-22T00:38:51	I interviewed Grove some time ago. He didn't give me a hard time - kinda wish he had. 
JohnCFierce	712056838292967425	2016-03-21T23:22:34	Did he tell Biden how much they plan to sell it for? 
JohnCFierce	712015495134879744	2016-03-21T20:38:17	Something they didn't bother to mention. 
JohnCFierce	712014411356086272	2016-03-21T20:33:58	It's presented as KOL backing, which is complete rubbish. 
JohnCFierce	712012246914879488	2016-03-21T20:25:22	johncfierce I was shocked by the ill-informed vitriol I received when I questioned the approvability of eteplirsen &amp; other DMD candidates
JohnCFierce	712012194930671616	2016-03-21T20:25:10	Day trader trolls. Business as usual on Twitter. 
JohnCFierce	712011904890376194	2016-03-21T20:24:01	The negative opinion on this drug is tied to skepticism on the trial size tied to the fda review. period. 
JohnCFierce	712011616452284416	2016-03-21T20:22:52	I'm saying their ties to the company create a clear conflict. Whether you agree or disagree with them. 
JohnCFierce	712010672889008128	2016-03-21T20:19:07	I don't buy or sell any stocks. SRPT 
JohnCFierce	712009251602964480	2016-03-21T20:13:28	Also, the two leads on the SRPT letter are parent/patient advocates at UCLA&gt;
JohnCFierce	712007563374624768	2016-03-21T20:06:46	Those letter writers for SRPT would have done well to spell out conflicts.
JohnCFierce	712006858744197122	2016-03-21T20:03:58	Duchenne docs – and Sarepta trial investigators – back biotech's controversial case for eteplirsen SRPT 
JohnCFierce	711965161746276352	2016-03-21T17:18:16	....Must love humans (and R&amp;D). 
JohnCFierce	711941881224159232	2016-03-21T15:45:46	Theranos gets the boot as host for Clinton campaign fundraiser: 
JohnCFierce	711918749050347520	2016-03-21T14:13:51	Biotech startup trendsetters at Arch hunting up $400M-plus for venture fund JUNO BLUE 
JohnCFierce	711912907873734656	2016-03-21T13:50:38	JohnCFierce 
JohnCFierce	711910995334144000	2016-03-21T13:43:02	What are you willing to pay for a female libido pill with no market and little efficacy?  
JohnCFierce	711906994458927104	2016-03-21T13:27:08	Trending nicely:  Merck's $20M-plus Harvard deal offers a lesson on the new Economics 101 of preclinical R&amp;D MRK 
JohnCFierce	711906393557770240	2016-03-21T13:24:45	CEO wanted: Transforming rogue pharma co. into an industry leader catch your fancy? Willing to testify before Congress? Hardy type? VRX
JohnCFierce	711903982709555200	2016-03-21T13:15:10	Montgomery Burns=Bill Ackman? VRX 
JohnCFierce	711902871265153025	2016-03-21T13:10:45	Every new CEO gets to blame the old CEO for everything that goes wrong for at least 6 months. In VRX 's case, may need to make that 2 yrs
JohnCFierce	711901997566447616	2016-03-21T13:07:17	VRX looking for a new CEO. What a challenge!
JohnCFierce	711897267142266881	2016-03-21T12:48:29	Atlantic Healthcare closes $24M round and gains Salix founder as new CSA 
JohnCFierce	711892678552784896	2016-03-21T12:30:15	BioMarin wilts as a big PhIII study disappoints investors, again BMRN 
JohnCFierce	711882537174507520	2016-03-21T11:49:57	down 4.25% -- not a good sign 
JohnCFierce	711869988718641153	2016-03-21T11:00:05	Merck's $20M-plus Harvard deal offers a lesson on the new Economics 101 of preclinical R&amp;D 
JohnCFierce	711669956421787649	2016-03-20T21:45:14	NICE backs Entresto - but only in v severe pts; does not back drug as cost effective across its full label pop’n: 
JohnCFierce	711619375372083201	2016-03-20T18:24:14	Breakthrough cure for overeating inmice 
JohnCFierce	711564385936916480	2016-03-20T14:45:44	Love him or hate him, Trump has shown that Twitter is one of the best new tools for the deconstructed presidential candidacy.
JohnCFierce	711324625578369025	2016-03-19T22:53:01	Interesting! Charles Darwin wrote another popular book... and this one involved crowdsourcing his research data! 
JohnCFierce	711235854610657281	2016-03-19T17:00:16	matthewherper Always believe in need to invest in science to be a Pharma co. How you best invest is good question to debate. No one way.
JohnCFierce	711227416191045632	2016-03-19T16:26:44	Fits my firm belief that everything that comes from McK***** will turn out to be smart-looking crap… 
JohnCFierce	711215373207654400	2016-03-19T15:38:53	I would think that it's a sure sign of many things. 
JohnCFierce	710954768450101249	2016-03-18T22:23:20	"Two companies stand out: JNJ and BMS ... are indisputably the leading innovators today" innovation JNJInnovation 
JohnCFierce	710920455390035968	2016-03-18T20:06:59	XOMA NASDAQ delisting notice
JohnCFierce	710888994670841856	2016-03-18T18:01:58	celg Oral Ozanimod Showed Histologic Improvements in Patients with Ulcerative Colitis  Phase 2 TOUCHSTONE Trial 
JohnCFierce	710861706411560960	2016-03-18T16:13:32	$1.5B counter offer for AFFX -- (Wei Zhou) 
JohnCFierce	710835856903413761	2016-03-18T14:30:49	Too bad, if so. SFY has a beautiful building in Paris. And after its recent Gallic eruption, Paris looks like home 
JohnCFierce	710816211391610880	2016-03-18T13:12:45	What we can learn from Valeant's wreckage (insert Hegel and Santayana quotes here); 
JohnCFierce	710649316050870272	2016-03-18T02:09:34	Europe is not a desert of innovation. It develops drugs for the U.S. market just like everyone else.  
JohnCFierce	710639453988065280	2016-03-18T01:30:23	JohnCFierce We will see how it ends.  Either way neither were representative of the industry they worked in.
JohnCFierce	710639302594707456	2016-03-18T01:29:47	And Shkreli took a common pharma practice to an extreme. brentlsaunders 
JohnCFierce	710638697880920065	2016-03-18T01:27:23	Madoff broke the law, Shkreli simply took advantage of it.  
JohnCFierce	710637823125229568	2016-03-18T01:23:54	JohnCFierce brentlsaunders Alas, competition won't fix cases where competition seems to have led to higher prices (see Gleevec.)
JohnCFierce	710637020171915264	2016-03-18T01:20:43	If the alternative to price controls is a world where the Shkrelis get to engage in gouging, what's pharma's answer? 
JohnCFierce	710631984276639744	2016-03-18T01:00:42	The MartinShkreli model: I'm a genius, you're a moron. Gwahahahahaha 
JohnCFierce	710533492392792064	2016-03-17T18:29:20	Biggest single day stock increase for GSK ADRs in months...ouch! 
JohnCFierce	710532597072445440	2016-03-17T18:25:46	It's clear that millions of young Americans will be left thoroughly disillusioned with national politics this year. Welcome to the club.
JohnCFierce	710525528055398400	2016-03-17T17:57:41	My hat is off to you, Adam. Best I get from GILD is, hey, everyone's out back. Call back next year, maybe. 
JohnCFierce	710482200207036416	2016-03-17T15:05:31	Odd, so many kids I know think that drugs are way cool....Oh, wait. 
JohnCFierce	710419673276424192	2016-03-17T10:57:03	As in everything, GSK moves SOOOOO slowly. CEO Witty will leave March, 2017. No rush.
JohnCFierce	710177317755219968	2016-03-16T18:54:01	no Martin Shkreli but lots of Turing folks testifying at SenateAging hearing on drugprices tomorrow. RTRX in spotlight too. pharma
JohnCFierce	710162566845231104	2016-03-16T17:55:24	Amgen prevails in high-stakes PCSK9 patent fight with Sanofi, Regeneron AMGN by TracyStaton 
JohnCFierce	710147631675260928	2016-03-16T16:56:03	Remember regorafenib, son of Nexavar, which Bayer pretty much lifted from Onyx -- and was forced to settle on? 
JohnCFierce	710142736712802304	2016-03-16T16:36:36	JohnCFierce Here's our story about royalties:  REGN AMGN
JohnCFierce	710142293295165440	2016-03-16T16:34:51	Looking for info on the REGN patent suit AMGN just won? Here you go:  pharma via FiercePharma
JohnCFierce	710142266363539456	2016-03-16T16:34:44	Generally the attorneys eventually get down to royalties and $$$. After they bill a bundle.  
JohnCFierce	710092110565937152	2016-03-16T13:15:26	Novimmune's NI-0501 wins FDA breakthrough status in primary hemophagocytic lymphohistiocytosis  phama
JohnCFierce	710081484099592196	2016-03-16T12:33:13	Congratulations to the DiCE team; looking forward to working together! 
JohnCFierce	710070034371055616	2016-03-16T11:47:43	They had a chance, they blew it, lost credibility and got crushed. If that's not a cautionary tale, there aren't any 
JohnCFierce	710068171965865985	2016-03-16T11:40:19	Also moves us deeper into the European scene. Ben will also be helping with Asia coverage. onebiotechworld 
JohnCFierce	710067551448014848	2016-03-16T11:37:51	Let me introduce Ben Adams, an experienced UK-based biopharma writer who will be taking Damian's place Fierce. 
JohnCFierce	710066842212167681	2016-03-16T11:35:02	Biotech Lesson: Be overtly transparent. If you're hiding something bad, you're asking for it. AVEO, ZFGN, etc
JohnCFierce	710066290359140352	2016-03-16T11:32:50	AVEO has set aside $4M as they try to settle up with the SEC on failing to tell investors that the FDA asked for another Tivo trial 5/12.
JohnCFierce	710061471674322944	2016-03-16T11:13:41	Congrats KevinJudice, sounds quite interesting 
JohnCFierce	710051541097512960	2016-03-16T10:34:14	UK combo: Skyepharma to merge with Vectura 
JohnCFierce	710050451941691393	2016-03-16T10:29:54	From the midnight bureau: Sanofi is rolling the DiCE on a small molecule R&amp;D platform; Kevin Judice-$2.2B milestones 
JohnCFierce	709982639097303043	2016-03-16T06:00:26	Sanofi is rolling the DiCE on a small molecule R&amp;D platform 
JohnCFierce	709897454171398146	2016-03-16T00:21:56	there must be a biotech company in here somewhere 
JohnCFierce	709892586748682245	2016-03-16T00:02:36	Not many surprises tonight. Trump/Clinton take FL. Rubio's toast. Kasich/Clinton ahead in OH. Trump/Clinton lead NC.
JohnCFierce	709882138347307008	2016-03-15T23:21:05	Florida votes with 16% in  Trump — 48.0% Rubio — 23.5% Cruz — 15.8% Kasich — 7.3%
JohnCFierce	709873484403494914	2016-03-15T22:46:42	I'm in the process of paying for a third college education. The rest of my money goes for food and shelter and beer. 
JohnCFierce	709869258805796865	2016-03-15T22:29:54	JohnCFierce LLY will have to admit defeat with solanezumab. But keeping trials going helps maintain the illusion it's a valuable asset
JohnCFierce	709871691598532610	2016-03-15T22:39:34	Thank you, Roy. Always the most reliable of my fans.  
JohnCFierce	709864088562769920	2016-03-15T22:09:22	NWBO can't complete its year-end numbers on time? Oh. 
JohnCFierce	709861117238091777	2016-03-15T21:57:33	LLY was gaming the system today. They took a mixed negative out of the pic and raised prospects for a claimed + Sola is the same lousy drug
JohnCFierce	709860104502427648	2016-03-15T21:53:32	Well, we'll see about that. But you were overdue before the big job at NVS. Cheers. 
JohnCFierce	709859376304144384	2016-03-15T21:50:38	Just the opposite. The exception that proves the rule is not a viable strategy. It's a bad bet that pays off. 
JohnCFierce	709857675555807232	2016-03-15T21:43:53	You know, I'm not an investor. But unless there's a bull market, why would you do anything other than go short on a biotech stock? theodds
JohnCFierce	709857292783636480	2016-03-15T21:42:21	MNKD - doubt about going concern status; you don't say. 
JohnCFierce	709856217510887425	2016-03-15T21:38:05	DC 1 of the 3 worst cities in the US for traffic. The only commuting done tomorrow in DC should be telecommuting. 
JohnCFierce	709853761804566528	2016-03-15T21:28:19	DC metro is shutting down for a day. Stay at home. Don't go further than your nearest Starbucks. Life as you know it will be suspended/
JohnCFierce	709774994893475840	2016-03-15T16:15:20	Some interesting new ideas being explored here to optimise the impact of CAR T cell therapy in both leukemias and so…
JohnCFierce	709756466702458881	2016-03-15T15:01:42	damiangarde STATnews Best wishes for your new endeavor, Damian. You'll be missed. Hasta la vista.
JohnCFierce	709749236716453888	2016-03-15T14:32:59	LLY has no confidence in its own, second, Phase III program for solanezumab.   
JohnCFierce	709748839884988416	2016-03-15T14:31:24	2016 is the year that all the chickens came home to roost in biopharma. As a journalist, it's a damned interesting time.  VRX
JohnCFierce	709726243357396992	2016-03-15T13:01:37	When a CEO says this, R&amp;D cuts follow. Wait a sec, VRX doesn't do R&amp;D! 
JohnCFierce	709719846968291329	2016-03-15T12:36:12	The most influential people in biopharma today. 
JohnCFierce	709716179783385088	2016-03-15T12:21:37	Gee, Lilly drops function as a co-primary endpoint for sola. Anyone a wee bit nervous? 
JohnCFierce	709478843350970368	2016-03-14T20:38:32	CPXX up 442%, from 0 to hero  on OS data for myeloid leukemia -- 
JohnCFierce	709470894100451329	2016-03-14T20:06:57	I'm marking my 2023 calendar right now -- Jan. 1, call Pascal. 
JohnCFierce	709463385734119424	2016-03-14T19:37:07	JohnCFierce yes, Naked underwear was a bit odd....for men only. Nada for me!
JohnCFierce	709461816225767424	2016-03-14T19:30:52	dnajd So I've heard from men and women alike that Roth is handing out "naked" underwear, complete with that weird codpiece. Bit odd, no?
JohnCFierce	709450234871554050	2016-03-14T18:44:51	And they knew it at the time. Which is why no one will let them forget such nonsense. 
JohnCFierce	709419491101380608	2016-03-14T16:42:41	The 28th annual Roth frat party, er, conference is underway. And I hear the nudge, nudge, wink, wink thing is well underway.
JohnCFierce	709398017439350784	2016-03-14T15:17:21	A rally for those who were too drunk or stoned to hear about the federal notice. 
JohnCFierce	709375982839451648	2016-03-14T13:49:48	Bristol-Myers bucks trend toward precision medicine with new cancer drug  via WSJ w/ jonathanrockoff BMY MRK
JohnCFierce	709359284673388544	2016-03-14T12:43:27	GW Pharma soars as its cannabis-derived drug aces Phase III  [h/t FierceBiotech]
JohnCFierce	709306200316313601	2016-03-14T09:12:31	February breaks global temperature records by 'shocking' amount 
JohnCFierce	709127884523315205	2016-03-13T21:23:57	JohnCFierce SpiritAirlines I would happily be in a middle seat on southwest than this unruly shit show
JohnCFierce	709127589386952704	2016-03-13T21:22:46	I flew Southwest on my last excursion around the U.S. Very efficient. Just had to steer clear of the dread Group C. 
JohnCFierce	709046915623755776	2016-03-13T16:02:12	Torture Big Data enough &amp; it will confess to anything. Most papers will be garbage in, garbage out. Next new fad.  
JohnCFierce	708651423744053248	2016-03-12T13:50:40	NEJM correction acknowledges CAR developers Dario Campana and Chihaya Imai. 
JohnCFierce	708637470292889600	2016-03-12T12:55:13	Enjoyed meeting our Emeryville team a.k.a. gram negative bacteria’s worst nightmare as shown in this video: 
JohnCFierce	708456460972396544	2016-03-12T00:55:57	JohnCFierce Stemcentrx is next Pharmacyclics?? Delusional!Biotech is f'hard &amp; should be left to those who have done it their entire careers
JohnCFierce	708427323113082880	2016-03-11T23:00:10	JohnCFierce  1. "its approach isn’t new." 2. No well known hc investors 3. Big valuation 4. Closed ipo window (?)  Not a great mix...
JohnCFierce	708426085613105152	2016-03-11T22:55:15	As much as ALNY. Three times as much as AGIO. 
JohnCFierce	708423090066292736	2016-03-11T22:43:21	Oh, yeah, the biotech bubble. I remember that. Sillyvaluations.  stemcentrx 
JohnCFierce	708374031834226690	2016-03-11T19:28:24	endpts No, no endpoints bot (!) -- that was last year.
JohnCFierce	708373357981515776	2016-03-11T19:25:44	adamfeuerstein bradloncar Looks marginal. Failed PhII (from damiangarde) 
JohnCFierce	708367683780284417	2016-03-11T19:03:11	CGrantWSJ Hey, I did NOT have an affair with a super model.
JohnCFierce	708366935180886016	2016-03-11T19:00:12	Quite a cx for GALE -- hey, we are NOT under investigation. We forgot to add the word NOT. OK?
JohnCFierce	708335466974748673	2016-03-11T16:55:10	BREAKING: GALE Named Target of Federal Criminal Probe Into Painkiller Use —&gt;  Same criminal case involves INSY
JohnCFierce	708314798031765504	2016-03-11T15:33:02	Packed house for the CRISPR Therapeutics presentation. Company has $200M cash and $300M committed via JV. VRTX 
JohnCFierce	708305638997172226	2016-03-11T14:56:38	PredatorDiaries matthewherper That was 8 years -- I should have covered politics as a career. Lifetime employment covering what went wrong
JohnCFierce	708301793852321793	2016-03-11T14:41:21	PhIII studies for failed PhIII drugs dominates the entire Alzheimer's field. 
JohnCFierce	708301251050643457	2016-03-11T14:39:12	Interesting to think that pointing out what Trump got wrong could become a full-time job for the next 4 years. 
JohnCFierce	708297802254831617	2016-03-11T14:25:30	Tufts re-estimates costs to bring a drug to market to $2.9bn. At odds with actual past 5yrs  
JohnCFierce	708297141123473408	2016-03-11T14:22:52	"inadequate staffing levels, resulting in insufficient time spent on review and approval of certain information" 
JohnCFierce	708291548862156802	2016-03-11T14:00:39	MedDeviceMark Adcomms offer an education on how regulators handle new technology. The trends that emerge inform investors, execs, etc.
JohnCFierce	708288821805387776	2016-03-11T13:49:49	MedDeviceMark So let me whine on your behalf. Devices would be a better/stronger field if FDA made the adcomms more easily accessible.
JohnCFierce	708281173160697856	2016-03-11T13:19:25	Boston_Biotech Sure, and without it? They'd be toast.
JohnCFierce	708280796638007298	2016-03-11T13:17:55	Story on that topic coming next week -- 
JohnCFierce	708278822442045440	2016-03-11T13:10:05	The SFY/$REGN team is one of the best in the business. Smart, focused, well financed. Damned impressive.
JohnCFierce	708276619119558657	2016-03-11T13:01:19	Akashi is facing a crisis as well. 
JohnCFierce	708275662772183040	2016-03-11T12:57:31	Another Humira competitor: Sarilumab beats out Humira in RA head-to-head PhIII.  SNY REGN ABBV 
JohnCFierce	708269028607832064	2016-03-11T12:31:10	Today is 10 years for me in biotech media. Grateful for the first 8 years leading the FierceBiotech team. Plan to be here 10 more endpts 😎
JohnCFierce	708268212966842369	2016-03-11T12:27:55	From the midnight bureau: Alzheon makes its case for another high-risk, high-reward Alzheimer's PhIII 
JohnCFierce	708160355160055811	2016-03-11T05:19:20	Alzheon makes its case for another high-risk, high-reward Alzheimer's PhIII 
JohnCFierce	708093003806724097	2016-03-11T00:51:42	JohnCFierce I would guess that everyone who traded out when the catalyst timing was uncertain is now trading back in
JohnCFierce	708084802407243777	2016-03-11T00:19:07	Scoop: Inside the just-returned Valeant CEO's meetings with top execs:  VRX
JohnCFierce	708076266742792192	2016-03-10T23:45:12	SRPT up 15% on an adcom date? Puh-leeze, people. What are you drinking?
JohnCFierce	708072218480287744	2016-03-10T23:29:06	After GSK deal, Novartis ends Genmab drug PhIII; ITM bags €20M; KDEV rethink enables big round by NickPaulTaylor 
JohnCFierce	708027156555767808	2016-03-10T20:30:03	Scholarship established in memory of treasured Padlock founder and team member Kerri Mowen. Please consider a gift. 
JohnCFierce	708012609111461889	2016-03-10T19:32:14	Looking for great team members in our quest to help patients with cancer &amp; autoimmune diease.  
JohnCFierce	707987505019224064	2016-03-10T17:52:29	Exactly.  
JohnCFierce	707971190980272132	2016-03-10T16:47:40	For some reason I'm getting blitzed on requests for "overview" biotech interviews. I rarely do them.They don't do much for me.
JohnCFierce	707969638194421760	2016-03-10T16:41:29	If you are one of the 40% thats a cure! I think its pretty impressive actually 
JohnCFierce	707947769441488896	2016-03-10T15:14:35	Strike 3: Struggling Xoma jettisons its lead drug after (another) PhIII failure XOMA -- 1 year of cash left 
JohnCFierce	707939316744503296	2016-03-10T14:41:00	Join us for a Women in Bio JNJInnovation Event: “The WIB Lobster Pot" with female CEOs pitching to female VCs! 
JohnCFierce	707936540639563776	2016-03-10T14:29:58	Sarepta has a new date with an FDA AdCom for Duchenne drug eteplirsen SRPT 
JohnCFierce	707930205868924928	2016-03-10T14:04:48	Which is nuts --- FDA 
JohnCFierce	707927985630748673	2016-03-10T13:55:59	Good to see! SRPT 
JohnCFierce	707926757349920770	2016-03-10T13:51:06	The science committee didn't have trouble with animal studies that randomly killed primates with super high doses, but the activists will.
JohnCFierce	707924517453172736	2016-03-10T13:42:12	I thought this was fascinating -- Experts: Drug trial disaster followed several missteps; new rules needed 
JohnCFierce	707855133766492160	2016-03-10T09:06:29	'Molecule to blame' in fatal French drug study, says France's drug regulator:  pharma biotech
JohnCFierce	707744635712626688	2016-03-10T01:47:25	Begs the question: What if Trump is operating at his peak? 
JohnCFierce	707742991293751296	2016-03-10T01:40:53	If you gaze long enough into an abyss, the abyss will gaze back into you 
JohnCFierce	707705814451146752	2016-03-09T23:13:09	.dereklowe covers our research with pfizer that set the record straight about a strategy for cancer therapy. 
JohnCFierce	707702834259759104	2016-03-09T23:01:18	XOMA to stop all Gevokizumab related development activities and is initiating a formal sales process for the asset.
JohnCFierce	707686325529550849	2016-03-09T21:55:42	bio_pharmer they do. Marek Biestek and I have known each other for 15 years and Dr. Vaino for 10. They never heard of PKAN before me.
JohnCFierce	707683570773581826	2016-03-09T21:44:46	After nine primaries (AL, AR, KS, ID, ME, MS, SC, TN, TX), average finish of a candidate endorsed by that state's GOP governor? Third place.
JohnCFierce	707682690070351873	2016-03-09T21:41:16	Israeli biotech firm, Medasense Biometrics, closes $8M Series B from Benslie International Ltd.  
JohnCFierce	707678893365444609	2016-03-09T21:26:10	Big Harvard Prize for CRISPR goes five ways, but snubs folks who made it work in human cells. 
JohnCFierce	707635090138992641	2016-03-09T18:32:07	The BroadInstitute will present at BES16. COO Samantha Singer was named a Top Woman in Biotech FierceBiotech 
JohnCFierce	707623944438857728	2016-03-09T17:47:50	what a great idea 
JohnCFierce	707600439236284416	2016-03-09T16:14:25	I'll be in London for a couple of days ahead of April BioTrinity panel, then off to Mother Russia to discuss aging. 
JohnCFierce	707599264629792768	2016-03-09T16:09:45	The long play: Aprea starts recruiting a U.S. team as it preps for PhII on p53 'Holy Grail' cancer drug 
JohnCFierce	707578341134569472	2016-03-09T14:46:37	Editor-in-Chief of FierceBiotech JohnCFierce is to chair panel discussion at biotrinity 2016 OBN_UK 
JohnCFierce	707586544870227968	2016-03-09T15:19:13	LOL my MDVN down 2.3% on FDA release from clinical hold of mystery drug.
JohnCFierce	707567169010331649	2016-03-09T14:02:13	I have a gut feeling that UC and The Broad are going to settle up on CRISPR. Excellent summary from sxbegle 
JohnCFierce	707548551107072000	2016-03-09T12:48:14	Looking forward the conversation where I inform our analysts that pharma class for pidlizumab should be changed to "Not A PD-1 Mab."  MDVN
JohnCFierce	707540250491486208	2016-03-09T12:15:15	It's not an 11 -- Penny biotech EBIO gets a delisting notice. 
JohnCFierce	707539419197259777	2016-03-09T12:11:57	That PD-1 drug that's not a PD-1 drug is now out from under a partial hold -- so MDVN's CEO can figure out just why he's so excited.
JohnCFierce	707535145646092288	2016-03-09T11:54:58	30 get the ax -- UPDATED: Sarepta shrinks as execs wait for FDA's decision on Duchenne drug SRPT 
JohnCFierce	707399769862377472	2016-03-09T02:57:02	538 had Clinton as a 99% likely winner in Michigan. She's behind right now.
JohnCFierce	707394906810097665	2016-03-09T02:37:43	SRPT confirms 30 layoffs in consolidation. 
JohnCFierce	707377816904572928	2016-03-09T01:29:48	The company's in limbo right now. If Kaye pulls this out, somehow, they'll make him czar. But, yes, long time. SRPT 
JohnCFierce	707373988650086400	2016-03-09T01:14:35	Sarepta shrinks as execs wait for FDA's decision on Duchenne drug SRPT 
JohnCFierce	707311431247650817	2016-03-08T21:06:01	Based on the FDA review, SRPT would seem to be tarred with the same brush. 
JohnCFierce	707309617945116673	2016-03-08T20:58:48	No one thinks of this as a neat little industry farce? 
JohnCFierce	707222585180889090	2016-03-08T15:12:58	Interested in virtual biotechs? Check out Capella: (antibodies) 
JohnCFierce	707219380602535936	2016-03-08T15:00:14	we're looking for another sharp science reporter: 
JohnCFierce	707219535468883968	2016-03-08T15:00:51	Female founders grab record VC deal share—but still just 18% [datagraphic]  via PitchBook
JohnCFierce	707203299259371520	2016-03-08T13:56:20	The reviews are so bad I don't even want to watch it now. I'll stick with the meat lovers special at Walking Dead 
JohnCFierce	707200085302644737	2016-03-08T13:43:34	Sanofi restructuring claims its JV for vaccines with Merck 
JohnCFierce	707192475623006208	2016-03-08T13:13:19	Sanofi, Merck end joint vaccine ops in Europe 
JohnCFierce	707182929907154945	2016-03-08T12:35:23	With $70M in VC cash, Tizona takes a fresh approach to immuno-oncology 
JohnCFierce	707168957791399936	2016-03-08T11:39:52	Capella Bio harnesses a virtual global team to a targeted antibody R&amp;D strategy.  by JohnCFierce
JohnCFierce	707147504123559938	2016-03-08T10:14:37	Capella Bio harnesses a virtual global team to a targeted antibody R&amp;D strategy 
JohnCFierce	706883810021871616	2016-03-07T16:46:48	Bristol-Myers prints a pair of 'Golden Tickets' for Cambridge biotech startups BMY by @DamianFierce  
JohnCFierce	706878416360857601	2016-03-07T16:25:22	XBI up 2.75% while the SPY is flat/red
JohnCFierce	706875574506143744	2016-03-07T16:14:04	JohnCFierce P2 great results leading to abysmal P3 failure - a few examples: CLDX, ZIOP, THLD, OGXI . Just statistics, or sth worse?
JohnCFierce	706873188102184961	2016-03-07T16:04:35	cancer vaccines have become the inside straight of biotech. You're almost always going to be one card short. CLDX
JohnCFierce	706856743289143296	2016-03-07T14:59:15	pavansut JohnCFierce Needs to be a vaccine inducing responses to patient specific neoantigens to have much hope of success, even in combo
JohnCFierce	706845448116543488	2016-03-07T14:14:22	As an add-on in combo therapy, I would agree. But as a mono therapy it's unappealing at best - so far. 
JohnCFierce	706838386070392832	2016-03-07T13:46:18	AbbVie hands over $595M upfront to partner with Boehringer on PhIII psoriasis drug 
JohnCFierce	706828050965655552	2016-03-07T13:05:14	that's upfront
JohnCFierce	706828004928987136	2016-03-07T13:05:03	AbbVie paying $595M to partner with Boehringer on immunology -- 
JohnCFierce	706824924619472896	2016-03-07T12:52:48	JohnCFierce agree with that sentiment - good target but not with a vaccine
JohnCFierce	706822663537295360	2016-03-07T12:43:49	Roth analysts predicted that Rintega was on a path to approval. I'd count that as a red flag.
JohnCFierce	706820901510234112	2016-03-07T12:36:49	CLDX down 60%-plus -- never bet on a cancer vaccine.  
JohnCFierce	706819701431771136	2016-03-07T12:32:03	Celldex's cancer vaccine Rintega implodes in glioblastoma PhIII CLDX 
JohnCFierce	706812659820269568	2016-03-07T12:04:04	adamfeuerstein GBM. Where every study f&amp;$@ fails
JohnCFierce	706812752355004416	2016-03-07T12:04:26	Here's the CLDX PR on Rintega fail. Blame it on the control arm. Look out below. 
JohnCFierce	706658203199782912	2016-03-07T01:50:19	PD-1 Blockade Expands Intratumoral Memory T Cells UCLA Antoni Ribas  ImmunoOnc AACR
JohnCFierce	706217389348622336	2016-03-05T20:38:41	Very decent, eclectic collection at the Nelson. van Gogh, Monet, Caravaggio. Trip through the centuries. One find: George Fuller's Hannah.
JohnCFierce	706156023120338945	2016-03-05T16:34:50	Synthetic biology nytimes ; Andrew Pollack profiles RJ Kirk/Intrexon's array of enterprises.  
JohnCFierce	706147513418514433	2016-03-05T16:01:01	We're lucky to have him --&gt; Derek Lowe: The chemist who puts a human face on drug development  via BostonGlobe
JohnCFierce	706089986207174656	2016-03-05T12:12:25	I'm always struck how overtly friendly people are in KC. Kind of irritating, really.
JohnCFierce	706080497282228224	2016-03-05T11:34:43	Finally got around to watching Steve Jobs last night. Loved the way Sorkin/Boyle structured it like a play in three acts.
JohnCFierce	705826139864956928	2016-03-04T18:44:00	A_E_Hansen -- I worked at the Star from 78-82. Then left for Central America and later Ireland. My walkabout decade.
JohnCFierce	705812922686173184	2016-03-04T17:51:28	And now...Kansas City. A very pleasant place to call home. My initial impression is that little has changed here in, like, forever.
JohnCFierce	705755749830406149	2016-03-04T14:04:17	Tim Anderson is digging deep to find cause to believe that MRK's anacetrapib PhIII could be +; would certainly surprise the hell out of me.
JohnCFierce	705749181269458944	2016-03-04T13:38:11	After much delay, the EMA finally prepares for trial transparency drive from Sept. 
JohnCFierce	705721569146875905	2016-03-04T11:48:28	The immuno-oncology watch -- Autolus fundraising now tops $105M for next-gen CAR-T work h/t BiotechJon 
JohnCFierce	705689452769845248	2016-03-04T09:40:51	Biding its time on Nasdaq IPO, Genfit extends runway with €50M private placement 
JohnCFierce	705558552245456897	2016-03-04T01:00:42	93 this afternoon in Harlingen. Nice breeze, though, and someone shoved a marguerita into my hand. So no complaints.
JohnCFierce	705475929607245824	2016-03-03T19:32:23	Autolus fundraising now tops $105M for next-gen CAR-T work CEO- Christian Itin, of Micromet fame AMGN 
JohnCFierce	705457743184863232	2016-03-03T18:20:07	Trump's healthcare plan backs drug reimportation, but leaves out Medicare price negotiation  pharma by TracyStaton
JohnCFierce	705455709521973248	2016-03-03T18:12:02	Just can't get enough on I-O? Come to my immuno-oncology panel at BioTrinity in London, April 26 -- 
JohnCFierce	705452411654017025	2016-03-03T17:58:56	That's for Congress to decide now. 
JohnCFierce	705448767152119808	2016-03-03T17:44:27	Reminder: Spark Therapeutics gene therapy SPK-TPP1 also going after CLN2 disease  I'm long both ONCE &amp; BMRN
JohnCFierce	705448796503810052	2016-03-03T17:44:34	Sanofi plots accelerated path to Zika vaccine 
JohnCFierce	705431757282127872	2016-03-03T16:36:51	JohnCFierce how about the Rare disease company perspective, the voucher is only incentive to attract investors 
JohnCFierce	705427828355964928	2016-03-03T16:21:15	That priority review voucher program? The FDA hates it biotech pharma 
JohnCFierce	705396247847424001	2016-03-03T14:15:45	Horizon and Centauri join forces to create new cancer spin-off Avvinity (a shame Astra was already taken):  biotech
JohnCFierce	705395597218443265	2016-03-03T14:13:10	Syndax braves a market tempest in second IPO try, scores a $53M raise SNDX 
JohnCFierce	705384241052274688	2016-03-03T13:28:03	Still licking Duchenne wounds, BioMarin makes an early run at Batten drug OK BMRN 
JohnCFierce	705124362802696192	2016-03-02T20:15:23	Rare-disease specialist Alexion hails progress on Sanfilippo B drug ALXN 
JohnCFierce	705114421379530752	2016-03-02T19:35:53	KITE spiked nearly $2 in the last minute
JohnCFierce	705082989974261760	2016-03-02T17:30:59	CD40: Penn investigators say they may have found the Achilles' heel of pancreatic cancer 
JohnCFierce	705072896377356288	2016-03-02T16:50:52	JUNO, KITE race to the FDA finish line with breakthrough CAR-T drugs 
JohnCFierce	705054570796417024	2016-03-02T15:38:03	Rare-disease specialist Alexion hails progress on Sanfilippo B drug.  by JohnCFierce ALXN
JohnCFierce	705021561472847872	2016-03-02T13:26:53	ICYMI: Gilead's latest HIV cocktail wins FDA approval with a blockbuster pedigree GILD 
JohnCFierce	704790885498654721	2016-03-01T22:10:16	Headed soon to pick up tex-mex at Pepe's in Harlingen. Had breakfast tacos from the Santa Rosa coffee shop (priceless). Pass the salsa.
JohnCFierce	704788129207549952	2016-03-01T21:59:18	Gilead's latest HIV cocktail wins FDA approval with a blockbuster pedigree GILD by @DamianFierce  
JohnCFierce	704787964983836673	2016-03-01T21:58:39	Dereklowe daviesbj Could be. Weird year. But I see Bloomberg as the classic Rep. for group that can't stomach Trump/won't vote clinton.
JohnCFierce	704785535257018368	2016-03-01T21:49:00	Which he'll do if he wants to guarantee a Clinton win - which may be the strategy. 
JohnCFierce	704783609878564864	2016-03-01T21:41:21	Not much doubt that we'll have a Clinton/Trump race by the end of today. For journalists covering the race 24/7, that's a gift.
JohnCFierce	704781270350434305	2016-03-01T21:32:03	For Boston beer lovers: The Ginger Man, a very good NYC craft beer bar, is opening a Boston location this wknd —&gt; 
JohnCFierce	704746692583821314	2016-03-01T19:14:39	Why did my Breakfast Club interview get 10x viewers of SenSanders ? Cause my shit is fire &amp; I cant be stopped, fam. 
JohnCFierce	704683567897444352	2016-03-01T15:03:49	Does Roche's IL-13 setback in PhIII signal similar trouble ahead for AstraZeneca? AZN 
JohnCFierce	704659650700931072	2016-03-01T13:28:47	Simos Simeonidis says PTCT is probably at the end of the road in the U.S. for ataluren. Has to mount a new PhIII.
JohnCFierce	704649137988378624	2016-03-01T12:47:00	ICYMI: PTCT: With no evidence of Duchenne MD efficacy, FDA barred regulators' doors to ataluren 
JohnCFierce	704442655988514816	2016-02-29T23:06:31	Chicken enchiladas at Las Vegas restaurant in Harlingen. Mid-80s. Habla espanol. Perfect.
JohnCFierce	704428367026630656	2016-02-29T22:09:45	And what are they waiting for now?  It stunned me at the time. No evidence of efficacy. Nothing. 
JohnCFierce	704426276296065025	2016-02-29T22:01:26	This is interesting 
JohnCFierce	704425762418507777	2016-02-29T21:59:24	johncfierce matthewherper Interesting for the regulatory person! Now I want to pull up guidance…
JohnCFierce	704422650781650944	2016-02-29T21:47:02	Exactly. As a shift, it's hugely important to biopharma. 
JohnCFierce	704421094300610561	2016-02-29T21:40:51	OK, so the FDA barred ataluren from the agency in the RTF --on efficacy decision; isn't that a fundamentally new role for the RTF?
JohnCFierce	704420619903848448	2016-02-29T21:38:57	PTC: With no evidence of Duchenne MD efficacy, FDA barred regulators' doors to ataluren PTCT 
JohnCFierce	704363438152118272	2016-02-29T17:51:44	'Brexit' risks serious side effects for U.K. life sciences by PharmaceuticBen 
JohnCFierce	704342538824462336	2016-02-29T16:28:41	Worst FDA decision of the past 5 years 
JohnCFierce	704307882804666369	2016-02-29T14:10:59	In a setback, AstraZeneca's immunotherapy tremelimumab flunks mesothelioma test AZN 
JohnCFierce	704299445400174592	2016-02-29T13:37:27	Well done to AKAarsalan for the new  site.. Excellent job! Must view for biotech readers. 👍
JohnCFierce	704300710398193664	2016-02-29T13:42:29	With ataluren under a cloud, PTC plunges (again) after a market setback in Germany.  by JohnCFierce PTCT
JohnCFierce	704287264998760449	2016-02-29T12:49:03	I'm still surprised he made it to last Christmas.  
JohnCFierce	704286193244962816	2016-02-29T12:44:48	Happy to see Spotlight hit in the Oscars. A worthy film. I suppose DiCaprio was not to be denied the Oscar for biggest star to go scruffy.
JohnCFierce	704282251110932480	2016-02-29T12:29:08	Top asthma drug at Roche posts 1 win, 1 flop in identical PhIIIs lebrikizumab 
JohnCFierce	704269437461860352	2016-02-29T11:38:13	Spell check strikes again.  
JohnCFierce	703951338128867332	2016-02-28T14:34:12	I don't have a clue who's going to win Oscars tonight. Guessing The Revenant, as Hollywood loves a roughed up star. But no true standouts.
JohnCFierce	703817773370073088	2016-02-28T05:43:28	So my wife is having a mini college reunion in texas and I'm drinking dogfish head 90 minute IPA. Which is very good. Try it, if u like beer
JohnCFierce	703574004439891968	2016-02-27T13:34:49	JohnCFierce adamfeuerstein and you know that notion just crossed the sell side mind
JohnCFierce	703572261328932864	2016-02-27T13:27:53	PTCT plunged another 30% yesterday on troubles in German market for ataluren. Trouble ahead, trouble behind.  adamfeuerstein
JohnCFierce	703340893328302081	2016-02-26T22:08:31	They brighten up a gloomy day when you see the absurdity like the CLDN $90 target last year 
JohnCFierce	703336435991101444	2016-02-26T21:50:48	Johnny on the spot. 
JohnCFierce	703336248207765504	2016-02-26T21:50:03	No, I don't think that's likely. 
JohnCFierce	703334616711561216	2016-02-26T21:43:34	I've heard that 
JohnCFierce	703334331293405184	2016-02-26T21:42:26	Just curious, but what's the rep out there on Roth Capital? Your opinions?
JohnCFierce	703256439398076417	2016-02-26T16:32:55	Forgot that AZN had partnered on  bavituximab combo with durvalumab. Not a good choice! 
JohnCFierce	703255209317781504	2016-02-26T16:28:02	PPHM down 62% on bavituximab PhIII flop. 
JohnCFierce	703254290857459712	2016-02-26T16:24:23	Where are all those PPHM trolls who gave me such a hard time over bavituximab? Phase 3 failure in lung cancer should not be a surprise
JohnCFierce	703254225636098048	2016-02-26T16:24:07	Baxalta dives into CAR-T with a $1.7B bet BXLT by @DamianFierce  
JohnCFierce	703229394131652608	2016-02-26T14:45:27	Does anybody expect government to really drive R&amp;D? Antibiotics? blah, blah, blah. DARPA? blah, blah, blah. Biodefense? Blah, blah, blah.
JohnCFierce	703221596513705984	2016-02-26T14:14:28	And on that score, top story of the week - so far - is the piece on Forty Seven, the Stanford/SF CD47 spinout. 
JohnCFierce	703218330841194496	2016-02-26T14:01:29	Glad to see the top trending story yesterday was the Exicure profile. Doesn't always happen with little biotechs. 
JohnCFierce	703217732917919744	2016-02-26T13:59:07	JohnCFierce Come to MN... Lots of up and coming biotech here!
JohnCFierce	703215573103054848	2016-02-26T13:50:32	Alfred Mann died -- MNKD 
JohnCFierce	703213784655986688	2016-02-26T13:43:25	BXLT and Precision Biosciences did a CAR-T deal (allogeneic), $105M upfront 
JohnCFierce	703208479519997956	2016-02-26T13:22:21	Light analysis on Twitter tells me my 3 top cities are New York, Boston and London. That's cool. But I need to spend more time in San Fran
JohnCFierce	703187483413106689	2016-02-26T11:58:55	EuroBiotech Report: Eye startup snags £13.5M; J&amp;J exits Galapagos; Micreos bags €12M for antibiotic alternative. 
JohnCFierce	703090106228412416	2016-02-26T05:31:58	No. 
JohnCFierce	703087825902645248	2016-02-26T05:22:55	You know you've arrived in Houston when three minutes after you get on the highway a Ford pickup roars past you going 100 mph. everytime
JohnCFierce	702993462115868672	2016-02-25T23:07:57	Steppin' on to my Houston flight in a few minutes; headed to the land of breakfast burritos and Lyle Lovett.
JohnCFierce	702926613420351488	2016-02-25T18:42:19	This is why you should hang with macbiocom at JPM - Thx JohnCFierce  mbi jpm16 jpm17 macbiocom
JohnCFierce	702900236214267905	2016-02-25T16:57:30	Backed by Bill Gates, low-profile Exicure steps into spotlight with a $42M R&amp;D gamble 
JohnCFierce	702879296227024897	2016-02-25T15:34:17	Everybody makes mistakes. That's the law. Apology accepted. 
JohnCFierce	702870919417614336	2016-02-25T15:01:00	oakazaki BioDueDiligence JohnCFierce it was the 2d mistake i made this a.m. my apologies. was why i re-tweeted.
JohnCFierce	702862630684332032	2016-02-25T14:28:04	Mais non! (And I commend your command of French.) 
JohnCFierce	702843587344646144	2016-02-25T13:12:24	Congrats JohnCFierce on 25k followers. You must be doing something right (or: interesting). From one of the 25k 
JohnCFierce	702842578811617280	2016-02-25T13:08:23	So after lo these many years I finally hit 25K Twitter followers. Thanks to all of you who have stuck around. It's been...really weird.
JohnCFierce	702839238019121152	2016-02-25T12:55:07	Will the EMA keep PTC's failed/spurned ataluren on the market for Duchenne MD? PTCT - CHMP will do an assessment 
JohnCFierce	702835271839129601	2016-02-25T12:39:21	Can't understand why Google, which has one of the best brand names on the planet, has to rebrand ops with dumb names like Verily, Alphabet
JohnCFierce	702608728286240768	2016-02-24T21:39:09	Trending today -- UPDATED: Google backs $75M A round for Stanford's immuno-oncology spinout Forty Seven 
JohnCFierce	702560986818023424	2016-02-24T18:29:26	Senate clears Califf as the FDA's next commissioner.  by @DamianFierce
JohnCFierce	702548118575915008	2016-02-24T17:38:18	West Coast biotechs not as well trained in PR as the Boston bunch - I used to regret it, now I love it. 
JohnCFierce	702538994765139968	2016-02-24T17:02:03	Juno scientific co-founder Stan Riddell adds another upgrade to CAR-T.  by JohnCFierce JUNO
JohnCFierce	702534163543543808	2016-02-24T16:42:51	According to CEO, it's all guaranteed 
JohnCFierce	702531070135238657	2016-02-24T16:30:34	Updated my story on Forty Seven - anti-CD47 - with CEO comments. They're hiring 
JohnCFierce	702522910947336192	2016-02-24T15:58:08	I'll see you there, Ted. -- (now what's that panel I'm moderating?) 
JohnCFierce	702518150387146752	2016-02-24T15:39:13	"Woodford's 2 funds have invested a combined £141M in Northwest since 2014." now worth about £40M. 
JohnCFierce	702504491686490112	2016-02-24T14:44:57	JohnCFierce didn't realize lightspeed had a healthcare team. Odd choice for lead.
JohnCFierce	702500305318113280	2016-02-24T14:28:19	JohnCFierce There are many trolls pumping this stock now. 55M mcap says everything you should know.
JohnCFierce	702497418143780864	2016-02-24T14:16:50	TRIL is based in Toronto, just started a PhI (but Forty Seven starts out with two PhI studies in the clinic) 
JohnCFierce	702494724222017536	2016-02-24T14:06:08	So, I get that Weissman has done key work on stem cells, but a CIRM grant for CD47? What's up with that.
JohnCFierce	702494206816886786	2016-02-24T14:04:05	Congrats to Prof Weissman, a leader in biotech since the beginning! 
JohnCFierce	702493453003988992	2016-02-24T14:01:05	Google backs $75M A round for Stanford's immuno-oncology spinout Forty Seven 
JohnCFierce	702477129552957441	2016-02-24T12:56:13	First, drill holes-- Pitt investigators start a proof-of-concept study of Voyager's gene therapy for Parkinson's 
JohnCFierce	702317337165303808	2016-02-24T02:21:16	Bush got 4 delegates and spent $32.5 million for each one.  Has to be a record of some kind.
JohnCFierce	702316450711793664	2016-02-24T02:17:44	Tell that to 24/7 cable, which camped outside their doors. There has to be a better way to cover an outbreak.  
JohnCFierce	702309360421179395	2016-02-24T01:49:34	ebola burned out, they couldn't enroll the numbers needed. the problems of outbreak r&amp;d 
JohnCFierce	702271832678862848	2016-02-23T23:20:27	I recall a story about Bill Clinton checking balance at an ATM. Ex-prez, big speaker fees: $1M+ Laughed his ass off 
JohnCFierce	702248235495251968	2016-02-23T21:46:41	And PTCT closes down 61%
JohnCFierce	702247727640551424	2016-02-23T21:44:40	What's left to lose? Even more share price. I'm curious whether the FDA rules on RTFs may be shifting. AlecGaffney 
JohnCFierce	702244998495002627	2016-02-23T21:33:49	RTF letters from the FDA really need to be public. PTCT
JohnCFierce	702229160341725184	2016-02-23T20:30:53	Kate Bingham (SV Life Sciences) - EU makes VC fundraising more difficult. Brexit could be positive biotuesday
JohnCFierce	702220489838690304	2016-02-23T19:56:26	Odd, slow, steady fall for PTCT, now down 57%. Usually this is all done in a matter of minutes.
JohnCFierce	702179376293609472	2016-02-23T17:13:03	Pronutria has built a hell of a team and has ample funds for R&amp;D. This one will be interesting to watch. 
JohnCFierce	702166744673206273	2016-02-23T16:22:52	PTCT now down 48%
JohnCFierce	702163490279137281	2016-02-23T16:09:56	Fine article by lisamjarvis on a day in the life of a small company at the JPMorgan conf.:  
JohnCFierce	702161647390031874	2016-02-23T16:02:36	ClaudiaHirawat JohnCFierce matthewherper  A proposed 'novel mechanism' which defies credulity, that is...
JohnCFierce	702151170513641472	2016-02-23T15:20:59	But if you're not sure the drug works, why apply at all? 
JohnCFierce	702146396594561025	2016-02-23T15:02:00	ClaudiaHirawat matthewherper OK, but why exactly didn't they do that? (And I'm not being argumentative)
JohnCFierce	702145856863129601	2016-02-23T14:59:52	Claudia's president of PTCT -- and the Phase III fail followed an earlier failure, which should have guided design 
JohnCFierce	702141525665439744	2016-02-23T14:42:39	JohnCFierce A consequence of unjustifiable optimism (by patients desperate for options and by companies seeking profit)
JohnCFierce	702141211050700800	2016-02-23T14:41:24	Of course, PTCT's drug always sucked and always failed. How it got a conditional OK in Europe still amazes me.
JohnCFierce	702137356460171264	2016-02-23T14:26:05	Incredible what a horrible, awful, no good year this has been for Duchenne MD patients and families. Nothing but rout and disaster.
JohnCFierce	702136003880943616	2016-02-23T14:20:43	PTC plunges after FDA spurns its failed Duchenne muscular dystrophy drug PTCT SRPT BMRN 
JohnCFierce	702127955359744000	2016-02-23T13:48:44	Nestlé pays $42.5M to buy into Pronutria as it blazes a trail to pivotal data 
JohnCFierce	702122714174193664	2016-02-23T13:27:54	PTCT - look out below   
JohnCFierce	702113624962236421	2016-02-23T12:51:47	Big congrats to AKAarsalan for the new  site. I love it. You should check it out.
JohnCFierce	701867843051249664	2016-02-22T20:35:08	Probably not. But you know that doesn't prevent anybody from making conclusions anyway. :) 
JohnCFierce	701834826530340864	2016-02-22T18:23:56	Winter is coming. 
JohnCFierce	701818544770719744	2016-02-22T17:19:14	Something more equivalent to RDUS rival, so dosing advantage could create market dominance. 
JohnCFierce	701814736250388480	2016-02-22T17:04:06	Geoffrey Porges at Leerink also pouring cold water on Amgen's romo data. Lotso skepticism --$RDUS AMGN
JohnCFierce	701813381821378560	2016-02-22T16:58:43	sciencescanner JohnCFierce TracyStaton you think? They are tough to take and we have one trial with great outcome that nobody can explain
JohnCFierce	701812409980297216	2016-02-22T16:54:52	JohnCFierce TracyStaton Nice list. But SGLT2 inhibitors will be in the mix if macrovascular protection data keeps panning out
JohnCFierce	701810564864016384	2016-02-22T16:47:32	The top 20 drugs in 2020--worldwide sales (Revlimid is no. 2) by TracyStaton 
JohnCFierce	701798735622307840	2016-02-22T16:00:32	Syndax readies its 2nd IPO attempt during a market tempest SNDX (maybe) 
JohnCFierce	701787639414988801	2016-02-22T15:16:26	Sanofi cuts the FDA line with a diabetes combo, hoping to lap Novo.  by @DamianFierce SNY NVO
JohnCFierce	701788453097381888	2016-02-22T15:19:40	RDUS up 26% on AMGN osteo drug data for romo -- 
JohnCFierce	701758655755116544	2016-02-22T13:21:16	RDUS up 18% in premarket trading. AMGN not comparing so well? 
JohnCFierce	701752941955444736	2016-02-22T12:58:33	Amgen's osteoporosis drug 'romo' comes through with promising PhIII AMGN 
JohnCFierce	701742398024638464	2016-02-22T12:16:40	CMRX, back to PhII - ICYMI: Chimerix scraps two PhIII trials as it regroups in wake of a setback 
JohnCFierce	701502623082528768	2016-02-21T20:23:53	Chimerix scraps two PhIII trials as it regroups in wake of a setback ($CMRX) 
JohnCFierce	701388752237756417	2016-02-21T12:51:24	CMRX shut down two other PhIIIs for brincidofovir - following the first PhIII failure in Dec.  
JohnCFierce	701214761212583936	2016-02-21T01:20:01	Reporter who just came from the Jeb event says, “I’ve seen happier funerals."
JohnCFierce	701118339188400128	2016-02-20T18:56:52	Or offer a healing touch at $50 a pop? 
JohnCFierce	701115519336890368	2016-02-20T18:45:40	realDonaldTrump: Better to say that both parties are stupid on healthcare. Need Medicare neg.s (transparency) +industry pricing innovation.
JohnCFierce	701110540576411650	2016-02-20T18:25:53	Trump's brain trust on healthcare? Those little voices in his head. 
JohnCFierce	701097094262685696	2016-02-20T17:32:27	50 F -- Just another spring day in Vermont, in what should be deep winter. interestingtimes
JohnCFierce	700853450553348096	2016-02-20T01:24:18	RPRX: man, the work that went in to that sentence
JohnCFierce	700853267270598656	2016-02-20T01:23:34	(Repros) believes that it was clear during the meeting that the FDA is not closed to entertaining secondary hypogonadism as an indication.
JohnCFierce	700819292938444800	2016-02-19T23:08:34	Week ahead: A microcap biotech and a SPAC INTR RRR SRAQU KLREU YERR AITPU MAPI IPO IPO 
JohnCFierce	700815170638061568	2016-02-19T22:52:11	I've been watching The Hollow Crown -- excellent Shakespeare. Good stuff. Lots of RADA graduates on the set.
JohnCFierce	700795597096296449	2016-02-19T21:34:25	Armand: discussing pidilizumab anti-PD1 data “inconclusive” but this is the MDVN agent that’s not really an anti-PD1! bmttandem16
JohnCFierce	700723309726593024	2016-02-19T16:47:10	Valeant's Canadian tax-parent got David Maris (of the bearish Wells Fargo note) fired a decade ago (h/t JFinDallas) 
JohnCFierce	700722911330566144	2016-02-19T16:45:35	Nope, hadn't heard yet. 
JohnCFierce	700681322491199489	2016-02-19T14:00:19	Alfred Mann Steps Down as Executive Chairman of Mannkind MNKD
JohnCFierce	700672082611458052	2016-02-19T13:23:37	ICYMI: Adimab issues a challenge: Use new tech to build a rapid-response R&amp;D platform for infectious diseases 
JohnCFierce	700670248958164992	2016-02-19T13:16:19	eurobio -- Forbion, ex-Dezima team gun for Intercept; Ipsen ousts deputy CEO; e-Therapeutics defends data 
JohnCFierce	700483777190088704	2016-02-19T00:55:21	I was asked for intro to big pharma X. Of my 16 contacts there, zero remain. Luckily the beneficial recipient is biotech ExodusOfPharma
JohnCFierce	700443201048604672	2016-02-18T22:14:07	Biotech companies can have a great stock long before becoming a viable business--troublesome when funding dries up. 
JohnCFierce	700443582319218689	2016-02-18T22:15:38	Great piece looking at the systematic bias women face in science from male colleagues.  
JohnCFierce	700431464312283136	2016-02-18T21:27:29	Bottom-dwelling biotech Hemispherx dumps its CEO and vows to stamp out nepotism.  by @DamianFierce HEB
JohnCFierce	700392781622222848	2016-02-18T18:53:46	Thanks .JohnCFierce for survey - brings the genderparity issue front &amp; center HBAimpact .FierceBiotech 
JohnCFierce	700395213320286208	2016-02-18T19:03:26	Antibody tech cuts a lengthy process down to a matter of weeks. Hello BillGates -- you'd like this one: 
JohnCFierce	700394476548857856	2016-02-18T19:00:30	Adimab issues a challenge: Use new tech to build a rapid-response R&amp;D platform for infectious diseases 
JohnCFierce	700358284524527618	2016-02-18T16:36:41	biotech vet grabs AstraZeneca drug, $26M to start building a new cardio biotech AZN 
JohnCFierce	700315162520248320	2016-02-18T13:45:20	Zafgen touts its obesity drug as safety threat continues to plague outcomes ZFGN 
JohnCFierce	700294395325718528	2016-02-18T12:22:49	Third Rock launches Pliant, gambling $45M on a next-gen approach to fibrosis.  by JohnCFierce
JohnCFierce	700275535545552896	2016-02-18T11:07:52	Re: LifeSci Advisors at JPM16 you must see this:  JohnCFierce
JohnCFierce	700282453085286400	2016-02-18T11:35:22	ZFGN Adverse event summary 
JohnCFierce	700185863502872576	2016-02-18T05:11:33	Third Rock launches Pliant, gambling $45M on a next-gen approach to fibrosis 
JohnCFierce	700025157885259776	2016-02-17T18:32:58	Good times...I miss that 
JohnCFierce	699998084990894081	2016-02-17T16:45:23	Regulus shares spike on a high success rate for RG-101 hep C combos.  by JohnCFierce RGLS
JohnCFierce	699993319271608321	2016-02-17T16:26:27	It’s heating up in bladder cancer as AZN durvalumab gets breakthrough status. RHHBY atezolizumab already filed 
JohnCFierce	699978697252728832	2016-02-17T15:28:21	autocorrect does not speak biotech.
JohnCFierce	699961362760466432	2016-02-17T14:19:28	Analysis: Scrap the NIH funding model and switch to a lottery.  by JohnCFierce
JohnCFierce	699943096948297728	2016-02-17T13:06:53	An update on Catalyst Pharmaceuticals, another jack-the-price-on-an-old-compound business plan: 
JohnCFierce	699943471017279488	2016-02-17T13:08:22	It's been fun watching the traffic/responses on the gender issue last few wks. There's a whole segment of the male audience tuning it out.
JohnCFierce	699938294298210304	2016-02-17T12:47:48	How well is biopharma doing on gender diversity? Well, depends on who you ask... Survey results -- 
JohnCFierce	699937109629657090	2016-02-17T12:43:05	Hiring in the UK: immunocore: regulatory, antibody discovery group leader, sr scientists-cell biology &amp; formulation 
JohnCFierce	699933246319128577	2016-02-17T12:27:44	INO keeps to its Hollywood timetable on Zika, gets a robust response in mice, oh my. Stock juiced 8%. 
JohnCFierce	699930662493646848	2016-02-17T12:17:28	While durvalumab ($AZN) and Roche's ocrelizumab both get BTD status today.
JohnCFierce	699929890276167680	2016-02-17T12:14:24	How embarrassing. Catalyst CPRX gets a refuse-to-file letter on Firdapse NDA --  
JohnCFierce	699926272345010177	2016-02-17T12:00:01	Orbimed helps bankroll Synlogic's drive to the clinic with $40M round 
JohnCFierce	699703908273360898	2016-02-16T21:16:26	In politics, patriotism is the last refuge of scoundrels. In biopharma, it's patients. 
JohnCFierce	699685913769672704	2016-02-16T20:04:56	And the view from most men and women split apart. 
JohnCFierce	699685560714203136	2016-02-16T20:03:31	Survey: Biopharma gets a bad grade on gender diversity 
JohnCFierce	699626196506669057	2016-02-16T16:07:38	writing the gender diversity survey -- 462 very interesting responses, with a distinct divide between a male/female perspective. Coming soon
JohnCFierce	699620616719065088	2016-02-16T15:45:28	That makes me feel ever so much better.... 
JohnCFierce	699619665878917122	2016-02-16T15:41:41	I'm using it loosely, of course. Cash=survivability. I suspect it also helps on a certain reproductive score basis. 
JohnCFierce	699604091073339392	2016-02-16T14:39:47	Got plenty of cash? Market carnage sets up a Darwinian showdown in biotech 
JohnCFierce	699602240986816514	2016-02-16T14:32:26	Akarna joins the NASH race with a $15M fundraise by PharmaceuticBen 
JohnCFierce	699589918230781953	2016-02-16T13:43:28	JUNO will benefit the most from this, but not the last word on CAR-T by a long shot.  
JohnCFierce	699587356270194688	2016-02-16T13:33:18	TNXP down 38% on PhII fail. Not a great time to flag a flop. 
JohnCFierce	699570079596412928	2016-02-16T12:24:39	ICYMI: Another depression drug flops as e-Therapeutics tallies PhIIb data AIM: ETX 
JohnCFierce	699366046944210944	2016-02-15T22:53:53	So, is the anti-roci crowd factoring in the low, low bar for FDA cancer drug approvals? Methinks not. But, hey. 
JohnCFierce	699361373445361665	2016-02-15T22:35:19	MRK gets a CRL for Zetia/Vytorin for cardio -- 
JohnCFierce	699244254330253313	2016-02-15T14:49:56	It's a wheat-from-chaff time. We'll see who stands out and who gets trampled. It's going to be fascinating to watch 
JohnCFierce	699242545562447877	2016-02-15T14:43:08	As I mentioned before, most conversations with biotech CEOs these days quickly turn to $$ in the bank.
JohnCFierce	699242157606100992	2016-02-15T14:41:36	We'll see some leaky boats out there, but I wonder how much of a bargain they'd be. Lotso biotechs tanked up on $$ 
JohnCFierce	699236762854539265	2016-02-15T14:20:10	Yesterday I spoke with a trusted source who is long GILD. On the M&amp;A question he was clear: "I want them to wait."
JohnCFierce	699235935725228032	2016-02-15T14:16:52	That uncomfortable moment when you try to tout a depression drug that was worse than the 55-y-o generic. 
JohnCFierce	699231788758134784	2016-02-15T14:00:24	Another depression drug flops as e-Therapeutics tallies PhIIb data (AIM: ETX) 
JohnCFierce	699203044794310656	2016-02-15T12:06:11	Quantifying The Carnage: Biotech IPO Markets In Turmoil - 74% of 2013-2016 IPOs are under their offer price. 
JohnCFierce	699007688957530113	2016-02-14T23:09:54	I thought JNJ went at this in a very straightforward manner.  
JohnCFierce	698412599998808064	2016-02-13T07:45:14	[Video] Experts predict the future of BigData at JPM16  | FierceBiotech 
JohnCFierce	698944608764588032	2016-02-14T18:59:15	I'm always left wondering from time to time if this is another hack job. 
JohnCFierce	698904697508339712	2016-02-14T16:20:39	JasonHolman5 If the tables were turned the Dems would do what the Reps are doing -- and vice versa.
JohnCFierce	698896803190743041	2016-02-14T15:49:17	U.S. politics today is the art of holding multiple contradictory opinions and selling it as common sense. bothsides 
JohnCFierce	698864238622859266	2016-02-14T13:39:53	And yes, I'll make fun of Palin---in case there are a few confused followers left who need to buy a clue and stop following me.
JohnCFierce	698863541990920192	2016-02-14T13:37:07	All fun politicizing aside, Obama will come up with a fine nominee for SCOTUS and the Rep.s will button it up until after the election.
JohnCFierce	698691781337202689	2016-02-14T02:14:36	We're getting a cold snap up here in the frozen north. Wish we had three feet of snow.
JohnCFierce	698635150880591872	2016-02-13T22:29:34	JohnCFierce he struck up a convo with me at DCA once; no idea who he was. what line of work you in? "I work in the judiciary". Googled him.
JohnCFierce	698634020029075458	2016-02-13T22:25:05	Keep your eye on DC Circuit Judge SRI SRINIVASAN as scalia successor on SCOTUS
JohnCFierce	698633683343962112	2016-02-13T22:23:44	JeffreyToobin thinks so too --   
JohnCFierce	698632519248379904	2016-02-13T22:19:07	Twisted, sick and plausible in '16 
JohnCFierce	698632262712164353	2016-02-13T22:18:06	Michelle O. Think about it. 
JohnCFierce	698632023905271808	2016-02-13T22:17:09	And of course, the Republicans tonight can compete to see who has the most radical name in mind.
JohnCFierce	698631022376853505	2016-02-13T22:13:10	I'm figuring if nothing else Obama will think about this strategically, around the election. 
JohnCFierce	698627918977724416	2016-02-13T22:00:50	Been awhile since I've thought about supreme court appointments. I'm assuming the Senate can keep it buttoned up until the election.
JohnCFierce	698627587862609922	2016-02-13T21:59:31	Scalia died in Big Bend country, south of Marfa. Maybe the prettiest place in Texas. Stark landscape.
JohnCFierce	698623956048330752	2016-02-13T21:45:05	Antonin Scalia reported dead at age 79 
JohnCFierce	698300973815431172	2016-02-13T00:21:40	JohnCFierce adamfeuerstein BiotechPhD not solid gold - fools gold...
JohnCFierce	698295471412891650	2016-02-12T23:59:48	Clovis looks to rebuild the case for its cancer drug at FDA panel  [h/t FierceBiotech]
JohnCFierce	698292404911267840	2016-02-12T23:47:37	justjokingtobeperfectlyclear 
JohnCFierce	698292015394635777	2016-02-12T23:46:04	Typos? What are typos? Is this Greek for some sort of human failing? IamperfectOK? 
JohnCFierce	698275105927876608	2016-02-12T22:38:53	It's a half-day ODAC for Clovis' CLVS rociletinib for NSCLC patients w EFGR T90M mutation  
JohnCFierce	698274995382919168	2016-02-12T22:38:26	Game. Over. 
JohnCFierce	698269449313452032	2016-02-12T22:16:24	Independent goes digital-only in the UK, FT and guardian may be next -- BBC 
JohnCFierce	698253262508716032	2016-02-12T21:12:05	Headed straight to $4.50. You bet. Analysis you can rely on roth - peak sales $1B+ CTIC  
JohnCFierce	698250237593391104	2016-02-12T21:00:04	Biopharma and gender diversity via johncfierce pharma  
JohnCFierce	698238474659483649	2016-02-12T20:13:19	ICYMI: my post ASH15 in-depth look at the multiple myeloma landscape: 
JohnCFierce	698239498577186816	2016-02-12T20:17:23	Nobody invites me to the islands. Biotech seems to gravitate to gritty, astronomically expensive urban areas. alas 
JohnCFierce	698217026238685189	2016-02-12T18:48:05	Once again, I end the week envying MaverickNY 
JohnCFierce	698211954704441345	2016-02-12T18:27:56	My bad, Adam. That's S-P Russia. We could do a hell of a tweet up; Except for Miami Beach, I really can't stand FL. 
JohnCFierce	698209958228312064	2016-02-12T18:20:00	I'm being invited to speak at an aging R&amp;D conference in St. Petersburg in April. Hmmmm. I think yes.
JohnCFierce	698208672317620227	2016-02-12T18:14:54	But that's a great idea. You can get Roth to sponsor it and send in their solid gold go-go dancers. surefirehit 
JohnCFierce	698204427258347520	2016-02-12T17:58:02	Grizzly bear biotech market. Like in the Revenant 
JohnCFierce	698173460338622465	2016-02-12T15:54:59	headed to 400 responses on the gender diversity in biotech survey -- join in. Final results next Wednesday. 
JohnCFierce	698155197445459968	2016-02-12T14:42:24	printisdead 
JohnCFierce	698147574386200576	2016-02-12T14:12:07	Apellis raises $47M after pulling the plug on an $86M IPO.  by @DamianFierce
JohnCFierce	698146197442334720	2016-02-12T14:06:39	Really? I saw most of CLVS downside post launch, going against AZN. Pazdur, as we know, can accept quite a lot. 
JohnCFierce	697905657564000256	2016-02-11T22:10:49	Biotechs lean heavily on insider buying to complete Quasi-IPOs AVXS PTI EDIT BGNE IPO  
JohnCFierce	698129907369558018	2016-02-12T13:01:55	Google cool: I spend no time fundraising,” Maris tells CarolineYLChen. “Alphabet can give us as much $$ as we want. 
JohnCFierce	698128936912474112	2016-02-12T12:58:03	GOOG's GV seeks to make name as a farsighted health investor: 
JohnCFierce	698127603409035264	2016-02-12T12:52:45	... just shows how moderate U.S. political rhetoric on drug pricing really is.   
JohnCFierce	697904471255416832	2016-02-11T22:06:07	No worries about the tax lien? 
JohnCFierce	697887680781291520	2016-02-11T20:59:23	That's what I've been hearing/ 
JohnCFierce	697883122155724800	2016-02-11T20:41:17	Received a few different queries asking if they can fill out the gender diversity survey anonymously. That is fine 
JohnCFierce	697828474426408960	2016-02-11T17:04:07	They've had their fun. Time to suck it up for awhile. 
JohnCFierce	697827058542649344	2016-02-11T16:58:30	Why subject yourself to this punishment if you have more than 2 years cash in the bank? 
JohnCFierce	697814041926959104	2016-02-11T16:06:47	JAK inhibition for solid tumors flops, forcing Incyte to pull the plug on a slate of trials.  by JohnCFierce INCY
JohnCFierce	697812029017624577	2016-02-11T15:58:47	JAK inhibition for solid tumors flops, forcing Incyte to pull the plug on a slate of trials INCY down 23% 
JohnCFierce	697808896308703236	2016-02-11T15:46:20	Added CEO comments on new deals to AEGR reorganization/layoffs story -  
JohnCFierce	697790884449017856	2016-02-11T14:34:45	With an eye on growing the pipeline, Szela axes staffers in Aegerion reorg AEGR 
JohnCFierce	697778009714065408	2016-02-11T13:43:36	Two more IPOs out. It's like the Great Escape AveXis and Proteostasis survive the market storm, raise $145M for R&amp;D 
JohnCFierce	697763689303318528	2016-02-11T12:46:42	ICYMI: Just how well do you think biopharma is handling the gender diversity issue? - interesting comments coming in 
JohnCFierce	697758782575742976	2016-02-11T12:27:12	Going where LLY failed, Heptares plans PhII Alzheimer's, schizophrenia trials after M1 agonist clears clinical test 
JohnCFierce	697757131957780480	2016-02-11T12:20:38	early next week -- take the survey:  
JohnCFierce	697604035956908032	2016-02-11T02:12:17	HeptaresTL plans PhII Alzheimer's, schizophrenia trials after M1 agonist clears 1st clinical test NickPaulTaylor 
JohnCFierce	697568079363055616	2016-02-10T23:49:24	JohnCFierce 106 board seats on IBB's top 10 companies. Just 10 non-white. Only 1 AA GILD's Kevin Lofton. 
JohnCFierce	697530426395648000	2016-02-10T21:19:47	I want to take my car to the shop and I have no time. (I feel so much better) 
JohnCFierce	697525917594288128	2016-02-10T21:01:52	Many other reasons to have woman in leadership roles but good to learn it pays off financially too 
JohnCFierce	697490299531223040	2016-02-10T18:40:20	Well.... 
JohnCFierce	697485206996045825	2016-02-10T18:20:06	Cool, we're already generating dozens of responses from biotech execs on gender diversity. What are your thoughts? 
JohnCFierce	697473310964256768	2016-02-10T17:32:50	No poll really required, read our reports from 2014 and 2015 and you'll see quite clearly how well its doing 
JohnCFierce	697465003641806848	2016-02-10T16:59:49	I'm a lot less interested in butting heads on Twitter than most people think, but you'd be wrong - again. 
JohnCFierce	697461991582121984	2016-02-10T16:47:51	A or F?  Poll: Just how well do you think biopharma is handling the gender diversity issue? ROTHCapital 
JohnCFierce	697409871675846657	2016-02-10T13:20:45	Celgene, Google ante up for Armo's next-gen IL-10/PD-1 immuno-oncology combos CELG GOOG 
JohnCFierce	697399568317681664	2016-02-10T12:39:48	Arsalan, no one should have a Trump voice in their head. Listen to some Pee Wee Herman tapes. Clean the palate. 
JohnCFierce	697392982622924802	2016-02-10T12:13:38	AbbVie taps Synlogic to take a microbiomic approach to IBD ABBV by @DamianFierce  
JohnCFierce	697386989025423361	2016-02-10T11:49:49	Now, wait. This is important. Aaron Sorkin is writing To Kill A Mockingbird for Broadway. I can hear the dialogue. 
JohnCFierce	697383646286708737	2016-02-10T11:36:32	PearlF sciencescanner Concept quite academic at this stage. Tough target. Likely tox issues. Useful for oncology? 
JohnCFierce	697384335373168640	2016-02-10T11:39:16	ICYMI: FDA panel backs Pfizer and Celltrion's Remicade biosimilar over J&amp;J's objections PFE JNJ by @DamianFierce 
JohnCFierce	697382953685544960	2016-02-10T11:33:47	Shouldn't there be a three strikes law in biotech? CTIC hit with complete hold following deaths. 
JohnCFierce	697380870446039041	2016-02-10T11:25:30	JohnCFierce Absolutely, but not before first extracting a few million dollars for himself.
JohnCFierce	697380681211650048	2016-02-10T11:24:45	I really think that if you handed CTIC/Bianco a really great drug, he'd find a way to screw it up. 
JohnCFierce	697378129917177856	2016-02-10T11:14:37	Biogen, Sanofi back Tony Coles' neurodegeneration player Yumanity BIIB SNY 
JohnCFierce	697257318568873984	2016-02-10T03:14:33	sorry, my bad - referring to the usual suspects found on google. 
JohnCFierce	697254756348227584	2016-02-10T03:04:22	Speaking of patient deaths, it's just weird that no one else wrote up the Akashi patient death in Duchenne's study - 
JohnCFierce	697251127771979777	2016-02-10T02:49:57	Patient deaths force FDA to slam the brakes on PhIII program for CTI/Baxalta's pacritinib CTIC BXLT 
JohnCFierce	697189902530707457	2016-02-09T22:46:40	FDA panel backs Pfizer and Celltrion's Remicade biosimilar over J&amp;J's objections PFE JNJ by @DamianFierce 
JohnCFierce	697177408701489152	2016-02-09T21:57:01	JohnCFierce Only 1 no voter commented so far. Concern was lack of safety data in IBD 2 b addressed in ongoing studies. Other indications OK
JohnCFierce	697176968190513152	2016-02-09T21:55:16	FDAadcomm What were the reasons for the 3 no votes? This looked like a unanimous no brainer.  Somebody just doesn't like biosims.
JohnCFierce	697170489479991296	2016-02-09T21:29:32	If I ever go that route, you'll be the first contact. 
JohnCFierce	697162872451948545	2016-02-09T20:59:16	The way I look at agbio, it's a huge business controlled by a few multinationals. From a reporter's perspective, it's narrow/closed
JohnCFierce	697161730246496256	2016-02-09T20:54:43	CLLS CEO Andre Choulika is passionate about all things, but he's really pumped about Calyxt -- plant genomics. Not my arena-but interesting
JohnCFierce	697076879329730561	2016-02-09T15:17:33	Are the big M&amp;A players in biopharma (like Sanofi/Gilead/Biogen) waiting out the bear market? CGrantWSJ biotech 
JohnCFierce	697009943191355392	2016-02-09T10:51:34	Sanofi falls to its lowest level in 2 years after flat forecast  via business
JohnCFierce	696904006086631424	2016-02-09T03:50:37	where do they get these calorie numbers? fitbit
JohnCFierce	696903362877530112	2016-02-09T03:48:04	fitbit says i walked 13,161 steps and burned 2,852 calories today; oh, and i ran a 2-minute mile on the fitbit clock.
JohnCFierce	696811209392332800	2016-02-08T21:41:53	The underlying theme with biotech CEOs these days is $$ in the bank. Time to ride out the storm.
JohnCFierce	696810957750857728	2016-02-08T21:40:53	The new rule -- EDIT and BGNE the exceptions. 
JohnCFierce	696724065231511552	2016-02-08T15:55:36	Likewise 
JohnCFierce	696723910973374464	2016-02-08T15:54:59	It was the prison yard tatts and wife beater shirt that got my attention. justjoking 
JohnCFierce	696723603140800513	2016-02-08T15:53:46	Just ran into bradloncar at BIOCEO16
JohnCFierce	696706312084791300	2016-02-08T14:45:03	SRPT down 6%. Seems a delay could only help its case, which has been very weak.
JohnCFierce	696703912779390976	2016-02-08T14:35:31	AstraZeneca's cancer checkpoint combo looks promising in small lung cancer study AZN MRK 
JohnCFierce	696685068740386816	2016-02-08T13:20:38	CTIC and BCRX get taken back to the wood shed for another spanking. How do these biotech co.s retain investors?
JohnCFierce	696684717777756160	2016-02-08T13:19:15	Baxalta partner CTI plunges after FDA slaps partial hold on PhIII myelofibrosis drug CTIC BXLT 
JohnCFierce	696677406665474050	2016-02-08T12:50:12	ICYMI: UPDATED: A patient in Akashi's suspended Duchenne MD trial dies 
JohnCFierce	696676995166507008	2016-02-08T12:48:33	BioCryst shares tank after a PhII for hereditary angioedema flops ($BCRX shares tank, where have I seen that before? 
JohnCFierce	696530641689649152	2016-02-08T03:07:00	VRX But there I go again with that darn relentless criticism....
JohnCFierce	696530163576762369	2016-02-08T03:05:06	VRX and common sense haven't been closely linked in some time. 
JohnCFierce	696441735820525569	2016-02-07T21:13:43	JohnCFierce you’re free to take some of mine then in that case.
JohnCFierce	696438159085805568	2016-02-07T20:59:30	By my rough, back-of-the-envelope calculation, I've written more than 3 million words on biotech. And I still look forward to each new day.
JohnCFierce	696433782254149632	2016-02-07T20:42:07	Great Picasso sculpture exhibit at MOMA. Hell of a retrospective. 
JohnCFierce	696349575515340800	2016-02-07T15:07:31	JohnCFierce how shocking, 2 female dancers on stage..
JohnCFierce	696345289687302144	2016-02-07T14:50:29	JohnCFierce Nice work on this John
JohnCFierce	696344638421147648	2016-02-07T14:47:53	And number three in the series is under construction.
JohnCFierce	696343772737728512	2016-02-07T14:44:27	Number two with a bullet:  Hit with a storm of protest, LifeSci Advisors apologizes for its J.P. Morgan party 
JohnCFierce	696343630575964160	2016-02-07T14:43:53	Top story last week: 'Let this letter be a shot across the bow to the entire industry' 
JohnCFierce	696173127320129537	2016-02-07T03:26:22	Seeing Jeff Daniels and Michelle Williams in Blackbird this evening was interesting. Bit prolonged and necessarily grim, I s'pose.
JohnCFierce	695794971669098498	2016-02-06T02:23:43	Sources at Twitter tell me algorithms are strictly opt in.
JohnCFierce	696087791986307074	2016-02-06T21:47:16	Smirking Martin Shkreli tops Gail Collins' list of "the things we love to loathe" created a 'bipartisan desire to...strangle the witness. '
JohnCFierce	695976257507430401	2016-02-06T14:24:05	Twitter is a powerful platform for a huge no. of people; has to be acutely aware of the fallout if they screw it up 
JohnCFierce	695807956164722692	2016-02-06T03:15:18	My experience with algorithms leads me to believe that they are crude and dumb. Maybe in 10 years, but not now.  
JohnCFierce	695759250308669441	2016-02-06T00:01:46	I'll be headed to BIOCEO16 tomorrow -- Looking forward to a string of interesting meetings. --
JohnCFierce	695753479772577792	2016-02-05T23:38:50	matthewherper MartinShkreli NewYorker I thought I would disagree with this much more than I actually did.
JohnCFierce	695753135118221312	2016-02-05T23:37:28	oh, man -- woodford picked just the wrong time to get bullish in biotech. NWBO silence is painfully thin skinned-- 
JohnCFierce	695585974399692800	2016-02-05T12:33:14	Brit investor Neil Woodford clobbered by biotech bear market. No mention of NWBO in his January letter 
JohnCFierce	695372983976656897	2016-02-04T22:26:53	Congrats to Feng Zhang and the rest of the editasmed crew who joined FlagshipVenture for a post-IPO toast EDIT 
JohnCFierce	695737912298762240	2016-02-05T22:36:59	Behind the ROTHCapital story, interesting to see that Akashi trial death is trending strongly -- 
JohnCFierce	695731697808228352	2016-02-05T22:12:17	Yay! 
JohnCFierce	695729356941955073	2016-02-05T22:02:59	Starting a new hashtag for biotechjobs (internships too?) - eperlste LABioscienceHub LabLaunch indbio 
JohnCFierce	695728090736099328	2016-02-05T21:57:57	biotechjobs -- AKAarsalan 
JohnCFierce	695727064100556800	2016-02-05T21:53:52	I would peg it closer to 5 years, but... 
JohnCFierce	695722889220239360	2016-02-05T21:37:17	JohnCFierce Yes, please. I often use chemjobs, but something broader could work, too.
JohnCFierce	695723119152119809	2016-02-05T21:38:12	Hey AKAarsalan -- You could make it a thing. biotechjobs or something better 
JohnCFierce	695722629240614912	2016-02-05T21:36:15	Can we do a hashtag for jobs? biotechjobs or sumthin. I'd RT everything. You might too.   
JohnCFierce	695716995925479424	2016-02-05T21:13:52	fiercebiotech is doing a new (long overdue) design. But I really couldn't tell you what it's going to look like. we'llsee
JohnCFierce	695716614579363840	2016-02-05T21:12:21	statnews is kind of a confused adolescent when it comes to consumer--or is it industry?--news. But the web site is nice and clean.
JohnCFierce	695702551816175622	2016-02-05T20:16:28	Lame apology =&gt; Hit with a storm of protest, LifeSci Advisors apologizes for its J.P. Morgan party  FierceBiotech
JohnCFierce	695706570764783616	2016-02-05T20:32:26	JohnCFierce PharmaceuticBen Biotrial just released comment on the reports ICYMI
JohnCFierce	695704786046476288	2016-02-05T20:25:21	French investigators to Biotrial: You should have stopped fatal study earlier By PharmaceuticBen 
JohnCFierce	695698863517212672	2016-02-05T20:01:49	Why we HAVE to speak up! Kudos to fiercebiotech , Bernstein &amp; Bingham for speaking up and making change Diversity 
JohnCFierce	695692200525565952	2016-02-05T19:35:20	In an update, Akashi acknowledges that the FDA has stepped in directly, as expected. 
JohnCFierce	695673228212068352	2016-02-05T18:19:57	Excited to see such strong start for BeiGene's IPO this week. Congrats to BeiGene! It's one of our WuXi Ventures' portfolio companies!
JohnCFierce	695663792185802753	2016-02-05T17:42:27	A patient in Akashi's suspended Duchenne MD trial dies 
JohnCFierce	695660515209641985	2016-02-05T17:29:26	That Akashi DMD patient died...
JohnCFierce	695653765815410688	2016-02-05T17:02:37	That's fixin' to change. 
JohnCFierce	695609043159801856	2016-02-05T14:04:54	Big day. Colleagues uncovered a therapeutic approach for Phelan-McDermid and autism  ScienceMagazine
JohnCFierce	695646083234590720	2016-02-05T16:32:05	I'm still amazed how many people in the biotech industry don't understand the impact of social media on news flow. Digital media rocks.
JohnCFierce	695633969996546048	2016-02-05T15:43:57	Yep, this story is going viral -- 
JohnCFierce	695629997432639488	2016-02-05T15:28:10	My state has evolved to the point where it can kick your state's ass. 
JohnCFierce	695628371225542656	2016-02-05T15:21:42	OK, but I'll be forced to drive the Beemer as my limo driver says he's sick. 
JohnCFierce	695626783379611649	2016-02-05T15:15:23	I've also had plenty of this... 
JohnCFierce	695626285897359360	2016-02-05T15:13:25	The industry had to call it out. And now they've done that. itsanewdayboys 
JohnCFierce	695625301968228352	2016-02-05T15:09:30	This is SO CLASSY...  
JohnCFierce	695625953687560192	2016-02-05T15:12:06	Thanks, JohnCFierce. Those GWPH forecasts from Roth make a lot more sense now.
JohnCFierce	695625454909317121	2016-02-05T15:10:07	JohnCFierce and to think a Roth analyst called one of my pieces "juvenile" once.
JohnCFierce	695624398477402112	2016-02-05T15:05:55	JohnCFierce Ugh.
JohnCFierce	695623957748305920	2016-02-05T15:04:10	Hey, we got a picture to add to our JPM16 apology piece. From a Roth party. Check it out. 
JohnCFierce	695623429349892096	2016-02-05T15:02:04	Don't blow it, guys. Can't have word get out about the vast wealth showered on journos every day. 
JohnCFierce	695614157421441024	2016-02-05T14:25:13	I think they feel they got enough :) 
JohnCFierce	695610919318118400	2016-02-05T14:12:21	Here's the email address, dax@biocentury.com. That's all I have. 
JohnCFierce	695596762682232832	2016-02-05T13:16:06	Check out the open letter and the 230 signatures on it -- many, many more signed. 
JohnCFierce	695595963289903104	2016-02-05T13:12:55	Hit with a storm of protest, LifeSci Advisors apologizes for its JP Morgan party (hell yes) 
JohnCFierce	695424389798432769	2016-02-05T01:51:09	JohnCFierce- the heads are still rolling. No one to work on a press release or a tweet.. 
JohnCFierce	695389342760435712	2016-02-04T23:31:53	statesdj amitabhchandra2 matthewherper Cruz would be a nightmare for biopharma. He would set the industry back 20 years.
JohnCFierce	695387257142775812	2016-02-04T23:23:36	Man, ain't that so. 
JohnCFierce	695367041193107456	2016-02-04T22:03:16	BTW, srwellman was the founding editor of Fiercemarkets. One of the best digital biz journalists I ever met; true understanding of this.
JohnCFierce	695365234421161985	2016-02-04T21:56:05	Happy to say that even after the shkreli nonsense, gender issues in biotech remains our top trending topic. 
JohnCFierce	695351379657756672	2016-02-04T21:01:02	It's the last pose that's hilarious. Chapelle show - the 5th 
JohnCFierce	695346332559486977	2016-02-04T20:40:59	JohnCFierce Congrats mate. I know your service is invaluable to me and, it would seem by your readership, many, many, others. Thank you.
JohnCFierce	695324775896453120	2016-02-04T19:15:19	I'll be talking with Andre Choulika next week in NYC. Discussing autologous vs. allogeneic cells.  isntthisfun!
JohnCFierce	695316391503794176	2016-02-04T18:42:00	I'm going to line up a Hawaiian shirt and old, blue tennis shoes. I will not be beaten. 
JohnCFierce	695315560331091968	2016-02-04T18:38:42	I'm finally getting there this year. You going? 
JohnCFierce	695314479756763137	2016-02-04T18:34:24	only in comparison, and then just barely. 
JohnCFierce	695310853210509313	2016-02-04T18:20:00	Classic problem with everything preclinical micearenothuman 
JohnCFierce	695310666287169536	2016-02-04T18:19:15	Only Shkreli could make Congress look good. I think they know that.  
JohnCFierce	695310217886744576	2016-02-04T18:17:28	kyleserikawa That's what they will be working on now. Preclinical for some time to come.
JohnCFierce	695303176803713025	2016-02-04T17:49:30	At this point, I'm surprised they can even spell it. 
JohnCFierce	695302771915018240	2016-02-04T17:47:53	re the Twist Bio suit, I'm reminded of this line in Giant: "Bick, you shoulda shot that fella a long time ago. Now he's too rich to kill."
JohnCFierce	695295276509237248	2016-02-04T17:18:06	Thomson Reuters spotlights the R&amp;D trends behind 2016's top blockbusters GILD, ICPT, MRK, etc 
JohnCFierce	695281028529836033	2016-02-04T16:21:29	That was the easiest prediction I've ever made.  
JohnCFierce	695279032481480705	2016-02-04T16:13:33	Martin Shkreli takes the 5th, then turns to Twitter to blast 'imbeciles' -- quick ec 
JohnCFierce	695267317270339585	2016-02-04T15:27:00	Hey JohnCFierce, I give Lynch a B. That was OK, if run through a Jimmy Breslin filter.
JohnCFierce	695263207120859136	2016-02-04T15:10:40	JohnCFierce I'd like one question I would give a B. Just one.
JohnCFierce	695261893431271424	2016-02-04T15:05:27	Anybody expecting to hear a nuanced, insightful question from Congress on drug pricing is going to be disappointed.
JohnCFierce	695258217459400704	2016-02-04T14:50:50	Twist Bio's hard-charging CEO hit by claims she stole Agilent's trade secrets 
JohnCFierce	695239155257839616	2016-02-04T13:35:06	J&amp;J goes all in with ViaCyte, hands over BetaLogics assets in hunt for diabetes cure JNJ 
JohnCFierce	695235225513807872	2016-02-04T13:19:29	The industry-wide response to the reporting on LifeSciAdvisors pratfall at JPM16 has been enormous. I'll keep you posted on outcomes.
JohnCFierce	695220239718547457	2016-02-04T12:19:56	ICYMI: Backed by a lineup of marquee VCs, Unity Biotechnology tackles the hard science of aging 
JohnCFierce	695018760357421058	2016-02-03T22:59:19	Many of our VentureLabs associates got their start at our summer and fall fellows programs.  
JohnCFierce	695015087187304449	2016-02-03T22:44:44	Too bad Michael Pearson isn't around to testify to Congress. That's the worst case of pneumonia (that didn't kill someone) I ever heard of.
JohnCFierce	695009002871074816	2016-02-03T22:20:33	When Martin Shkreli is being perp walked, stands in court or in front of lawmakers, he will say nothing. Of course he's taking the 5th
JohnCFierce	694986166450417665	2016-02-03T20:49:48	Added some comments from Nathaniel David at Unity on his aging startup -- a smart, very engaging guy.  
JohnCFierce	694974932476911617	2016-02-03T20:05:10	Great editorial on the problem:  JohnCFierce FierceBiotech
JohnCFierce	694967081431908352	2016-02-03T19:33:58	Backed by a lineup of marquee VCs, a biotech startup tackles the hard science of aging (more on the $$$ anon) 
JohnCFierce	694954143924924416	2016-02-03T18:42:34	From my 9yo son: "Why did Adele cross the road?" Me: "I don't know. Why?" Him: "So she could say 'Hello' from the other side." kids
JohnCFierce	694949273109041152	2016-02-03T18:23:12	ARCH launches major anti-aging company Unity. Nature article attached. 
JohnCFierce	694908296084508672	2016-02-03T15:40:23	Martin Shkreli said one thing in court today: "yes, judge." 
JohnCFierce	694920111883427840	2016-02-03T16:27:20	Still waiting for that carefully worded apology from LifeSci Advisors about JPM16. Hello? You in there? It's getting warm.
JohnCFierce	694912037210738688	2016-02-03T15:55:15	So, FYI, you can tweet from prison, if you were wondering. 
JohnCFierce	694911614974296064	2016-02-03T15:53:34	At Shkreli court appearance, govt notes $45m E-Trade account accountable for $5m bond was mostly KBIO stock; value now closer to $4m
JohnCFierce	694898304166019072	2016-02-03T15:00:40	The allies are massing on this one.  
JohnCFierce	694897204259983360	2016-02-03T14:56:18	Editas and BeiGene break biotech's IPO drought and stoke hopes of a turnaround EDIT BGNE by @DamianFierce  
JohnCFierce	694896969299329025	2016-02-03T14:55:22	Gene therapy pioneer James Wilson uses CRISPR/Cas9 to target liver disease (promise, plus a problem) 
JohnCFierce	694885421596147713	2016-02-03T14:09:29	That's coming, but I think you'll find we covered the gist of it. 
JohnCFierce	694879914332438528	2016-02-03T13:47:36	I'm a woman working in biotech. And I'm tired of excuses. To all those moaning about "not enough women to hire": 
JohnCFierce	694878761372798976	2016-02-03T13:43:01	They can thank the biotech gods that there's a new viral scare every couple of years to keep these stock pumps going 
JohnCFierce	694876124166385664	2016-02-03T13:32:32	MRK 's Frazier: "Very active" in M&amp;A opportunities in oncology and other indications.
JohnCFierce	694874765107060737	2016-02-03T13:27:08	An embarrassment to the healthcare industry - I thought we were better than this 
JohnCFierce	694869777945387008	2016-02-03T13:07:19	My 87-year-old mother could get on the FDA's fast track.  
JohnCFierce	694860980237570050	2016-02-03T12:32:22	Exactly right.  
JohnCFierce	694860535582625792	2016-02-03T12:30:36	Takeda ups bet on Mersana's armed antibodies to $1B-plus, snags lead drug rights 
JohnCFierce	694855324038209536	2016-02-03T12:09:53	Trending (in a big way) overnight: 'Let this letter be a shot across the bow to the entire (biopharma) industry' 
JohnCFierce	694848804189782016	2016-02-03T11:43:59	Antoine Papiernik of Sofinnova giving good history lesson at Pulse of British Bioscience conf: Get some therapy and get over British Biotech
JohnCFierce	694840064623427584	2016-02-03T11:09:15	Two biotech IPOs make it out "in the range" despite mkt volatility. Congrats to both EDIT and BGNE.  Hope they trade well in aftermarket.
JohnCFierce	694646456590942209	2016-02-02T22:19:55	$95M for EDIT IPO is weak, which is strong in this market. $16, low end of the range.
JohnCFierce	694644697881399298	2016-02-02T22:12:56	Sinovac Biotech sees management-led buyout bid.  FiercePharmAsia
JohnCFierce	694643371558703105	2016-02-02T22:07:40	Web traffic for Fierce life sciences hit 1.45M in January. That's a record. Stocks may be down, but readership is trending upwards.
JohnCFierce	694636432175075328	2016-02-02T21:40:05	Turing, Valeant hiked prices for max profits, then scrambled to quash the bad PR: Documents by CarlyHFierce 
JohnCFierce	694635039762599937	2016-02-02T21:34:33	Forget all the greedy chatter, it's when Turing turns down a request for a DOG that's going to haunt them.  
JohnCFierce	694624412629385216	2016-02-02T20:52:20	It really is appalling behavior and symptomatic of treatment of women in the industry.  
JohnCFierce	694610900741922816	2016-02-02T19:58:38	Really appreciate the great response to this: 'Let this letter be a shot across the bow to the entire industry' 
JohnCFierce	694598817941843969	2016-02-02T19:10:37	Please read, then let Karen know you support efforts to ensure that biotech is seen as an industry open to all.  
JohnCFierce	694587182149931010	2016-02-02T18:24:23	Let's make this viral, folks -- JPM16  'Let this letter be a shot across the bow to the entire industry' 
JohnCFierce	694568857747480577	2016-02-02T17:11:34	Glaxo up-sizes its bet on Adaptimmune, racing forward with a cancer immunotherapy GSK ADAP by @DamianFierce 
JohnCFierce	694565022215839745	2016-02-02T16:56:20	Roche, Novartis, J&amp;J among top 10 R&amp;D spenders last year, according to PWC (Hey j_c_atkinson!)  
JohnCFierce	694562465737211904	2016-02-02T16:46:10	The AXON IPO was strong evidence of existence for the biotech bubble. IBB  
JohnCFierce	694560025390485504	2016-02-02T16:36:29	UPDATED: Axovant routed after Pfizer flags failure of rival Alzheimer's drug.  by JohnCFierce PFE AXON
JohnCFierce	694557923922571264	2016-02-02T16:28:07	UPDATED: Axovant routed after Pfizer flags failure of rival Alzheimer's drug AXON down 25%,  
JohnCFierce	694554192979996672	2016-02-02T16:13:18	I'm a professional skeptic when it comes to Alzheimer's. As for 5-HT6, if it works, it probably won't help a lot. 
JohnCFierce	694539730248138752	2016-02-02T15:15:50	andybiotech The bulls not just out in force for AVXL - if AXON is ‘only’ down 25% they must have their share of bulls too!
JohnCFierce	694539230639452160	2016-02-02T15:13:51	So, AXON down 20% as investors discover that Alzheimer's R&amp;D is a mine field. PFE 
JohnCFierce	694528754589171712	2016-02-02T14:32:13	Sanofi is going to wait until Feb. 9 to discuss the retrenchment. SNY UPDATE 
JohnCFierce	694518420889534464	2016-02-02T13:51:09	Pfizer flags a failed PhII Alzheimer's drug study, putting spotlight on rivals PFE AXON - 16% 
JohnCFierce	694509060008349696	2016-02-02T13:13:57	Sanofi chops into R&amp;D operations in France in latest retrenchment SNY 
JohnCFierce	694505633589137408	2016-02-02T13:00:20	Glaxo, Atlas syndicate bankrolls Spero's drive into the clinic with $30M round GSK 
JohnCFierce	694485724624715776	2016-02-02T11:41:14	From the midnight bureau: Backed by J&amp;J and Glaxo, veteran VC group splits from Index, unveils $227M fund JNJ GSK 
JohnCFierce	694423123920314368	2016-02-02T07:32:29	Medicxi: Backed by J&amp;J and Glaxo, veteran VC group splits from Index, unveils $227M fund JNJ GSK 
JohnCFierce	694362555784040448	2016-02-02T03:31:48	Dems are a draw. Break it up and move on to NH.
JohnCFierce	694362073711693824	2016-02-02T03:29:53	Well, when the hoopla is over, Rubio could look like the big winner tonight. itsjustiowa
JohnCFierce	694355190082703360	2016-02-02T03:02:32	Updated w analyst info: Stryker to buy disposable device maker for $2.8B to reduce hospital-acquired infections 
JohnCFierce	694300663874977792	2016-02-01T23:25:52	Trending: Will Zika frenzy fuel an overnight vaccine R&amp;D miracle? Don't bet on it  INO 
JohnCFierce	694177815953051649	2016-02-01T15:17:43	Will Zika frenzy fuel an overnight vaccine R&amp;D miracle? Don't bet on it INO XON SNY 
JohnCFierce	694154042956718080	2016-02-01T13:43:15	ICYMI: The synNotch solution: UCSF scientists engineer a next-gen T-cell immunotherapy 
JohnCFierce	694147597800448000	2016-02-01T13:17:38	Following big setback, Avalanche ties the knot with gene therapy player Annapurna;lots of familiar west coast names 
JohnCFierce	694143164827832320	2016-02-01T13:00:01	My look at new drug approvals in 2015 (includes our traditional big ol' chart w/pretty structures): 
JohnCFierce	693830776706748416	2016-01-31T16:18:42	This gets my vote for way cool science: (synNotch) UCSF scientists engineer a next-gen T-cell immunotherapy 
JohnCFierce	693649632891633664	2016-01-31T04:18:54	Craft beer and cider party tonight included The Vermonster from Rock Art Brewery. Highly recommended. Citizen Cider always welcome.
JohnCFierce	693529663637950464	2016-01-30T20:22:11	Should know soon if EDIT and BGNE can make it. If not, the biotech window is closed until further notice. 
JohnCFierce	693424816607600640	2016-01-30T13:25:34	The race for the zika vaccine features several small biotechs. Seen this movie before? 
JohnCFierce	693240311695433728	2016-01-30T01:12:24	If you live in downtown Tampa and you love Italian food, you seriously need to hit up Cena in Channelside - awesome.
JohnCFierce	693231662335967233	2016-01-30T00:38:02	Oxitec's genetically modified mosquitoes may help fight Zika if FDA will allow it  via business
JohnCFierce	693146713658429440	2016-01-29T19:00:29	Another theranos partner pulls back: Capital BlueCross suspends blood draws at its Pennsylvania store  via WSJ
JohnCFierce	693115909393747968	2016-01-29T16:58:04	Genentech snags a PhII-ready IL-33 asthma/COPD drug from Amgen AMGN linked w/ lebrikizumab 
JohnCFierce	693087076946972672	2016-01-29T15:03:30	Naked self-promotion time: My 250-historical-moments book, "The Chemistry Book" is now shipping from Amazon (earlier than I expected).
JohnCFierce	693075363388354560	2016-01-29T14:16:58	Jan 29: as some quietly pull their IPOs the biotech queue is anemic &amp; has atypical companies. Good luck EDIT BGNE 
JohnCFierce	693072996676849665	2016-01-29T14:07:33	Allergan links with AstraZeneca, US agency on new antibiotic treatment 
JohnCFierce	693058797087133697	2016-01-29T13:11:08	Paging George Scangos. BIIB.
JohnCFierce	693058473576271872	2016-01-29T13:09:51	First CELG... GILD CEO Martin to be exec chair. All the power w/o the long days ’s-John-C.-Martin-PhD-Assume-Role
JohnCFierce	693052895512629248	2016-01-29T12:47:41	Gee, so Allergan does R&amp;D? How surprising. (droll overtone here.) rapastinel/GLYX-13 BTD AGN 
JohnCFierce	693052096757784576	2016-01-29T12:44:30	NMDA -- closely watched ketamine 
JohnCFierce	693049203401068544	2016-01-29T12:33:00	Gimme those self-limiting transgenic Aedes aegypti mosquito strains.  
JohnCFierce	693047706500100097	2016-01-29T12:27:04	Genticel crashes after HPV immunotherapy misses interim efficacy endpoint 
JohnCFierce	693047456611876866	2016-01-29T12:26:04	Twitter has become the poor man's Bloomberg terminal.  
JohnCFierce	693046014920491008	2016-01-29T12:20:20	Listening to some Guns n Roses classics to start the day.
JohnCFierce	693045047315398656	2016-01-29T12:16:30	Resistance is a global issue. AGN Announces Collaboration with AstraZeneca to Develop and Commercialize ATM-AVI 
JohnCFierce	693038772095594497	2016-01-29T11:51:33	JohnCFierce No doubt POTUS candidates will be quick to laud how Pharma sector market efficiencies generate both innovation + competition:-)
JohnCFierce	693034258651283456	2016-01-29T11:33:37	The FDA OK of MRK's hep C combo was not a surprise -- the price, though, was. 
JohnCFierce	692904752376602624	2016-01-29T02:59:01	JohnCFierce Good review. It will be interesting to see how these drugs are impacted by FDA's fast track approach vs safety and efficacy
JohnCFierce	692877241135411201	2016-01-29T01:09:41	jq1234t matthewherper Melikeitalot HillaryClinton The market is the pressure.
JohnCFierce	692869030772740097	2016-01-29T00:37:04	princetongb But they won. GILD does despicable things, hides behind a high wall. But when they gamble and win, give 'em the win.
JohnCFierce	692867501856653313	2016-01-29T00:30:59	The hep C thing is a market correcting itself. GILD earned the big $$$. Reward innovation. Cure disease.  
JohnCFierce	692865743558291456	2016-01-29T00:24:00	Right on! 
JohnCFierce	692865011924881408	2016-01-29T00:21:06	Will PFE do the same if their PCSK-9 inhibitor gets approved? Competition can help in pricing. 
JohnCFierce	692862360692723713	2016-01-29T00:10:34	My big trend piece today: The top 10 (possible) blockbusters that (might) launch this year (includes MRK) 
JohnCFierce	692861710693044225	2016-01-29T00:07:59	Awwwright!!!! MRK getting aggressive on price. What say ye? 
JohnCFierce	692860710003421185	2016-01-29T00:04:00	54,600 for 12 weeks MRK ™-elbasvir-grazoprevir
JohnCFierce	692860040336662528	2016-01-29T00:01:20	er, rocketeer
JohnCFierce	692859933948153858	2016-01-29T00:00:55	like rockateer to the rescue 
JohnCFierce	692859361257869313	2016-01-28T23:58:39	Loftus mais non!
JohnCFierce	692856144407080960	2016-01-28T23:45:52	Nature does not care...nature just is. Great read. Stay honest. 
JohnCFierce	692854604040527872	2016-01-28T23:39:44	MRK is circulating a vacuous quote on hep C OK. Really, guys, you had weeks to prep a PR. I just want the price. Just hit send.
JohnCFierce	692850856627015681	2016-01-28T23:24:51	They'll price relative to the competition, and then dicker big time on the discounts for payers. Cest la vie  
JohnCFierce	692846379849285632	2016-01-28T23:07:04	List by BostInno says atlasventure is #1 VC 4 women-founded/led ventures: Avila, Intellia, Luc, Nimbus, Spero 
JohnCFierce	692844877483155456	2016-01-28T23:01:05	I've asked for a price, but I'm sure I'll be the last to be told. MRK
JohnCFierce	692844659089866755	2016-01-28T23:00:13	Wrote that story in 15 seconds. Zap! MRK
JohnCFierce	692844354155597825	2016-01-28T22:59:01	Merck gets FDA OK to go toe-to-toe with Gilead's hep C market goliath MRK GILD 
JohnCFierce	692840208065126403	2016-01-28T22:42:32	Yeah, what's up with that? 
JohnCFierce	692835088560553984	2016-01-28T22:22:12	And then, of course, we must make special mention of the VRX enthusiasts.... 
JohnCFierce	692834732363526144	2016-01-28T22:20:47	Must be cold, lonely days in the sell-side world. Every day starts now with a funeral dirge.
JohnCFierce	692825646263726080	2016-01-28T21:44:40	This was surely coming - CRISPR mediated PD-1 deletion in T cells  cancer immunotherapy 
JohnCFierce	692814396305707008	2016-01-28T20:59:58	dhovekamp42 Well, yes, in a way. But GSK is a big, deadly (almost boringly) serious pharma co--not a biotech looking to juice the stock.
JohnCFierce	692812327226208256	2016-01-28T20:51:45	Now what biotechs will try and benefit immediately from zika? Hmmm. Could it be, INO?  But of course 
JohnCFierce	692801235775287296	2016-01-28T20:07:40	.AdamSinger an employee might've run away from me... Sign says it's closed "until further notice"
JohnCFierce	692790398100586496	2016-01-28T19:24:36	Domino effect. Click, click, click, click-- boom 
JohnCFierce	692789707932069889	2016-01-28T19:21:52	Theranos’s main retail partner, Walgreens, is suspending some ties to the blood-testing lab 
JohnCFierce	692784060783939585	2016-01-28T18:59:26	We pause this channel to bring you a brief whine: Am I really going to have to wait 'til end of day for the FDA OK on MRK's hep C combo?
JohnCFierce	692782724722089985	2016-01-28T18:54:07	Grizzlybearmarket 
JohnCFierce	692765983526752262	2016-01-28T17:47:36	Miss Ebola? You're going to love Zika.
JohnCFierce	692765304183771136	2016-01-28T17:44:54	Ugh IBB down 2.7%, more a grizzly market than a bear market for biotech
JohnCFierce	692756202598633472	2016-01-28T17:08:44	Merck bets up to $515M on an epigenetic project for cancer and blood disease.  by @DamianFierce MRK
JohnCFierce	692746657876832256	2016-01-28T16:30:48	Roche/AbbVie's Venetoclax grabs third FDA 'breakthrough' for blood cancer - on the blockbuster list PharmaceuticBen 
JohnCFierce	692738340005810176	2016-01-28T15:57:45	Bring a little salt to the picnic. But the list looks pretty solid. From evaluatepharma 
JohnCFierce	692479656767938560	2016-01-27T22:49:50	Case against GSK scientists accused of stealing secretas seen a test  FiercePharmAsia
JohnCFierce	692473932297957377	2016-01-27T22:27:05	U.S. Regulators: Some Theranos Tests "Pose Immediate Jeopardy To Patient Health And Safety" via forbes 
JohnCFierce	692471296853147648	2016-01-27T22:16:37	Nope, not going to go there. Waiter, bring me scotch, straight up, no ice. 
JohnCFierce	692470481585344512	2016-01-27T22:13:22	Good point  
JohnCFierce	692465326244696065	2016-01-27T21:52:53	Turn out the lights, the party is over: Gov't finds Theranos lab poses 'immediate jeopardy to patient safety' 
JohnCFierce	692463931676299264	2016-01-27T21:47:21	Top 10 animated characters in pharma marketing EmilyWFierce BethSBulik  FiercePharmaMarketing 
JohnCFierce	692461888253358082	2016-01-27T21:39:14	endpts steveusdin1 JohnCFierce Manchin, whose daughter is CEO of Mylan.
JohnCFierce	692459027528167424	2016-01-27T21:27:52	Manchin will Filibuster FDA Nominee Robert Califf for Big Pharma Ties  [h/t steveusdin1]
JohnCFierce	692458671796830209	2016-01-27T21:26:27	So a kind of state-government version of NICE? Curious to see how that works out. 
JohnCFierce	692452492198727680	2016-01-27T21:01:53	BioClinica notches up another deal, this time with EPS (my first Fierce story): 
JohnCFierce	692437138869243904	2016-01-27T20:00:53	Kochenderfer's opinion on autologous v allogeneic in CAR-T really hit a nerve out there. Expert opinions are hot. 
JohnCFierce	692426972853616641	2016-01-27T19:20:29	JohnCFierce Look in here, John. 
JohnCFierce	692426653734166528	2016-01-27T19:19:13	So, where's the excited buzz about MRK and hep C potential? Hello?
JohnCFierce	692419312095752192	2016-01-27T18:50:03	J&amp;J investors push for shake-up: Activists sounded out over taking stake in healthcare company 
JohnCFierce	692413648577388545	2016-01-27T18:27:32	The quotes are good. They are always good. Martin Shkreli gets the Vice treatment: 
JohnCFierce	692409303295234048	2016-01-27T18:10:16	After starting last year as a growth stock, Biogen trades in the value bin. Q4 results should help: 
JohnCFierce	692400455113129985	2016-01-27T17:35:07	We're hiring! Check out our careers page for latest vacancies  jobs 
JohnCFierce	692396523561287680	2016-01-27T17:19:29	Clearly, it's those damn snails that can sneak up on you when you least expect it. 
JohnCFierce	692392228774281217	2016-01-27T17:02:26	Big day for the drug pricing controversy. GILD being challenged. Trump takes populist turn. Not just Shkreli/$VRX 
JohnCFierce	692379048127926274	2016-01-27T16:10:03	Thanks, but it was email. Anyway, best to hear from the man himself. 
JohnCFierce	692376451056848901	2016-01-27T15:59:44	That whole autologous vs "allogeneic" CAR-T discussion? NCI's Kochenderfer weighs in. 
JohnCFierce	692359118091370496	2016-01-27T14:50:51	MNKD call on Feb. 3 gives investors a chance to ask a few questions. 
JohnCFierce	692341678158548992	2016-01-27T13:41:33	Whoa. Has this happened before? 
JohnCFierce	692338226527391744	2016-01-27T13:27:50	The co. position: We can operate comfortably for quite some time - money to burn, baby, burn. MNKD 
JohnCFierce	692336425908473856	2016-01-27T13:20:41	That would seem to be option 1 at this stage 
JohnCFierce	692336326629310464	2016-01-27T13:20:17	So best to file Ch. 11, clean it up and see what you have left for them. 
JohnCFierce	692335153369190400	2016-01-27T13:15:38	Let's see, who would like to buy Mannkind?  What? No one?  MNKD 
JohnCFierce	692332346360610816	2016-01-27T13:04:28	BIND enrollment is being discontinued in the cholangiocarcinoma and bladder cancer cohorts in the iNSITE 2 trial due to slower enrollment.
JohnCFierce	692325819709014017	2016-01-27T12:38:32	JNJ, NVS &amp; PFE-backed IO bio Merus pulls forward target date for solid tumor data, reiterates intent to file IPO 
JohnCFierce	692326225746853888	2016-01-27T12:40:09	'we believe that the first therapeutic use of CRISPR will be to treat an eye disease'  ?
JohnCFierce	692321616445992960	2016-01-27T12:21:50	BIIB forecasts 2016 revenue of $11.1 to $11.3 billion, or 4% growth at midpoint. Consensus was ~ 6%.
JohnCFierce	692316486694785026	2016-01-27T12:01:27	Say hello to Tarveda: Langer-backed biotech reboots with $38M, new name and new cancer drug tech 
JohnCFierce	692190216006795268	2016-01-27T03:39:42	MikeNGladstone JohnCFierce AlpineBV_Miller My sense is it was called a PD1 but actual binding target never made clear.
JohnCFierce	692190125363716097	2016-01-27T03:39:20	MikeNGladstone JohnCFierce AlpineBV_Miller BAT was basically a mouse mAb that activated lymphocytes. Was never raised against PD1
JohnCFierce	692286094126227456	2016-01-27T10:00:41	Backed by Novartis and Orbimed, Adicet joins immunotherapy crowd with $51M round 
JohnCFierce	692155476767850498	2016-01-27T01:21:39	Symbiotic. Trump blusters, reporters broadcast, high ratings follow and Trump rises in the polls. Rinse and repeat. 
JohnCFierce	692146079740116992	2016-01-27T00:44:19	JohnCFierce as I read on the Twitter feed: He may as well have worn an "I &lt;3 Obamacare" tshirt.
JohnCFierce	692137233273507840	2016-01-27T00:09:10	Great to see Trump calling for negotiating drug prices. Perfectly rational. Wonder if this is what will cost him Republican support!
JohnCFierce	692133753423007744	2016-01-26T23:55:20	LifeSciVC Loftus JohnCFierce except that Xalkori really is a c-MET inhibitor, it just so happens to hit ALK too, a big difference
JohnCFierce	692129881442930688	2016-01-26T23:39:57	Cover of Forbes.... "Solving the Shrkreli Problem" 
JohnCFierce	692123982959661057	2016-01-26T23:16:31	JohnCFierce LifeSciVC Loftus does it matter that much? It did meet primary endpoint in post-SCT NHL.
JohnCFierce	692119145610092544	2016-01-26T22:57:17	JohnCFierce AlpineBV_Miller it uniquely does not bind PD-1, unlike other PD-1 inhibitors
JohnCFierce	692118765237092357	2016-01-26T22:55:47	If they don't know what it is, how do they know it's unique?  
JohnCFierce	692110521156423680	2016-01-26T22:23:01	JohnCFierce i would think that would require some explaining. ;)
JohnCFierce	692110270886461441	2016-01-26T22:22:02	So let me ask you something, Bruce. If anyone you know bought a PD-1 that wasn't a PD-1, would it be embarrassing? 
JohnCFierce	692105309301673984	2016-01-26T22:02:19	Note to self: Boston MFA got a Frida Kahlo painting. 
JohnCFierce	692074081177305089	2016-01-26T19:58:13	JohnCFierce If you go back to the source science from 1980s on this, it was clear that it couldn't have been a PD1. Poor diligence.
JohnCFierce	691633998079135744	2016-01-25T14:49:29	Just launched the website for our newest seed company Morphogen-IX  based on work of Prof Morrell &amp; team on PAH: 
JohnCFierce	692051699876413444	2016-01-26T18:29:17	MDVN down 4.5% this today
JohnCFierce	692044285500342272	2016-01-26T17:59:49	I seem to recall that Pfizer's Xalkori was initially thought to have a different mechanism than targeting ALK. PFE 
JohnCFierce	692048953198690304	2016-01-26T18:18:22	Loftus JohnCFierce Iniparib SNY 
JohnCFierce	692034437614309376	2016-01-26T17:20:41	JohnCFierce the company that got $5 million upfront is Clal Biotechnology..Remember HPTX and Andromeda Biotech ..
JohnCFierce	692029030783176704	2016-01-26T16:59:12	trending: Anti-PD-1? Well, no, says Medivation as a partial hold forces a halt to 'pivotal' cancer study MDVN 
JohnCFierce	692020567520735232	2016-01-26T16:25:35	So I'll be hanging out at BIOCEO16 in NYC for a couple of days. Should be fun.
JohnCFierce	692020263899242496	2016-01-26T16:24:22	macbiokari JohnCFierce yes correct thanks! BIOCEO16 - we have tweets &amp; hashtag on main page: 
JohnCFierce	692011460558462977	2016-01-26T15:49:23	Trump backs Medicare negotiating drug prices, saying it  could save $300 billion a year. 
JohnCFierce	692004497657180161	2016-01-26T15:21:43	AmeriQuest postpones $74 million IPO AMQ IPO IPO 
JohnCFierce	691999893079134209	2016-01-26T15:03:25	With a Duchenne MD patient struggling for life, little Akashi suspends study SRPT BMRN 
JohnCFierce	691987604242309120	2016-01-26T14:14:36	Get an invite here:  
JohnCFierce	691985485162393600	2016-01-26T14:06:10	Launched my new blog BioPharma Observer today! Check out my latest piece on drug pricing at 
JohnCFierce	691984057291243521	2016-01-26T14:00:30	Galapagos' bowel drug misses the mark in Phase II.  by @DamianFierce GLPG
JohnCFierce	691980567705968641	2016-01-26T13:46:38	MikeNGladstone FierceBiotech I love a good mystery, but this drug has been in the clinic for years, and the MOA was wrong
JohnCFierce	691978815585808385	2016-01-26T13:39:40	So, how do you buy a drug that's been studied by Teva, scientists at MD Anderson and not know the MOA? Israel is the new Texas.
JohnCFierce	691978414178332673	2016-01-26T13:38:04	Think you've seen everything? MDVN hit with partial hold as it tries to explain MOA. (Hint: it's not anti-PD-1) 
JohnCFierce	691955194712723457	2016-01-26T12:05:48	Were the fabricated economic numbers not bullish enough? 
JohnCFierce	691776607497928704	2016-01-26T00:16:10	JohnCFierce Olive oil, garlic clove, thinly sliced sweet onion, fry til golden, add tomato, chopped basil,1/4 cup red wine, gentle boil 1 h
JohnCFierce	691768312259284992	2016-01-25T23:43:12	Clearly a touchy subject, spaghetti sauce and mama. But I can understand that,. 
JohnCFierce	691767076004958209	2016-01-25T23:38:17	I'm enjoying this. Leeks and diced carrots, I can see a whole new recipe taking shape 
JohnCFierce	691766410507350016	2016-01-25T23:35:39	Now we're talking 
JohnCFierce	691766324549271554	2016-01-25T23:35:18	I find that rather bizarre. But...hmmmm 
JohnCFierce	691765405824729088	2016-01-25T23:31:39	Clearly, the most important single aspect to making a great spaghetti sauce lies in ignoring any imposed limits on oregano and minced garlic
JohnCFierce	691738682580156417	2016-01-25T21:45:28	PETX - Aratana Therapeutics Files for First FDA Approval
JohnCFierce	691683133876518912	2016-01-25T18:04:44	I'm headed to NYC in a couple of weeks for the BIO CEO conference. Need to do a couple of face-to-face interviews. Is there a hashtag?
JohnCFierce	691672322680295424	2016-01-25T17:21:47	Whoa! humanlongevity has 20,000 whole human genomes stored, and reaching run rate of 100k per year! PMWC16
JohnCFierce	691658559113842690	2016-01-25T16:27:05	Arguing about Zafgen's chances (spoiler: I'm not optimistic) 
JohnCFierce	691657272200687616	2016-01-25T16:21:58	Theranos flagged by CMS for serious problems at California lab: WSJ: 
JohnCFierce	691654274414153728	2016-01-25T16:10:03	Why is Martin Shkreli still posting his every move online?  
JohnCFierce	691653373226016769	2016-01-25T16:06:29	JohnCFierce seems like covering going on now. piece likely aimed at helping them dig themselves out of dangerous position. zfgn
JohnCFierce	691651552377966592	2016-01-25T15:59:15	Hedge fund's attack on troubled Zafgen draws blood ZFGN 
JohnCFierce	691639709387341824	2016-01-25T15:12:11	For the same reason its legal for sell-side to tout co.s; biotechs to report how delirious they are about new data. 
JohnCFierce	691639003381153793	2016-01-25T15:09:23	Yep 
JohnCFierce	691632447503634435	2016-01-25T14:43:20	OMED, meanwhile, down 43%
JohnCFierce	691631846061424641	2016-01-25T14:40:56	ZFGN down 10% on short attack from Kerrisdale 
JohnCFierce	691629332549259265	2016-01-25T14:30:57	Editas tests CRISPR/Cas9 enthusiasm--and a turbulent market--with $122M IPO EDIT 
JohnCFierce	691628378693079040	2016-01-25T14:27:09	UPDATED: DC blizzard gives MartinShkreli more time to wrestle with lawmakers over demand performance 
JohnCFierce	691612909475069953	2016-01-25T13:25:41	OncoMed hits the brakes on PhII pancreatic cancer trial, shares plummet OMED down 38% -- 
JohnCFierce	691597281854885888	2016-01-25T12:23:35	PearlF I haven't heard anything -- not even sure if it's still all that active.
JohnCFierce	691595948728979456	2016-01-25T12:18:18	Pearson's return to work is "uncertain" -- due to a severe case of reputation-related toxicity. VRX 
JohnCFierce	691595026271490048	2016-01-25T12:14:38	GSK, AstraZeneca and J&amp;J back $57M effort to springboard university drug research GSK AZN JNJ 
JohnCFierce	691422406288773120	2016-01-25T00:48:42	Of course, INO will get out front early --  
JohnCFierce	691422002217881600	2016-01-25T00:47:05	The zika virus has arrived. Next: 20 vaccine co.s say they are working on it and have a solid lead and there's an antiviral frenzy.
JohnCFierce	691370205725982720	2016-01-24T21:21:16	Everyplace but. Houston. The Valley. Austin and Bryan College-Station.  
JohnCFierce	691367574102241286	2016-01-24T21:10:49	Headed to Tejas and KC at the end of February/early March. I expect part of that trip to be warm and laden with Mexican food.
JohnCFierce	691307326679162880	2016-01-24T17:11:25	Pathophilia JohnCFierce any eye you roll can and will be the used against you
JohnCFierce	691286198975746048	2016-01-24T15:47:27	JohnCFierce What's the legal view of eye rolls? Are they testimony?
JohnCFierce	691285533692141568	2016-01-24T15:44:49	He can only plead the 5th while lawmakers scold him for being such a bad person. It's theater, and he hates his line 
JohnCFierce	691280618769027072	2016-01-24T15:25:17	Pathophilia Shkreli's risking contempt. Which is why he'll go, take the 5th, and Tweet out his outrage. Hours of online streaming to come.
JohnCFierce	691270582437056512	2016-01-24T14:45:24	Yep. 
JohnCFierce	691270217058664449	2016-01-24T14:43:57	Here's the latest back-and-forth on Shkreli's demand performance in DC Tuesday. My guess: He hops the shuttle. 
JohnCFierce	691249156237725696	2016-01-24T13:20:16	I want to make the UK a beacon of innovation 
JohnCFierce	691240082125225984	2016-01-24T12:44:12	Saw The Revenant last night. Third movie in the past 6 weeks with Domhnall Gleeson in it. The guy is everywhere.
JohnCFierce	691064000319242240	2016-01-24T01:04:31	JohnCFierce jmsnowshill It's not that long...they were broke and didn't have enough money for a 13th.
JohnCFierce	691056371714797568	2016-01-24T00:34:12	Trump says he could stand in 5th Ave and shoot somebody and not lose votes. He should have said he would gain votes with gun play.
JohnCFierce	691054656391352320	2016-01-24T00:27:23	That's a long, long story.... 
JohnCFierce	690999207872892933	2016-01-23T20:47:03	So Jeb Bush is still running for president?  
JohnCFierce	690968055174819842	2016-01-23T18:43:16	And that boiling vat of federal hot water that reaches up to his chin? I'd say some would disagree. 
JohnCFierce	690958048098193408	2016-01-23T18:03:30	He's not an idiot. He just acts like one, convinced he can scamper free; probably another terrible miscalculation. 
JohnCFierce	690904956904325120	2016-01-23T14:32:32	Lawmaker to MartinShkreli: Come to DC and take the 5th, in a live performance 
JohnCFierce	690716592666185729	2016-01-23T02:04:03	Panel voted yes in 07, FDA rejected. Then approved in 2010. But rival drugs destroyed it. Biotech = huge risk.  
JohnCFierce	690661546977038336	2016-01-22T22:25:19	Not going to happen. Martin has good ratings, Congress knows that. 
JohnCFierce	690661142738370560	2016-01-22T22:23:42	Right now an alien attack on DC would not be considered reasonable grounds for a no-show. martinmakesnewfriends 
JohnCFierce	690651677658107905	2016-01-22T21:46:06	House tells MartinShkreli: Hey, Waksal could make it, so can you. Plead the 5th in person, or else. 
JohnCFierce	690638570516824064	2016-01-22T20:54:01	In solidarity with my colleagues in Washington DC, I'magettingoutofhere.
JohnCFierce	690626256858169344	2016-01-22T20:05:05	Speaking of Skorney: "The FDA continues its evisceration of DMD drug applications." His recap of the week. SRPT.
JohnCFierce	690617402271342592	2016-01-22T19:29:54	JohnCFierce like I said, SRPT didn't do a good job. But it seems to me things are as they were, for whatever it's worth.
JohnCFierce	690617071634350080	2016-01-22T19:28:35	Aside from advocacy (which is significant) Sarepta goes in weak. And we know these people can say no on Duchenne. 
JohnCFierce	690599963022139392	2016-01-22T18:20:36	Jun Wang's iCarbonX healthcare data mining startup seeks $106M in Series A funding 
JohnCFierce	690582542102175744	2016-01-22T17:11:23	johncfierce Whitemare on K Street
JohnCFierce	690577674985721857	2016-01-22T16:52:02	Whitemare in DC!!! Blizzapalooza Snowtastraphe 
JohnCFierce	690547643685179392	2016-01-22T14:52:42	You've got to have a code for Twitter: Rule #1. If you want to poke at me, fine. But if you're anonymous, you get blocked. comeoutandplay
JohnCFierce	690541779137990656	2016-01-22T14:29:24	GlaxoSmithKline bails on Basilea's eczema drug, nixing a $72M payout.  by @DamianFierce GSK
JohnCFierce	690529470420221954	2016-01-22T13:40:29	Editas EDIT IPO road show has not started, per my quick buyside checks. Whether it’s been delayed due to lousy mkt conditions unclear.
JohnCFierce	690525180142174212	2016-01-22T13:23:26	So what's the word on the EDIT IPO? If that one has trouble, fahgeddaboutit. (What an awful time for a biotech IPO. Why not wait it out?)
JohnCFierce	690350953321598976	2016-01-22T01:51:08	The average biotech stock is currently down over 50% from its high. 
JohnCFierce	690519787756195840	2016-01-22T13:02:01	I created a bot (endpts) to read BioTwitter so I didn’t have to. Here’s all 3,778 stories its tracked since Sept: 
JohnCFierce	690509013600043008	2016-01-22T12:19:12	ALKS lost $4B in market cap yesterday. Bit of an overreaction, don't you think?  
JohnCFierce	690356994553876480	2016-01-22T02:15:08	JohnCFierce it's almost 20 years s old. Letterman slogan for nyc: our city can kick your city's ass.
JohnCFierce	690352365204041729	2016-01-22T01:56:44	I've heard of Letterman. (Cabin Boy, right?) But the last 20 years or so, the TV references go right by me.  
JohnCFierce	690333738337734656	2016-01-22T00:42:43	That argument wouldn't get you very far in the independent republic of Vermont. We punch above our weight class. 
JohnCFierce	690331782173032449	2016-01-22T00:34:57	Or would any states that were first and second in the primaries lose their predictive qualities? toomuchattention 
JohnCFierce	690317295940403201	2016-01-21T23:37:23	utterly absurd 
JohnCFierce	690306141650341892	2016-01-21T22:53:04	What fun. But I am away.
JohnCFierce	690305521035931648	2016-01-21T22:50:36	You'd have to clear it with Perlmutter MRK. But, OK 
JohnCFierce	690304672670826500	2016-01-21T22:47:13	ha! 
JohnCFierce	690304308806549504	2016-01-21T22:45:47	JohnCFierce The Beast from 2,000 Fathoms RTRX
JohnCFierce	690303841032626177	2016-01-21T22:43:55	Dark, I like that and speaking of B Traven Eli Lilly (yes, pharma) Death Ship 
JohnCFierce	690302411924246528	2016-01-21T22:38:14	Now you're rolling  Axovant: Treasure of the Sierra Madre 
JohnCFierce	690297993640062976	2016-01-21T22:20:41	Calico: The Once and Future King JohnCFierce
JohnCFierce	690297381447962625	2016-01-21T22:18:15	JohnCFierce VRX fifty shades of grey
JohnCFierce	690296982053715968	2016-01-21T22:16:40	Books and biotech: CELG Game of Thrones BIIB Le Morte D'arthur GILD The Dark Tower
JohnCFierce	690295452386877443	2016-01-21T22:10:35	But we'd have to know WHICH  biotech in order to answer... 
JohnCFierce	690290831224410113	2016-01-21T21:52:13	The letter from Congress to Martin Shkreli's lawyer: 
JohnCFierce	690288711670571010	2016-01-21T21:43:48	It will be, but first Fergus has to get a fulltime job! speakingasaparent 
JohnCFierce	690288429305847809	2016-01-21T21:42:41	Yes, and the study is a setback for that design. The placebo effect reigns in depression, still. 
JohnCFierce	690286738695176192	2016-01-21T21:35:58	Perfect sunrises: The Dead Sea, sitting on Masada after hiking up. Cape Cod. And Dublin, 1986, sitting in a pub after my son was born.
JohnCFierce	690286229452120064	2016-01-21T21:33:56	I'm headed to Cape Cod in May. Last time I was there was 1978, in the middle of a cold winter. Drove there to see the sun come up.
JohnCFierce	690283837419577350	2016-01-21T21:24:26	To say nothing of dozens of angry parents... 
JohnCFierce	690257201307459585	2016-01-21T19:38:35	MartinShkreli takes the 5th, on Twitter - 'I have constitutional rights,' tweets Martin Shkreli, defying subpoena 
JohnCFierce	690251731310092288	2016-01-21T19:16:51	Members of the House didn't think this was funny. Odd, their lack of bro' humor.  
JohnCFierce	690246868073316352	2016-01-21T18:57:32	.RepCummings: I hope MartinShkreli reconsiders his current course &amp; avoids any addtl legal action against him. 
JohnCFierce	690245690614611969	2016-01-21T18:52:51	FDA has now banned China plants of Zhejiang Hisoar &amp; PFE partner Zhejiang Hisun. Is there a connection?  pharma
JohnCFierce	690233024009605120	2016-01-21T18:02:31	ryanbeckwith great question. I don't think so since the subpoena is for the hearing at a specific place and time
JohnCFierce	690229681963024384	2016-01-21T17:49:14	Legit legal question: Does tweeting at a senator mean you have given up the right to take the Fifth? 
JohnCFierce	690230258822418432	2016-01-21T17:51:32	OK, ALKS is a buyout target, right? Please start the speculation and rumor-mongering now, no need to wait. :)
JohnCFierce	690222255427735552	2016-01-21T17:19:44	Exactly, right? Damn good analogy. 
JohnCFierce	690221042585960448	2016-01-21T17:14:54	One of the best pieces I’ve seen written on the whole crispr debacle: 
JohnCFierce	690221427996360704	2016-01-21T17:16:26	This MNKD deal looks kinda sketchy. Transferring tech to a new entity? Ahead of what? 
JohnCFierce	690213608874188800	2016-01-21T16:45:22	Levaquin users slap J&amp;J with $800M RICO suit, claiming pharma giant hid serious side effects:  JNJ pharma
JohnCFierce	690213057390329856	2016-01-21T16:43:11	General insanity. Dogs and cats sleeping with each other. Reps and dems reaching consensus. But it's only a day or 2 
JohnCFierce	690211860390514688	2016-01-21T16:38:25	1 inch of snow=9 hrs of chaos in DC. Stay at home or take the subway.  
JohnCFierce	690206700842778624	2016-01-21T16:17:55	Interesting niche biotech story: Abingworth tees up a unique, $105M co-development fund for PhIII deals 
JohnCFierce	690198398876663809	2016-01-21T15:44:56	Bullish Leerink note after the Forward fails: ALKS "can and should consider an acquisition to bolster its pipeline". ACAD ITCI
JohnCFierce	690196614204538880	2016-01-21T15:37:50	Trending (why am I not surprised)  'I have constitutional rights,' tweets Martin Shkreli, defying Senate subpoena 
JohnCFierce	690194073274208258	2016-01-21T15:27:44	Brave man, preclin in depression gets a big, big discount in a world where PhII data is suspect. 
JohnCFierce	690186111952523264	2016-01-21T14:56:06	J&amp;J halts a depression program in the shadow of a fatal French trial JNJ by @DamianFierce  
JohnCFierce	690185762961244160	2016-01-21T14:54:43	ALKS down 37%. The glass-half-full debate not working so well.
JohnCFierce	690179979884236800	2016-01-21T14:31:44	GlaxoSmithKline scientists accused of stealing drug R&amp;D secrets for China scheme GSK 
JohnCFierce	690160260292702208	2016-01-21T13:13:23	ArGEN-X pulls in €16M to push cancer, autoimmune programs to clinical POC 
JohnCFierce	690158615978754049	2016-01-21T13:06:51	And onset of action is a key consideration. ketamine 
JohnCFierce	690158473930248192	2016-01-21T13:06:17	ICYMI: Who are the most influential people in biopharma today? (We want your suggestions.) 
JohnCFierce	690154109501116417	2016-01-21T12:48:56	bio_clouseau adamfeuerstein AF_biotech They took non-responders in the initial placebo group and re-randomized them.
JohnCFierce	690152043051401217	2016-01-21T12:40:44	Damn shame - Alkermes slammed as top depression drug fails two PhIIIs ALKS 
JohnCFierce	690143718763020289	2016-01-21T12:07:39	"I have constitutional rights" tweets Martin Shkreli, defying Senate subpoena MartinShkreli 
JohnCFierce	690125953121525760	2016-01-21T10:57:03	Abingworth tees up a unique, $105M co-development fund for PhIII deals PFE 
JohnCFierce	689961259010277376	2016-01-21T00:02:37	Let me tell you, two feet of snow would just be wasted on DC. Pray the white stuff veers up to Vermont, where we make money from it.
JohnCFierce	689946468388585472	2016-01-20T23:03:51	GSK, Qualcomm rumored to form $1B med tech joint venture by StacyALawrence 
JohnCFierce	689937185869471744	2016-01-20T22:26:58	WTF? 
JohnCFierce	689915338037788673	2016-01-20T21:00:09	J&amp;J halts a depression program in the shadow of fatal French trial.  by @DamianFierce JNJ
JohnCFierce	689913637994008576	2016-01-20T20:53:23	.seetokyo Happy to fix. Looking for asst to help w/cust service &amp; more. Someone who can do demographic analysis of TR subscriber roster
JohnCFierce	689906994191306752	2016-01-20T20:26:59	He's never required a subpoena to  talk before. The big problem for pharma is getting him to shut up. 
JohnCFierce	689903973864738817	2016-01-20T20:14:59	Now that's just mean. 
JohnCFierce	689872265899569152	2016-01-20T18:09:00	Man, I'm just not getting the same biotech invitations as JacobPlieth. What did I do wrong? 
JohnCFierce	689871200038883328	2016-01-20T18:04:45	Who are the most influential people in biopharma today? (we're looking for your suggestions, answers come later) 
JohnCFierce	689856548986863616	2016-01-20T17:06:32	3 years after the fact.... 
JohnCFierce	689813353942880256	2016-01-20T14:14:54	Seeing some silly reactions to ZFGN this a.m. No trial that ends in a complete hold is a "success," and efficacy data won't lift that hold.
JohnCFierce	689804709415239680	2016-01-20T13:40:33	CELG fans, take note: Scripps team spots a new mechanism that drives Celgene's ozanimod, potential rivals 
JohnCFierce	689802258993811456	2016-01-20T13:30:49	I'd love it if this were the last thing I wrote about MartinShkreli or pricing for a while. It won't be. 
JohnCFierce	689797915330633729	2016-01-20T13:13:33	It's an actual hipster fad. I had the same reaction, but, hey, innocent fun for many. 
JohnCFierce	689782174330064896	2016-01-20T12:11:00	I wonder if they included the two patients who lost 100% of their weight in the calculation ZFGN 
JohnCFierce	689780083087822848	2016-01-20T12:02:41	About the only thing the FDA will want to talk to ZFGN about is safety. For now, the safety profile is a threat to the biotech's existence.
JohnCFierce	689779205178052608	2016-01-20T11:59:12	Crippled by 2 deaths, Zafgen says obesity drug cut weight in PhIII ZFGN up 33% 
JohnCFierce	689658149813514240	2016-01-20T03:58:10	And speaking of alien invasions and other weird doings, I see that Palin has endorsed Trump.
JohnCFierce	689657539802329089	2016-01-20T03:55:45	I recall the first time I was in DC when it snowed. Panic, much like an alien invasion, except that they are better prepared for that.
JohnCFierce	689619806488756224	2016-01-20T01:25:49	We'll know in a matter of weeks. ALKS 
JohnCFierce	689581993458274304	2016-01-19T22:55:33	I think it's great that Biden is out there demanding action on cancer combos. Promising $$, FDA action. He jumped in 3 years too late.
JohnCFierce	689580816922472448	2016-01-19T22:50:53	There's a lot out there -- even Turing! 
JohnCFierce	689574338400522241	2016-01-19T22:25:08	DanBudwick Yeah, the last time I said bring it on we had a 200-year rain storm, flooding.
JohnCFierce	689574216803467264	2016-01-19T22:24:39	If anyone can develop a safe, long-acting version of ketamine, they'll have 1 of the biggest advances for depression/suicidal thinking ever
JohnCFierce	689573614635610112	2016-01-19T22:22:16	Preclinical safety study for GLYX-13. betterthanketamine? 
JohnCFierce	689572947309256704	2016-01-19T22:19:36	So you say there's a blizzard coming to the NE? awwwwright! bring it on! moresnow!
JohnCFierce	689561664564391936	2016-01-19T21:34:46	I believe you're right 
JohnCFierce	689529236823011328	2016-01-19T19:25:55	Biotech investors could use some cheering up, so here's my latest: Big pharma’s potential M&amp;A remedy 
JohnCFierce	689519444071026688	2016-01-19T18:47:00	FYI, we're gearing up for our next annual influentials list. Nom sheet up online soon. Easily top 3 report for the year.
JohnCFierce	689463627418501123	2016-01-19T15:05:13	J&amp;J axes 3,000 jobs in bid to save $1B and revive lagging medical devices business  by EmilyWFierce
JohnCFierce	689489332411838464	2016-01-19T16:47:21	Crossovers fund a $61M round for Twist Bio, spotlighting possible IPO.  by JohnCFierce
JohnCFierce	689487389543141378	2016-01-19T16:39:38	OK, latest update on megarounds now includes Denali, thanks to lisamjarvis. We're crowdsourcing a better list. 
JohnCFierce	689483045192146944	2016-01-19T16:22:22	lisamjarvis Nope -- keep em coming, folks. Denali raised a reported $217M.  
JohnCFierce	689476504061804545	2016-01-19T15:56:23	had Fierce links to all 10 of the top 10 VC rounds worldwide. But a careful reader pointed me to off-radar $375M.  
JohnCFierce	689470356910772224	2016-01-19T15:31:57	Top 10 mega-rounds fuel record VC pace, with a distinctly ex-U.S. biotech accent -- 6 of the 10 are in Europe/China 
JohnCFierce	689460472551047168	2016-01-19T14:52:40	J&amp;J axes 3,000 jobs in bid to save $1B and revive lagging medical devices business.  JNJ via FierceMedDev
JohnCFierce	689452761084092416	2016-01-19T14:22:02	Behind the late-stage highlights, deal $$ you'll see more early-stage $$, which is focused on disease modification. 
JohnCFierce	689451622208970752	2016-01-19T14:17:30	Neuroscience is making a comeback, no question about it. 
JohnCFierce	689431172900777985	2016-01-19T12:56:15	RBC's Simos Simeonidis came up with SRPT's top 20 challenges it faces in the FDA review. Just 20? Market perform.
JohnCFierce	689422066215325696	2016-01-19T12:20:04	And in case you missed it: Eleven Bio faces cash crunch as lead drug flunks another PhIII EBIO 
JohnCFierce	689421741613953024	2016-01-19T12:18:46	Oncobiologics looks to a $115M IPO to back its biosimilars business (Everyone is waiting for Editas as a bellwether) 
JohnCFierce	689420615632052225	2016-01-19T12:14:18	Big layoffs in JNJ's device group, searching for up to $1B in annual savings 
JohnCFierce	689415747882221568	2016-01-19T11:54:57	From the midnight bureau: Acorda bags PhIII Parkinson's drug in $363M Biotie buyout ACOR BITI 
JohnCFierce	689361611937701889	2016-01-19T08:19:50	Acorda bags PhIII Parkinson's drug in $363M Biotie buyout ACOR BITI 
JohnCFierce	689259606816591873	2016-01-19T01:34:30	Cancer drugs could be re-purposed to fight Alzheimer's disease  [h/t IAmBiotech]
JohnCFierce	689241517936914432	2016-01-19T00:22:38	Interesting article in TheEconomist. Which lifesci hub do you think is no. 1? JohnCFierce 
JohnCFierce	689215000754262017	2016-01-18T22:37:15	Also, "Brooklyn" is worth it, just seeing Julie Walters' 10 minutes of screen time.
JohnCFierce	689214585895653376	2016-01-18T22:35:36	Way too young 
JohnCFierce	689214265132056577	2016-01-18T22:34:20	Watching Denzel Washington in a Training Day. Execution gets 4 stars, but not up to James Caan in The Godfather 
JohnCFierce	689157737683369984	2016-01-18T18:49:43	O tempora, O mores - Oh NYTimes, Oh UCBerkeley! 
JohnCFierce	689100782612967424	2016-01-18T15:03:24	Straight Outta Compton is a classic American success story. A few hard working guys triumph over adversity-with lots of profanity and nudity
JohnCFierce	689079937312145409	2016-01-18T13:40:34	So you've been fast-tracked? :) (I have a nephew teaching at Stanford) 
JohnCFierce	689075892522332161	2016-01-18T13:24:29	Pellets? (shudder). Wood, about half birch. Split and stacked.  
JohnCFierce	689070935371022336	2016-01-18T13:04:47	Temperature in the teens, it's snowing, wood stove roaring. We finally entered deep winter here in Vermont.
JohnCFierce	688904339952418816	2016-01-18T02:02:48	Let's hope CRISPR just fixes it. A cure beats a tiny increase in dystrophin. 
JohnCFierce	688903616472678401	2016-01-18T01:59:56	Oh, yeah, the tweet heard around the world. Even my 87-year-old mama heard about it from friends. 15 minutes of cool 
JohnCFierce	688903172769865729	2016-01-18T01:58:10	A perfectly legitimate point. Duchenne's biotechs in general have built up hopes they couldn't deliver on.  
JohnCFierce	688762363399438336	2016-01-17T16:38:38	JohnCFierce it's from Chris IMO. If Kaye in charge whole time things would be diff now. Been shareholder 3 yrs. Considering moving on.
JohnCFierce	688761222980890624	2016-01-17T16:34:06	Does anyone recall Seaside's study on Fragile X? Parents swore by it, and it didn't work. (It is possible SRPT may yet prevail in PhIII)
JohnCFierce	688760497827655682	2016-01-17T16:31:13	I don't argue that the anguish isn't heartfelt. It is powerful and SRPT's only hope. But this is not biotech. 
JohnCFierce	688759260499587072	2016-01-17T16:26:18	"you have the right to remain silent" -- and other novel thoughts for the bad boy of biotech 
JohnCFierce	688758537997152257	2016-01-17T16:23:26	It would also still be a step above the standard used to approve flibanserin
JohnCFierce	688758457948831744	2016-01-17T16:23:07	Yes, they may say it's safe, why not give it a try because the advocates are demanding it? A new, very low, standard 
JohnCFierce	688710665645744128	2016-01-17T13:13:12	SRPT's posturing offers one of the worst disconnects with FDA reality I've seen. It's only realistic hope lies with patient advocates.
JohnCFierce	688707132129173504	2016-01-17T12:59:10	Class action suit against SRPT, first of many. Sarepta and the FDA clearly weren't speaking the same language. 
JohnCFierce	688463647136329729	2016-01-16T20:51:39	At least ASH is moving to San Diego this year.
JohnCFierce	688462976555307008	2016-01-16T20:48:59	So, ASCO16 and BIO16 overlap -- weekend in Chicago, fast flight to San Fran. Why do they do these things?
JohnCFierce	688425596339109888	2016-01-16T18:20:27	Hey LifeSciAdvisors, the 1950s called and they want their models back! badbusiness 
JohnCFierce	688425886249541632	2016-01-16T18:21:36	The long view on Nasdaq/biotech. {"range":"5y","allowChartStacking":true}
JohnCFierce	688421860657115136	2016-01-16T18:05:36	JohnCFierce depends whether investors think yr2yr vs LT patience. Woodford-type strategies better than hedgies? 
JohnCFierce	688051127745691648	2016-01-15T17:32:26	SRPT - I updated my story w/ more thoughts on today’s FDA review of eteplirsen and what it means for Jan. 22 —&gt;  
JohnCFierce	688384747018563584	2016-01-16T15:38:07	Let's hope the response triggers men in biotech to positively engage in the gender equality issue diversity 
JohnCFierce	688375848987152384	2016-01-16T15:02:46	I worked on this drug when it was in PII for DED, a few questions over clinical trial strategy then biotech 
JohnCFierce	688374052684230656	2016-01-16T14:55:38	Eleven Bio faces cash crunch as lead drug flunks another PhIII EBIO 
JohnCFierce	688217812855197701	2016-01-16T04:34:47	A scene from Wall Street's biotech ghetto last week: 
JohnCFierce	688214261902934021	2016-01-16T04:20:41	JohnCFierce Just Thank You.
JohnCFierce	688199142993088513	2016-01-16T03:20:36	Background on the discovery of FAAH inhibitors.  bial
JohnCFierce	688198604347981824	2016-01-16T03:18:28	During Mon. madness THLD  - .34 - announced that it was also scrapping a PhII TH-302 study and merck kgaa was out. 
JohnCFierce	688194212240621568	2016-01-16T03:01:00	JUST because they call it intelligence ----  
JohnCFierce	688187107374804993	2016-01-16T02:32:46	I was in Dublin that winter.
JohnCFierce	688186942731599873	2016-01-16T02:32:07	Watching Black Mass - Whitey Bulger sent an arms shipment to the IRA on the Marita Ann; I covered the seizure for Time in '84. What a kick.
JohnCFierce	688168986857476098	2016-01-16T01:20:46	JohnCFierce Kudos for this story. Wonder what the male Exec "flirters" would think about their daughters following in their footsteps?
JohnCFierce	688140212682162176	2016-01-15T23:26:26	printisdead longlivedigital 
JohnCFierce	688139993638776832	2016-01-15T23:25:34	Oncobiologics' IPO is necessary for biosim strategy. It's a bold gamble in turbulent times. We talked last summer. 
JohnCFierce	688136076301488129	2016-01-15T23:10:00	Q&amp;A with Juno Therapeutics CFO Steven Harr on the AbVitro buyout and other matters:  JUNO CELG KITE NVS AZN
JohnCFierce	688126864691310592	2016-01-15T22:33:23	Eleven is a Third Rock startup, now joining the ranks of the biotechcautionarytales EBIO
JohnCFierce	688126111587237888	2016-01-15T22:30:24	EBIO headed to penny stock status on a last roll of the dice. Skunked out PhIII -57% 
JohnCFierce	688125069906726919	2016-01-15T22:26:16	daviesbj Yes, no one looks like me in Austin (which is good for Austin!)
JohnCFierce	688124153665200129	2016-01-15T22:22:37	Hipster!  Say hello to my 26-year-old daughter if you see her. Gorgeous blond, looks nothing like her dad.  
JohnCFierce	688105277074243584	2016-01-15T21:07:37	MartinEglitis JohnCFierce there haven’t been such problems w/ related drugs so either that 1 cpd or a poor trial design could be at play
JohnCFierce	688101252367003648	2016-01-15T20:51:37	adamfeuerstein JohnCFierce but the lack of diversity in most sectors, including biotech, isn't highlighted nearly enough
JohnCFierce	688092345561137152	2016-01-15T20:16:13	Thanks for the B'brg props JohnCFierce Curious to see if there's any impact for JPM17 &amp; on the board level 
JohnCFierce	688046910624690176	2016-01-15T17:15:41	yes, and don't stop there.  
JohnCFierce	688045741089140737	2016-01-15T17:11:02	I've covered the rise, fall and fierce rebound in biotech. I look forward to covering what happens next.
JohnCFierce	688044223279542274	2016-01-15T17:05:00	common sense -- what a rare commodity in biotech 
JohnCFierce	688039155834744836	2016-01-15T16:44:52	JohnCFierce FierceBiotech makes for uncomfortable but true reading!
JohnCFierce	688025022594678784	2016-01-15T15:48:42	JohnCFierce ty for highlighting issue and update on response!
JohnCFierce	688037959350796288	2016-01-15T16:40:07	Very accurate description, John, thank you.  
JohnCFierce	688031678355345409	2016-01-15T16:15:09	_rjw agree. would argue media has also played a role in the hype.
JohnCFierce	688030233103101952	2016-01-15T16:09:25	lisamjarvis companies need to be more open about their data, I feel they have misled parents of boys with DMD
JohnCFierce	688026693362139141	2016-01-15T15:55:21	JohnCFierce  If its Bial likely their FAAH inh and compound specific toxicity as both Pfizer and Merck have safely tested their FAAH inh
JohnCFierce	688024441197047809	2016-01-15T15:46:24	Huge response to this JPM16 story. Thanks to all.  Note to party planners: Be careful how you step at JPM17 
JohnCFierce	688014775289249794	2016-01-15T15:07:59	MRK is mad about Merck, KGaA, Darmstadt, Germany, Earth's rebrand  
JohnCFierce	688013434445758464	2016-01-15T15:02:40	SRPT down 58%.
JohnCFierce	688010581312417798	2016-01-15T14:51:19	Botched drug trial leaves one patient 'brain-dead,' 5 hospitalized  
JohnCFierce	688009378650284032	2016-01-15T14:46:33	Drug trial mishap leaves one patient 'brain-dead,' 5 hospitalized 
JohnCFierce	688007873830465536	2016-01-15T14:40:34	Now that would be an interesting story :) 
JohnCFierce	688007395805675521	2016-01-15T14:38:40	The review boxes the FDA's outsiders into a neg. position. There's no room to move here.
JohnCFierce	688006852173508610	2016-01-15T14:36:30	It's curious, I'll give you that. But beats me what the deal is.  
JohnCFierce	688004809031565312	2016-01-15T14:28:23	Brutal. Shows just how far apart the FDA and a biotech can be with the data. 
JohnCFierce	688001911870648320	2016-01-15T14:16:52	Sarepta shares crash on a harsh FDA review of Duchenne's drug SRPT 
JohnCFierce	687999750864531456	2016-01-15T14:08:17	They're pretty much saying the data could have been skewed, suggesting that it was 
JohnCFierce	687999261141790720	2016-01-15T14:06:20	SRPT down 52% -- what a disaster
JohnCFierce	687996560785944576	2016-01-15T13:55:37	“(T)he clinical course of the 12 patients participating in Study 201/202 appears to be within the expected natural history of DMD.”
JohnCFierce	687993132168921088	2016-01-15T13:41:59	patients in Study 202 appeared to be receiving optimal care, including intensive physical therapy and intensive steroid regimens.
JohnCFierce	687992793004961792	2016-01-15T13:40:38	No conclusions from FDA, but they're essentially saying the data is a mess, what do you think? to the panel.  
JohnCFierce	687989740403048449	2016-01-15T13:28:31	A lot of this data on eteplirsen is useless without a placebo arm comparison. Fancy that.
JohnCFierce	687988635862458369	2016-01-15T13:24:07	Did I say the eteplirsen data was messy?  
JohnCFierce	687985729742487552	2016-01-15T13:12:34	SRPT briefing docs come early -  BRMN
JohnCFierce	687985437554688000	2016-01-15T13:11:25	JohnCFierce also, classic yeezus this morning said he met w/mgmt and 'the key here is that US DMD is a very small population'...
JohnCFierce	687980040735297536	2016-01-15T12:49:58	Funny how some analysts covering BMRN went from a coin toss on the FDA decision to being COMPLETELY unsurprised by CRL. Way to go, guys.
JohnCFierce	687796514081472514	2016-01-15T00:40:42	Thanks for highlighting this appalling behaviour JohnCFierce Not the first time  
JohnCFierce	687783527425961984	2016-01-14T23:49:05	Lack of women at jpm has always been disconcerting. JohnCFierce story even more disturbing 
JohnCFierce	687780107012812800	2016-01-14T23:35:30	juliacowens JohnCFierce LifeSciVC was surprised.  i went to several JPM parties last year with  "hostess"models and no female colleagues.
JohnCFierce	687766561189412864	2016-01-14T22:41:40	As I was saying, ketamine for suicidality...Turing (a martinshkreli idea) 
JohnCFierce	687761043477671937	2016-01-14T22:19:45	KapellerRosana LifeSciVC JohnCFierce Right!?! How about making an extra effort to reach out to female leaders to invite them instead?
JohnCFierce	687760168147271681	2016-01-14T22:16:16	Appalling. Can't believe that the way to solve the shortage of women at JPM is to hire models@JebKeiper LifeSciVC JohnCFierce
JohnCFierce	687750413433630720	2016-01-14T21:37:31	CMRX failed a critical P3 but apparently 65% of corp goals were achieved.Trial was only 35% looks like 
JohnCFierce	687747782707408896	2016-01-14T21:27:03	ICYMI: Celgene chief Bob Hugin ponders a new era for neurodegeneration R&amp;D CELG 
JohnCFierce	687742638963884032	2016-01-14T21:06:37	Not my experience at jpm16 - but I skipped that unfortunate event on principle.   
JohnCFierce	687738288711561216	2016-01-14T20:49:20	NIH urged to 'break taboo' against using its power to bypass drug patents:  pharma
JohnCFierce	687732246367858688	2016-01-14T20:25:19	Memantine for Alzheimer's is like 'Special K' Lite...but doesn't work in depression . Complex 
JohnCFierce	687732766977462272	2016-01-14T20:27:23	So you can own a trial design? There's some kind of secret sauce? 
JohnCFierce	687729246068961280	2016-01-14T20:13:24	JohnCFierce brentlsaunders That trial design (sequential parallel comparison; SPCD) gr8 for dz w/hi placebo resp. Well known, rarely used.
JohnCFierce	687725667467792385	2016-01-14T19:59:11	So nobody jump off a bridge or anything. Buck up. 
JohnCFierce	687725177505996800	2016-01-14T19:57:14	That's true. And happy to see it. It's been a slow, grueling slog for years now. Hoping we've turned a corner 
JohnCFierce	687723824696135684	2016-01-14T19:51:51	brentlsaunders Are you familiar with the 5461 study design? Re-randomized non responders in the placebo arm? It's intriguing
JohnCFierce	687722968873611264	2016-01-14T19:48:27	AKA GLYX-13, an NMDA drug from Naurex. Very promising, closely watched. popsalks and I were discussing at JPM16 
JohnCFierce	687715387094482945	2016-01-14T19:18:20	Why are pols so fixated on cancer R&amp;D? 2 years, some cash and the feds could revolutionize Duchenne's. CRISPR 
JohnCFierce	687712674268987393	2016-01-14T19:07:33	hysteria?  
JohnCFierce	687702348924231680	2016-01-14T18:26:31	JohnCFierce as a senior and single woman in biotech I actually love JPM16!  Sometimes good to stand out and not blend in w the suits!
JohnCFierce	687708957973082112	2016-01-14T18:52:47	katieksoh I find that bad behavior hates to get called out. That's the ticket.
JohnCFierce	687708028947140608	2016-01-14T18:49:05	As a woman, what do you do?Stay in biotech&amp;subject yourself 2 this kind of behavior?Or refuse 2 put up w it&amp;get out? 
JohnCFierce	687705854167003136	2016-01-14T18:40:27	JohnCFierce That was one of the strangest parties I have even been to!
JohnCFierce	687703231250731008	2016-01-14T18:30:01	Just got a note from a CEO about my story on women at JPM16. I'm thinking you might not see the models next year.
JohnCFierce	687702421041197056	2016-01-14T18:26:48	AF_biotech It's also a bit of a minefield. Treasure hunters mixed with academics and serious R&amp;D execs. Interesting topic. ketamine
JohnCFierce	687701345076293632	2016-01-14T18:22:32	dnajd JohnCFierce Like so many things, it's heterogeneous… JLABS has a strikingly great female team JNJInnovation
JohnCFierce	687701372645568512	2016-01-14T18:22:38	AdamSinger mugatushair The downside, and it's huge, is that the drug blasts the brain, triggering multiple side effects. ketamine
JohnCFierce	687699126713094144	2016-01-14T18:13:43	RT it's tough out there! JPM16 "JohnCFierce: Biotech has a problem with women? Or is it the other way around? …"
JohnCFierce	687699477457711106	2016-01-14T18:15:06	AdamSinger mugatushair Very useful as a rescue drug for suicide, severe depression. If a version could be used on a prolonged basis, wow.
JohnCFierce	687696766809042944	2016-01-14T18:04:20	Ketamine is an obsession of mine -- Johns Hopkins flags another possible successor to 'Special K' for depression 
JohnCFierce	687695287616466944	2016-01-14T17:58:27	Right now the pressure on the FDA to approve a troublesome eteplirsen has to be amped up to the max. SRPT What fun!
JohnCFierce	687675642310168576	2016-01-14T16:40:24	Girls' interest in STEM is growing, but they need more role models &amp; male supporters. Men, think of your daughters. 
JohnCFierce	687673351314116608	2016-01-14T16:31:17	Ugh. But thanks for bringing it up JohnCFierce 
JohnCFierce	687663777542725632	2016-01-14T15:53:15	Celgene chief Bob Hugin ponders a new era for neurodegeneration R&amp;D CELG 
JohnCFierce	687656776100085760	2016-01-14T15:25:26	Biotech has a problem with women? Or is it the other way around? 
JohnCFierce	687639055778070528	2016-01-14T14:15:01	FDA slaps down BioMarin's Duchenne's drug as rival nears a moment of truth BMRN SRPT 
JohnCFierce	687632907192631297	2016-01-14T13:50:35	I'll be tuning in. 
JohnCFierce	687632432833675264	2016-01-14T13:48:42	Post-restructuring, Biogen's top execs are back in the R&amp;D talent hunt BIIB 
JohnCFierce	687632139542736901	2016-01-14T13:47:32	Chances of an approval for eteplirsen are higher, though it won't be a cakewalk. One of the most interesting panels of the year coming up.
JohnCFierce	687629958127161345	2016-01-14T13:38:52	It had to happen. BMRN CRL 
JohnCFierce	687629704216494080	2016-01-14T13:37:51	BMRN..FDA Issues CRL for KyndrisaTM for Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping. 
JohnCFierce	687480188372922369	2016-01-14T03:43:44	JohnCFierce Vivek's domicile has a lower tax rate. And it's warmer.
JohnCFierce	687476330343051264	2016-01-14T03:28:24	Bought a Power Ball ticket. I'll be spending part of my fortune moving to a lower tax domicile. Maybe I should give Ian Read a ring?
JohnCFierce	687475799981731840	2016-01-14T03:26:18	Here I be. Sitting next to the wood stove in Vermont. From San Francisco hotel room to the casa in only 16 hours. Not bad.
JohnCFierce	687261066175352832	2016-01-13T13:13:01	Generic drug shortages and price hikes are being enabled by the FDA: 
JohnCFierce	687144050718195712	2016-01-13T05:28:02	Well, I'll have to get up tomorrow at 3:30 am to make my flight to NYC, but at least I won't be flying United. neverflyunited
JohnCFierce	687068395947175936	2016-01-13T00:27:25	No. Really? (and if it isn't? He's been holding that lollipop up for years.) 
JohnCFierce	686989053443506176	2016-01-12T19:12:08	When has Pfizer ever won an R&amp;D marathon in the last decade?  PFE
JohnCFierce	686985337915088896	2016-01-12T18:57:22	PFE IO strategy: "Going to be a leading player in 2nd wave of combos." launched 6 combo studies (3 in PhI/II, 3 PhIII). jpm16
JohnCFierce	686971033983713280	2016-01-12T18:00:32	Big Data shoutout: atulbutte, David Glazer google, Michael Pellini, Anthony Philippakis broadinstitute, and Matthew Trunnel at The Hutch
JohnCFierce	686909803952603136	2016-01-12T13:57:14	Bursatilbiotech Pero, hablo poquito Espanol. Vivi in Mexico hace muchos anos, y mi madre es de Argentina. (OK, probably not so well)
JohnCFierce	686888940091998208	2016-01-12T12:34:19	Likely to stay that way. The news flow is primarily ahead of JPM16 leading into Monday.  
JohnCFierce	686780423523794944	2016-01-12T05:23:07	Thanks, Richard. Always a treat. 
JohnCFierce	686665682461696000	2016-01-11T21:47:10	Merck buys out IOmet, adding new immuno-oncology tech MRK JPM16 
JohnCFierce	686656044605386752	2016-01-11T21:08:53	Reminds me of the time my father got drunk and tried to speak Spanish to Greek waiters. whatwehavehereis... 
JohnCFierce	686642042433323008	2016-01-11T20:13:14	JohnCFierce no, you'd give your left arm if you asked him a tough question :-)
JohnCFierce	686641933888847872	2016-01-11T20:12:48	There's a distinct tone of pro scorn about Sean Penn's El Chapo piece. All of the critics would have given their left arm for that interview
JohnCFierce	686618761453899776	2016-01-11T18:40:44	Sounds right. Deal fest in San Francisco while IBB takes an ugly 5% drop. Bon chance to you stock guys; off to a rough start at JPM16
JohnCFierce	686605647870230528	2016-01-11T17:48:37	The occasional mistake is a sure sign of authenticity. brentlsaunders
JohnCFierce	686604200675950592	2016-01-11T17:42:52	JohnCFierce megtirrell ScottWapnerCNBC CNBC good catch!  My sister's name is "Reed".  Just habit...
JohnCFierce	686604018492129280	2016-01-11T17:42:09	Um, should I point out he misspelled Read's name?   
JohnCFierce	686601423291744256	2016-01-11T17:31:50	Had a great chat with Elias Zerhouni about innovation. Really enjoyed it. Story tomorrow. SFY.
JohnCFierce	686581802488565761	2016-01-11T16:13:52	CELG Mark Alles promoted to CEO effective 03/01
JohnCFierce	686566477223219202	2016-01-11T15:12:58	JohnCFierce Yes, but at my hotel, the $500 rate upgrades you to enjoy construction/plumbing noises ALL NIGHT LONG.
JohnCFierce	686565698835886081	2016-01-11T15:09:53	Gotta love San Fran at JPM16, where else can you get a $200 hotel room for only $500?
JohnCFierce	686563481542377472	2016-01-11T15:01:04	SHP shares down &gt;5%, at lowest since Oct. 2014
JohnCFierce	686556326797811713	2016-01-11T14:32:38	January madness, biotech style.  
JohnCFierce	686538213285048320	2016-01-11T13:20:39	Congrats to SurfaceOncology and Novartis on new $170M  oncology partnership! Great piece on it by JohnCFierce - 
JohnCFierce	686539648034684929	2016-01-11T13:26:22	JUNO buys AbVitro for $125M, how to fit it in? JPM16 deal a minute. Are we up to 8.5 yet, ya'll? 
JohnCFierce	686533461356630016	2016-01-11T13:01:47	ONTY Robert Kirkman to Retire as Director, President and CEO 
JohnCFierce	686531187133661184	2016-01-11T12:52:44	Got biotech news? Hang on to it until tomorrow. JPM16
JohnCFierce	686530873848545280	2016-01-11T12:51:30	Shire finally gets it done, bagging Baxalta in $32B buyout SHPH BXLT JPM16 
JohnCFierce	686526318700187648	2016-01-11T12:33:24	It's a deal - SHPG BXLT - right on schedule, sort of -- 
JohnCFierce	686525955297284098	2016-01-11T12:31:57	SHPG  to Combine with BXLT
JohnCFierce	686518406581846016	2016-01-11T12:01:57	And this: Sanofi drops option, inks $750M R&amp;D collaboration with Warp Drive Bio 
JohnCFierce	686518253015793667	2016-01-11T12:01:21	And this: The Bradner factor: Roche bags a BET inhibitor in $535M Tensha buyout JPM16 
JohnCFierce	686518100741591040	2016-01-11T12:00:44	From the midnight bureau at Fierce: Novartis provides $170M to kick off Surface Oncology partnership NVS JPM16 
JohnCFierce	686517748940185600	2016-01-11T11:59:20	So, hmmm, I wonder what Elias Zerhouni wants to talk about at our upcoming interview. SFY
JohnCFierce	686513982761336832	2016-01-11T11:44:22	Sanofi commits €400M in second cancer R&amp;D deal with Innate Pharma SFY jpm16 
JohnCFierce	686431100453826560	2016-01-11T06:15:02	Novartis provides $170M to kick off Surface Oncology partnership NVS jpm16 
JohnCFierce	686427397948715010	2016-01-11T06:00:19	Sanofi drops option, inks $750M R&amp;D collaboration with Warp Drive Bio jpm16 
JohnCFierce	686425890369093632	2016-01-11T05:54:20	8.5 
JohnCFierce	686417698373275648	2016-01-11T05:21:46	We're just getting started with the late show at fiercebiotech. Stay tuned. JPM16
JohnCFierce	686417064446169088	2016-01-11T05:19:15	Accelerator's second NYC biotech startup sets out with $17M and some Gates-backed science by @DamianFierce  
JohnCFierce	686414431476056067	2016-01-11T05:08:48	Congratulations to jaybradner who sent out "tool" compound JQ1 to &gt;500 labs - including mine - without an MTA!  
JohnCFierce	686412487541960704	2016-01-11T05:01:04	The Bradner factor: Roche bags a BET inhibitor in $535M Tensha buyout jaybradner 
JohnCFierce	686253887247003649	2016-01-10T18:30:51	@DamianFierce Overheard at El Chapo's lair: "I don't prefer to chop off my enemies' heads, but it's the only way I can really make a point."
JohnCFierce	686249782378164225	2016-01-10T18:14:32	Yes! Exactly! I'm not an investor!  
JohnCFierce	686228134925066240	2016-01-10T16:48:31	And BTW, that last tweet was not a tip about an upcoming public co. buyout with a big upside for small investors. Sorry, guys.
JohnCFierce	686225283788214273	2016-01-10T16:37:11	Waiting for my Virgin American flight, writing stories for tonight's midnight showing of FierceBiotech
JohnCFierce	686224928115404801	2016-01-10T16:35:46	neverflyunited 
JohnCFierce	686224123035545600	2016-01-10T16:32:35	JormaStarratt Tarantino loves to linger on a scene. Like he can't let go.
JohnCFierce	686194551699206145	2016-01-10T14:35:04	Just found the link to the JPM16 webcasts &amp; agenda. ICYMI 
JohnCFierce	686183516435017728	2016-01-10T13:51:13	Caught Hateful 8 in the Lower East Side last night. A crafted, crude, unintentional comedy. Riotous.
JohnCFierce	685916292419825664	2016-01-09T20:09:22	michael_gilman ScripMandy JohnCFierce Not I. I don't think that at all!
JohnCFierce	685915647235244032	2016-01-09T20:06:48	WilliamGerber1 ScripMandy Not saying people can't be motivated by the greater good. But when that's all you talk about, it sounds phony.
JohnCFierce	685893351145517056	2016-01-09T18:38:12	JohnCFierce michael_gilman I think if there was no angle for investors in biotech there would never had been a Genentech.
JohnCFierce	685892524548976640	2016-01-09T18:34:55	michael_gilman It neglects the broader reality and invites public scorn. That's a very real issue.
JohnCFierce	685891857822408704	2016-01-09T18:32:16	And if it was just all about patients, does anyone think that malaria would still be killing people in droves?
JohnCFierce	685891326303432706	2016-01-09T18:30:10	michael_gilman It's the financial upside that brings in the investors. If investors just want to help people, they can give $$ to charity.
JohnCFierce	685888889979011072	2016-01-09T18:20:29	And please stow all the chatter about how this is all for patients, like you work for the Catholic Church.  
JohnCFierce	685641101072535553	2016-01-09T01:55:51	which by definition includes the legislature. 
JohnCFierce	685577394804121600	2016-01-08T21:42:42	One final note to end the week. Stock prices are one significant factor in the overall health of biopharma. But they're not the only one.
JohnCFierce	685576316251418624	2016-01-08T21:38:25	I'll be traveling to $JPM16 and three days of interviews, a sold out executive breakfast (500+) and some festive occasions. Good times :)
JohnCFierce	685487865892081665	2016-01-08T15:46:57	And from the dawn patrol:  Zymeworks bags a $61.5M round, with a merger on tap and an IPO in view 
JohnCFierce	685487663185571841	2016-01-08T15:46:09	Mylan bets $245M on a 50/50 biosimilar development pact with Momenta MNTA MYL 
JohnCFierce	685467593948446720	2016-01-08T14:26:24	Along with repeated reassurances about past reassurances about future data. 
JohnCFierce	685400435520311296	2016-01-08T09:59:32	Zymeworks bags a $61.5M round, with a merger on tap and an IPO in view 
JohnCFierce	685304987484815360	2016-01-08T03:40:16	Busy week ahead for pharma, all roads lead to JPM16 SFO ... big deals, big CEOs...bests to those at ground zero!
JohnCFierce	685241098873143296	2016-01-07T23:26:23	FiercePharmaAsia is the source for Asia-Pac biopharma news. Join biopharma leaders and get FiercePharmaAsia free! 
JohnCFierce	685240553546493952	2016-01-07T23:24:13	JohnCFierce agree, it's the best one (close 2nd is Billy Madison).
JohnCFierce	685240429781061634	2016-01-07T23:23:44	AdamSinger Happy Gilmore. A classic. My son, now 29, and I laughed our asses off.
JohnCFierce	685239864741236737	2016-01-07T23:21:29	My youngest daughter is checking out Adam Sandler movies! Recent! Nooooooo!
JohnCFierce	685192117073805312	2016-01-07T20:11:45	Shire, Baxalta to announce merger as soon as Monday - sources  [h/t SashaDamouni]
JohnCFierce	685190147302928384	2016-01-07T20:03:55	Interim CEO Schiller tells bydavidcrow VRX will shun "sharp" price increases and deals while de-levering in 2016: 
JohnCFierce	685171108358787072	2016-01-07T18:48:16	NWBO ... ?
JohnCFierce	685150705217331201	2016-01-07T17:27:12	Thanks to those that have helped us make our JPM16 reception/ party list more complete   See you at the clock!
JohnCFierce	685150743574245376	2016-01-07T17:27:21	David Pyott joins board of BioMarin Pharmaceutical BMRN 
JohnCFierce	685150372965560321	2016-01-07T17:25:53	Third Rock Ventures names former Cubist CEO Mike Bonney as partner  
JohnCFierce	685118809515122688	2016-01-07T15:20:27	After Monday morning I'm not expecting much news of note. I might be wrong, but theme is get out early, stay ahead 
JohnCFierce	685117226542841857	2016-01-07T15:14:10	Essential disconnect with the small investor crowd. I don't do stock predictions. Never have, never will. 
JohnCFierce	685115644895965184	2016-01-07T15:07:53	It's all happening so fast --Alector raises $29M; NextCure launches with $67M; Pfizer leads $15M round for Cortexyme 
JohnCFierce	685101978289106944	2016-01-07T14:13:34	Dynavax shares shoot up as hep B PhIII vaccine blasts by rival GSK DVAX GSK 
JohnCFierce	685084352548585474	2016-01-07T13:03:32	J&amp;J's global deals team pursues a cure for hep B in latest partnering frenzy JNJ 
JohnCFierce	685062130979180544	2016-01-07T11:35:14	From the midnight bureau: Dana-Farber spinout C4 tackles protein degradation with $73M round, $750M Roche deal 
JohnCFierce	685057010467901440	2016-01-07T11:14:53	Taking a step back from daily sentiment, some long term context for biotech today: "This Time May Be Different" 
JohnCFierce	684963338539917312	2016-01-07T05:02:40	Dana-Farber spinout C4 tackles protein degradation with $73M round, $750M Roche deal in hand 
JohnCFierce	684889240967090176	2016-01-07T00:08:14	Singapore's ASLAN expands licensing pact with Spain's Almirall  FiercePharmAsia
JohnCFierce	684802471609368576	2016-01-06T18:23:26	So cool, FierceBiotech went over the 50K mark. I love it. Big thanks to @DamianFierce
JohnCFierce	684801148486811648	2016-01-06T18:18:11	Wake me up when a deal actually happens. 
JohnCFierce	684770320809615360	2016-01-06T16:15:41	Fledgling Vtesse grabs a 'breakthrough' title at FDA for rare disease drug 
JohnCFierce	684749506445971456	2016-01-06T14:52:59	We need a few new eye-catching techniques on Twitter. GOSSIPNOW! SHAZAM! NOT NEWS BUT YOU'LL TALK ABOUT IT ANYWAY 
JohnCFierce	684723549244928001	2016-01-06T13:09:50	Vtesse gets a BTD on Niemann Pick drug -- 
JohnCFierce	684718134633328640	2016-01-06T12:48:19	And if we forget to slap ourselves, I'm sure adamfeuerstein will do the honors. :)
JohnCFierce	684717085927325696	2016-01-06T12:44:09	We should all slap ourselves once or twice a day, hard, until JPM16 is over. dontbegiddy 
JohnCFierce	684713313469517825	2016-01-06T12:29:09	Pretty cool that this is still trending: The biggest winners--and losers--in the 2015 race for new drug approvals 
JohnCFierce	684712456334217216	2016-01-06T12:25:45	Strike two: Gilead chalks up another setback for top pipeline prospect simtuzumab GILD NASH fibrosis 
JohnCFierce	684706327948570624	2016-01-06T12:01:24	Michelle dipp, one of a handful of female Boston area biotech CEOs, to step aside at OvaScience OVAS as of July 
JohnCFierce	684707973353095168	2016-01-06T12:07:56	Biogen backs Rodin's Alzheimer's efforts in a $500M deal BIIB @DamianFierce  
JohnCFierce	684707756167790596	2016-01-06T12:07:04	Merck bets up to $595M on Quartet's chronic pain pipeline MRK @DamianFierce  
JohnCFierce	684698836745469952	2016-01-06T11:31:38	It occurred to me that I should drop my editor title and change it to writer with executive producer credit. Old print titles are confusing.
JohnCFierce	684695378860597248	2016-01-06T11:17:54	Accelerator's $48M biotech project looks to spark the NYC startup scene by @DamianFierce  
JohnCFierce	684419002739863552	2016-01-05T16:59:40	Not surprising to see Sanofi bow out of Afrezza deal. Awful product; expensive pact never made sense. MKND=kaput 
JohnCFierce	684359406797111297	2016-01-05T13:02:52	Annapurna adds three new gene therapy programs from Ron Crystal's lab at Weill Cornell 
JohnCFierce	684349393353441282	2016-01-05T12:23:04	Biotechs launch an IPO blitz as Nasdaq stumbles out of the gate 
JohnCFierce	684345519800451072	2016-01-05T12:07:41	Ann Arbor biotech upstart grabs $62M round and a PhII drug from AstraZeneca.  by JohnCFierce AZN
JohnCFierce	684189075214065664	2016-01-05T01:46:01	BosBizDon portefeuillefun Syndax was aimed at this ever since they scrapped IPO number 1. 
JohnCFierce	684187077324353536	2016-01-05T01:38:05	JohnCFierce hoping it doesn't happen. bxlt seems keen to make oncology deals. xbi will lose oncology deal maker if shpg deal goes thru
JohnCFierce	684184415736606720	2016-01-05T01:27:30	I would agree with that. 
JohnCFierce	684181342108684288	2016-01-05T01:15:18	BXLT is a bit of a puzzler. In a normal world, it's a done deal. But that deal today, it looks weird. 
JohnCFierce	684180878369632256	2016-01-05T01:13:27	You'll know when JPM gets to be a down. Optimism will reign, but the smiles are crooked. :)
JohnCFierce	684180370569474049	2016-01-05T01:11:26	jq1234t This early in the week, maybe 7. Ended up a 9. For the record, I'm a writer. I'll cover the ups, and the downs. This is still an up
JohnCFierce	684179224173883392	2016-01-05T01:06:53	It's what I've been saying. Never. Fly. United. 
JohnCFierce	684179058805096453	2016-01-05T01:06:13	13 years of writing FierceBiotech :) 
JohnCFierce	684178113220194304	2016-01-05T01:02:28	Cambridge is a big player, but geography doesn't really mean much, as such. We have to lose the hub mentality. 
JohnCFierce	684169933253685248	2016-01-05T00:29:58	We're starting a super hot week for biotech. Record level deals coming up. I promise. Scale of 1 to 10. An 8.5.
JohnCFierce	684159636342095872	2016-01-04T23:49:03	SIX new US biotech IPO filings today: Reata wants up to $80m; Syndax, Audentes &amp; Bavarian Nordic $86.25m each, Editas $100m &amp; Corvus $115m.
JohnCFierce	684151803110281216	2016-01-04T23:17:55	So we're right at the #500 cutoff for next week's JPM16 event. Personal requests only after this point.
JohnCFierce	684139273902252033	2016-01-04T22:28:08	Gene-editing start-up Editas, helmed by ksbosley, files to go public:  Company developing Crispr-Cas9 drugs.
JohnCFierce	684146201931956224	2016-01-04T22:55:40	Damn, man. Sorry to hear it.  
JohnCFierce	684142565889851392	2016-01-04T22:41:13	The other ironic point? Briggs Morrison has a great reason not to talk to me directly. :) SNDX AZN
JohnCFierce	684142249681252352	2016-01-04T22:39:57	Here come the big biotech IPO tests. (But Reata? Eek.) 
JohnCFierce	684048724755091456	2016-01-04T16:28:19	Reliably informed there's a 2-month overlap, Fishman remains President NovartisScience until March 1 h/t rymcbr 
JohnCFierce	684041068095107073	2016-01-04T15:57:54	The deep hole that Pfizer has dug for itself: 
JohnCFierce	684039918847442944	2016-01-04T15:53:20	Syndax aligns with Merck KGaA and Pfizer on an immuno-oncology combo project by @DamianFierce  
JohnCFierce	684020855425363968	2016-01-04T14:37:35	Can laquinimod get any worse? The answer, evidently, is yes. 
JohnCFierce	684019931290152965	2016-01-04T14:33:54	Essential for JPM16 planning.  
JohnCFierce	684011788459982851	2016-01-04T14:01:33	The biggest winners--and losers--in the 2015 race for new drug approvals (19-year high on drug OKs) 
JohnCFierce	683983478547984384	2016-01-04T12:09:03	Hello, JPM16 Baxalta signs off on a $1.6B checkpoint pipeline deal as Shire buyout simmers 
JohnCFierce	683981230694621184	2016-01-04T12:00:07	Scholar Rock bags $36M to fuel muscle-wasting drug program, first clinical study 
JohnCFierce	683808263096430592	2016-01-04T00:32:49	Hat's off to the Globe staff. Spunky. Caring. But why are so many media companies making such brain dead moves? It's not that hard.
JohnCFierce	683786100947726336	2016-01-03T23:04:45	Very smart people. One of the best CEOs in the biz. 
JohnCFierce	683456618583973888	2016-01-03T01:15:30	JohnTuckerPhD JohnCFierce the dose makes the drug
JohnCFierce	683453930303406082	2016-01-03T01:04:49	JohnCFierce No surrogate endpoints John.  We're looking for a clinically meaningful impact on Overall Sobriety
JohnCFierce	683435471477805057	2016-01-02T23:51:28	And remember, using the scientific method, the bigger the numbers, the better the data. beer 
JohnCFierce	683411390489575425	2016-01-02T22:15:47	Last year's resolution. Never. Fly. United. Remains in force.
JohnCFierce	683411134607659012	2016-01-02T22:14:46	I finally came up with a New Year's resolution to live by. No more plastic sacks at the store. Ever. And I'm going to test more craft beers.
JohnCFierce	683291481914912769	2016-01-02T14:19:18	My only criticism would be that the story doesn't adequately clarify the new approval process for cancer drugs compared to other diseases.
JohnCFierce	683291207368327168	2016-01-02T14:18:13	Want some insights into what's driving Richard Pazdur/cancer drug OKs at the FDA? Read this from the nytimes 
JohnCFierce	683089637192155136	2016-01-02T00:57:15	I'd like to think that I could get through all of 2016 w/o some BS list of "must-follow" Twitter streams. I know I'm dreaming.
JohnCFierce	682986565732319232	2016-01-01T18:07:41	Happy New Year bradloncar JohnCFierce AdamSinger fezziwig2008 schenectady2 Great year coming! Be seeing you guys at ASH16! :)
JohnCFierce	682946398023716865	2016-01-01T15:28:04	Shkreli as Kylo Ren? Fun stuff on the bad boy of pharma and why we should all care about what comes next. 
JohnCFierce	682746324618473472	2016-01-01T02:13:03	The Revenant is a good novel, but it's not a revenge tale, it's a survival story. In that respect Michael Punke succeeds quite well.
JohnCFierce	682674546906890241	2015-12-31T21:27:50	Quietest final week of the biotech year ever. Here's to a hot and happening' start to 2016 -- Happy New Year, and all that.
JohnCFierce	682388658381570049	2015-12-31T02:31:48	Yes, good point. Wonder how much really good stuff is under the blanket right now. 
JohnCFierce	682200266486108160	2015-12-30T14:03:12	dhovekamp42 Pre-Christmas, Dieter. And no, not missed
JohnCFierce	682197451818708992	2015-12-30T13:52:01	Usually we get a few nice deals to round out the end of the biotech year. All I'm seeing so far is forensic reporting. CMRX, AVXL, KBIO
JohnCFierce	682190899384725504	2015-12-30T13:25:59	KaloBios files for bankruptcy in the shadow of Shkreli's arrest.  by @DamianFierce KBIO
JohnCFierce	681964568139141120	2015-12-29T22:26:37	SNY reports 22.6% stake in REGN
JohnCFierce	681848524410089473	2015-12-29T14:45:31	Alzheimer's player Anavex reveals SEC probe, shares dive (and they buried it deep) AVXL 
JohnCFierce	681577534538960896	2015-12-28T20:48:41	"It's a kid, and the gun is probably a fake" 911 call on Tamir Rice. At the very least his death was negligent. No indictment is disgraceful
JohnCFierce	681601497692520448	2015-12-28T22:23:55	Risky bidness: Chimerix shares crash as antiviral flops and deaths spike in first PhIII challenge CMRX 
JohnCFierce	681573307272052736	2015-12-28T20:31:54	Which format was it? They're beta testing a few new things and we're collecting responses. I appreciate the feedback 
JohnCFierce	681518199888818177	2015-12-28T16:52:55	Editor's Picks: The Best of TimmermanReport from  Year 1 
